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INTRODUCTION - HISTORY AND BACKGROUND

Atherosclerosis:

Pathogenesis and Etiology

The World Health Organization (1) defined atheroscle

rosis as "a variable combination of changes of the intima

of arteries consisting of the focal accumulation of lipids,
complex carbohydrates, blood and blood products, fibrous

tissue and calcium deposits and associated with medial
changes. "

Thus, the ma jor characteristic aspect of the

disease is thickening of the arterial walls caused by de
position of various lipid substances.

Both human and

animal, and experimental atherosclerosis have been studied

and described for many years (2, J), however, only in the
last twenty years have experimental techniques made pos

sible detailed pathological and biochemical descriptions
of the atherosclerotic lesion and its development.

The consequences of atherosclerosis may be extremely

severe since it contributes to or aggravates several other
diseased states.

Atherosclerotic disease is an almost

universal affliction and its occurrence and intensity in

crease with increasing age of the victim.

The ma jor

results of the disease include possible bursting of the
artery walls, proliferation of arterial tissues causing

blockage of the artery or the induction of clotting which

may interfere with or stop normal blood flow (4).

Addi

tionally, narrowing of the arterial lumen may cause an
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ischemic reduction of blood flow to an organ or an occlud
ing plaque may become dislodged and later become trapped

in a vessel or artery causing myocardial or cerebral
infarct (5),

The time required to develop such a condition

is measured in years or decades but the resulting accident
which may lead to death takes place over a period of
seconds.

Often, death due to atherosclerosis is premature

since at the time of death the unaffected bodily organs

are usually functioning well and could have been expected

to continue to do so for several more years (4).

There

fore, a cure or at least an inhibition which would retard

the progress of this disease would be expected to increase
the life expectancy of the victim.

In the large elastic arteries atherosclerosis appears

to begin as a focus where the innermost layers of the

artery wall exhibit indications of damage followed by
growth and repair of the tissue (4).

The repair processes

usually include cell proliferation and the production of
new fibrous tissue,

This very early lesion does not

contain abnormal quantities of lipids.

Soon after the initiating event the first ma jor type

of lesion, the fatty streak, begins to develop.

This is

a flat intimal lesion which stains with the lipid stain

Sudan IV and causes very little obstruction of blood flow

(5),

The predominant cell in the lesion is the modified

smooth muscle cell, which is elongated, has a central

nucleus, and contains longitudinally arranged myofilaments

in the cytoplasm (6).
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In human fatty streaks fat droplets

begin to accumulate in these smooth muscle cells to such

an extent that the cell becomes filled with lipid and is
called a foam cell (4, 7),

Most of the lipid enters through

junctions between the endothelial cells or, perhaps, by

pinocytosis (8).

Esterified cholesterol is the major and

triglycerides are the minor component of these lipids.

As the accumulation of fat in this lesion continues

more foam cells appear.

This process continues until some

foam cells in the center of the lesion die, perhaps from

anoxia.

The intima and inner media of the aorta obtain

oxygen by means of diffusion from the lumen (6).

Any

factor which causes interference with oxygen diffusion

(such as proliferation of cells or accumulation of lipid)
may inhibit respiration of the foam cells.

It is there

fore reasonable to suggest that continued lipid deposition
may contribute to oxygen starvation of the cells in the

developing lesion, resulting in death and necrosis of the
cells.

This is supported by the observation that hypoxia

increases susceptibility to atherosclerosis while high

oxygen tension appears to protect against the process (6).

The lipid released from dying foam cells begins devel

opment of fibrous plaques, the second major type of
atherosclerotic lesion.

This is a firm lesion which con

tains a fat base covered by a layer of fibrous connective
tissue (5),

Since this is a raised lesion it may cause

some obstruction of blood flow.

The lipid portion which
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is released from foam cells contains amorphous cholesterol,

some cholesterol crystals, triglycerides, phospholipids,
and steroids (4).

The cells around this deposit are

irritated by the cellular lipid debris and respond by pro

liferation to form a thick, fibrous cover over the lesion.
The extracellular fat may be phagocytized by macrophages,

which may also develop into foam cells by the continued
uptake of fat.

If these cells do not or are not able to

migrate away from the lesion they may disintegrate and

contribute their contents to the lipid deposit.

The

fibrous plaque spreads down into the artery wall destroying

the elastic lamella until the entire media has been trans
formed into a lipid paste.

As this process continues

cellular debris from destruction of arterial structural

cells contributes to the growing plaque.

This lesion is

capable of growth which is so extensive that it may break

through the outer adventitial vascular coat.

The final stage of plaque development consists of the

appearance of insoluble calcium deposits (4, 5) which

occur throughout the plaque and contribute to hardening of
the lesion.

This phase may be accompanied by vascular

ization by a system of capillaries, which may be an

attempt to provide nutrition for any cells remaining alive.
At this stage of development the lesion has caused no

ma jor compromise of vessel functions.

The destructive

phase begins when a piece of the plaque becomes dislodged

from the site of the lesion.

The dislodged portion of
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plaque may be carried away by the blood stream and become

trapped in a narrow vessel.

damage.

This contributes to occlusive

The gap remaining in the lesion after loss of a

portion of plaque may become filled with blood and form a

clot. . Continuation of ulceration in this manner may lead

to hemorrhage (4).

The artery wall may become so weakened

that it bulges outwards.

The resulting aneurysm is a

serious complication since it is capable of either pressing

on an ad jacent organ or rupturing.

Rupture of the artery

occurs most often if the vessel passes through soft or

yielding tissue, such as the brain, and is enhanced by

high blood pressure.

Another serious atherosclerotic complication is

thrombosis, which appears to occur more often in athero

sclerotic than in normal arteries and more often in

individuals with high blood lipids and hypertension.

Although the mechanism of thrombus formation related to

atherosclerosis is not well known, microscopic cracks in

the surface of plaques may initiate its development (4).
Study of atherosclerosis and its complications is

hampered by the lack of a readily available, suitable

experimental model for the disease.

Atherosclerosis in

man, the ob ject of most concern with respect to the disease,
can be studied only after death since the observation of

arterial interiors cannot readily be repeated with the same
sub ject.

However, observation of man does provide impor

tant information concerning possible factors which
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contribute to the disease.

Problems associated with the

choice of a suitable experimental animal are centered on

differences in the disease process between the animal model
and man.

In most cases the conditions required for devel

opment of atherosclerosis in an experimental animal are
too different from those apparently necessary for spon

taneous development in man, or the lesion itself is con
sidered too different from the lesion found in man (9) ,

Perhaps the best available model is the nonhuman primate;

some species of monkey develop atherosclerosis spontane
ously with.aging as well as by feeding lipid rich diets

which are similar to the diets related to the disease in
man (9),

However, the necessary facilities for housing

and caring for primates and the extended periods of lipid
feeding required to develop the disease often make it

impossible to use this animal as an experimental model.

Perhaps because of the ease of inducing lesions and the

reproducibility of these lesions, the rabbit has been the

major experimental animal studied.

Thus, muc·h of the

experimental data related to atherosclerosis in man has

been derived from observation of rabbits as well as rats

and may therefore be considered circumstantial evidence or

proof by analogy,

However, the overwhelming nature of

this data provides some support for its fidelity.

There are several theories which attempt to explain

the mechanism by which athe.rosclerotic lesions are initi
ated.

The single unifying feature of the various theories
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is the experimental fact that the lesion is composed of
lipid material of uncertain origin.

One of the theories

with much support is the filtration theory.

Very simply

stated this theory explains that arterial lesions are de

rived from filtration of plasma components into the arterial
wall (10-12).

The initiating event for this infiltration

of lipid is thought to be some irritation or in jury to the

arterial intima.

Accumulating lipids and lipoproteins are

irritants and they provoke a proliferation reaction by the

arterial tissues (4, 11) which results in a fatty metamor
phosis of the intimal cells, ending in disintegration.

This is based upon the fact that most vessel walls do not

have a vascular system, and therefore the metabolic needs

of the wall are supplied by continuous diffusion of fluid
from the lumen to adventitial lymphatic channels.

When

the blood lipids reach high levels, some of the largest

lipids and lipoproteins are not able to pass completely

through the artery wall and they begin to accumulate causing
a proliferative response by the arterial wall.

Support for

this theory is derived from the observation that human

populations with abnormally high concentrations of blood

lipids exhibit a higher occurrence of atherosclerosis

than populations with lower blood lipid concentrations.

Further, high blood lipid levels in animals are known to
induce atherosclerotic lesions similar to those found in

man.

Recent support for the filtration theory is the work
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of Colton et al. (1J) who studied ultrafiltration of

lipoproteins through synthetic membranes.

These workers

found that ultrafiltration of solutions containing low and

very low density lipoproteins was accompanied by the for
mation of a lipoprotein layer on the membrane, a phenom

enon known as concentration polarization.

It was proposed

that concentration polarization may be the major control

ling factor for the movement of lipoproteins into arterial
walls.

Low density lipoprotein concentrations are im

portant in coronary heart disease as well as atherosclerosis
and these results suggest that low density lipoprotein

transport into arterial walls would be favored by increased

concentration polarization under conditions of high con

centrations of low density lipoprotein relative to very low
density lipoprotein.

Zilversmit (14), however, has shown that simple fil

tration may not be the sole governing factor.

Study of

rabbit aorta lesions induced by high cholesterol diets

showed that the accumulated cholesterol in the lesions was
derived from circulating blood.

The kinetic studies of

lipid influx and accumulation suggested that, rather than
being governed by simple filtration and retention, there

was a gradual increase of permeability of the artery wall
which promotes influx and retention of serum lipoprotein
and cholesterol.

This evidence indicated that the fil

tration of lipid material into arterial walls was enhanced

by permeability changes of the wall itself and provided
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further support for the basic mechanism of filtration

theory,

An interesting variation of lipid filtration theory

has been suggested by the work of Constantinides (4, 12)

who has emphasized the importance of in jury to the arterial
wall.

These experiments showed that arterial walls which

have been either chemically or physically in jured exhibit
faster lipid deposition at lower blood lipid levels than
Furthermore, in jury alone did not

unin jured arteries.

appear to lead to atherosclerotic lesions, but in the

presence of elevated blood lipid levels lesion development
was rapid.

Agents capable of arterial in jury include free

fatty acids, desoxycholate, and phosphatidyl ethanolamine

when infused directly into the arterial lumen.

The in jury modification of the lipid filtration theory

maintains that under normal conditions small molecules

such as oxygen, water, electrolytes, sugars, and free fatty

acids readily cross the endothelium and that large mole
cules do not (12),

After arterial in jury the endothelial

junctions become so widened that the entire plasma with its

lipoproteins may enter the wall and begin the lipid
accumulation process.

In this context in jury includes

necrosis and sloughing off of cells and may be caused by
anoxia, amines, and high concentrations of lipids.

Other

investigators have also found evidence for the entrance of

plasma into the arterial wall through endothelial
junctions (15),
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When in jured artery wall is exposed to lipemia, ath

erGmata may form either at the center or margins of the
in jury site (4).

Atheromata developed from the center of

an in jury site are indistinguishable from early human fatty

streaks.

If these lesions are allowed to grow they develop

into plaques which are also indistinguishable from those

found in the human disease.

Those plaques which develop

from the marginal areas of in jury sites grow into foam

cells.

The thrombogenic theory differs considerably from the

filtration theory in explaining the origin of atheroscle
rotic disease.

The thrombogenic theory maintains that

atherosclerotic plaques are initiated by flat or mural

microscopic thrombi on the surface of arterial walls.

It

is postulated by this theory (11) that in the circulation
fibrin is constantly formed and degraded by fibrinolysis.

When the rate of fibrin formation exceeds that of fibri

nolysis the excess fibrin becomes deposited on an artery

wall and initiates formation of a thrombus.

Initiation of

the true plaque takes place when the thrombus is incor

porated into the arterial wall by overgrowth of epithelial
and vascular cells (4).

The most serious deficiency of the thrombogenic theory

is its inability to account for the formation of fatty dots
and streaks which are presumably the earliest gross
expressions of the atherosclerotic process (11).

The

theory requires all early lesions to be in the form of
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muFal thrombi deposited on normal arterial wall tissue
(12).

Thrombi observed in human atherosclerotic aorta

appear to take an intermediate position in development of

the lesion since they are usually found on the atheroscle
rotic wall with thick fibrous caps or on thick fibrous
arterial walls.

Additionally, the thrombogenic theory does

not provide for transitional forms between the early mural
thrombus and the plaque stages of development.

Thus, it

appears that thrombi make a much more important contri

bution to growth and development of atherosclerotic lesions

than to their initiation.

Each of the ma jor theories concerning initiation and

development of atherosclerotic lesions accounts for a vast
body of experimental observation.

However, each theory

contains deficiencies in its explanation of experimental
data.

Similarly, each contains common principles or con

cepts which relate it to the others.

Atherosclerosis and

its complications provide a problem of such a complex

nature that no single theory can be expected to account
for all its aspects at this time.

Therefore, rather than

attempt to formulate comprehensive theories it is probably
more productive to consider the process as the result of

several factors acting in concert to produce the observed
disease state,

Several of these factors are apparently

unrelated and require further study to clarify their

respective contributions.

Several factors have been shown to be correlated with
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the incidence of atherosclerosis and on this basis they are

said to contribute to or predispose an individual to the

disease more so than if a particular factor were absent.

Many of these contributing or risk factors are involved

with or are part of common daily practices.

Because of

interrelationships among some of these factors and the

habitual nature of others they have often been collectively
referred to as the effect of "life style'' on disease de

velopment.

Among the more important contributing factors

are blood cholesterol and triglyceride levels (5, 16, 17),

hypertension, diabetes and cigarette smoking (5, 17), and
exercise (18, 19),

Although they probably do not contri

bute to the disease directly, age and sex have been shown

to be highly correlated with its occurrence; atherosclero

sis is more prevalent in advanced age and is very rare in
premenopausal women.

The incidence of atherosclerosis has risen very

sharply since the beginning of the twentieth century.

This

is not an indication that the disease is new because evidence
of it has been found in Egyptian mummies over three
thousand years old.

The increased observation of athero

sclerotic events since the turn of the century is probably
due to the use of chemotherapeutic agents (20).

The preva

lence of infectious diseases, especially tuberculosis, in
the early years of this century caused death at an early
age.

Because serious complications associated with

atherosclerosis do not occur until late in life the many
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victims of death by infectious diseases did not live long

enough to become susceptible to atherosclerotic conditions.
The advent of chemotherapy removed infectious disease as

a ma jor cause of death and drastically increased life span

allowing much larger segments of the population to live

long enough to become victims of atherosclerotic diseases.
In addition, more ac�urate documentation of the cause of

death during this century has increased the awareness of
atherosclerosis.

Thyroid function has been proposed to be an important

factor in the development of atherosclerosis; thyroid

deficiency enhances atherosclerosis and thyroid adminis
tration delays the disease in experimental animals (20).

In an attempt to determine if this relationship is valid

in humans, Barnes (20) studied 70, 000 autopsies performed
in Graz, Austria.

This region of the world exhibited an

extremely high incidence of goiter until iodized salt was
introduced in 1963,

The autopsies indicated a strong

positive correlation between thyroid deficiency and oc
currence of atherosclerosis.

This suggested that premature

death from coronary disease might be prevented by thyroid

treatment.

Thus� after administering thyroid therapy to

1569 patients for approximately six years only four new

cases of coronary disease were observed, whereas 72 were
expected from comparing the experimental group with a
control group matched for age, sex, hypertension, and

hypereholesterolemia (20).

It should be noted that this
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apparent 94% protection against atherosclerotic complication
of coronary disease was associated only with thyroid therapy
since there were no reported changes in diet, smoking, or

exercise patterns.

Physical activity may play an important role in the

development of atherosclerosis.

In a study of Irish born

brothers, one of whom lived in Ireland, the other in Boston,
Brown et al. (18) were able to examine the effect of nu

trition on atherosclerosis.

The choice of brothers elimi

nated both hereditary and racial differences among the

sub jects and placed the emphasis of the study on nutrition
and mode of living.

With very few exceptions trends of

food consumption in Ireland and Boston were very similar;

although the Ireland brothers consumed J700-4JOO calories
per day while the Boston brothers consumed only approx

imately JOOO calories per day.

In light of the similar

nutritional conditions in the two experimental groups, the

U. S. death rate for atherosclerotic and myocardial disease

was JOO more per one hundred thousand than that observed in
Ireland (using 1950 statistics).

Furthermore, the death

rate increased the longer an Irish family had lived in this
country.

Since the Irish brothers consumed more calories

but weighed less than their Boston brothers it was con

cluded that the Irish brothers were more physically active

and stored fewer calories as fat.

Thus, it was suggested

that the quantity and general quality of food intake was

less important when a large proportion of calories consumed
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were expended by physical activity (18).

This study indi

cated the importance of exercise in prevention of athero
sclerotic development.

A possible physiological explanation of the apparent

protection afforded by exercise is the observation of
anoxia in the arterial wall.

It has been observed (19)

that the activity of certain enzymes in the human aorta

decreases with advancing age and increasing severity of

atherosclerosis, the loss being most severe in the middle

media.

This observation has led Adams et al. (19) to pro

pose that the loss of enzyme activity may be due to anoxia.
Since lipids enter the intima from the lumen and move

outward, anoxia of enzyme systems responsible for trans
port or metabolism of these lipids may cause them to

accumulate at the site of entry and therefore contribute

to an atheromatous lipid deposit.

It also seems reasonable

that the reverse process could take place, that is, the

accumulation of lipids by any of the previously discussed

mechanisms could contribute to anoxia which, in turn, con
tributes to further lipid deposition.

Thus, it is tempting

to suggest that physical exercise may prevent anoxia of

the affected enzyme systems and therefore make lipid accu

mulation an unfavorable process.

Smoking is also a risk factor for atherosclerosis (17)

and may be related to anoxia.

Decreased oxygen supply

caused by vasoconstriction and decreased oxygen carrying

capacity of the blood due to increased carbon monoxide
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levels could contribute to the effects of anoxia.

Turbulence of blood flow has also been implicated in

the genesis of atherosclerosis; however, the validity of
this hypothesis is in doubt.

The stenosis or arterial

constriction used to study this effect is accompanied by

increased blood pressure proximal to and turbulent blood
flow behind the constriction.

It is therefore uncertain

if the relationships between arterial stenosis and athero

sclerotic lesions are due to hypertension or to turbulent
blood flow.

Aars and Solberg (21) were able to cause a

stenotic constriction of the middle ascending aorta of

rabbits in such a manner that distal turbulence of the
blood flow was produced without proximal hypertension.

Development of atherosclerotic lesions in these animals by
cholesterol feeding showed that the stenosis did not
influence the location or extent of lesions.

These data

indicate the absence of a relationship between turbulent

blood flow and the development of lesions, and indirectly

support the view that hypertension is an important con
tributing factor.

Triglycerides are also frequently observed constituents

of atherosclerotic plaques.

An increase of the circulating

triglyceride levels, even though cholesterol levels may be
considered normal, is a condition predisposing to athero

sclerosis (16).

Both cholesterol and the triglycerides

are important contributors to lesion development.

For a

given cholesterol level, coronary disease increases with
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triglyceride concentration in the blood; similarly, for a

given triglyceride level incidence of these diseases in
creases with cholesterol concentration (16).

Therefore,

high cholesterol and high triglyceride levels in the blood
are both independent risk factors for atherosclerosis.

The most important contributing factor for athero

sclerosis is the concentration of lipids, especially
cholesterol, in the blood.

Of all the lipids found in the

blood and plaques, cholesterol is probably the most strongly
implicated lipid in atherogenesis.

A sixteen year follow

up study of the Framingham study (17)

found that of the

5209 adults examined the serum cholesterol level was one

of the highest correlating factors in development of
atherosclerotic diseases.

The high correlation between

serum cholesterol levels and atherosclerosis is diagnos

tically valid only when comparing geographically or

racially distinct populations and not when comparing
individuals within those populations (5),

This fact is

illustrated by the wide variation in the extent of lesions

in individuals from homogeneous subgroups.

Serum cholesterol levels have been correlated with

the occurrence of atherosclerosis in a vast number of

studies (22); however, the circumstantial nature of this

correlation is often noted by the investigator.

Similarly,

a logical step in the treatment of a disease is removal of

the causative factors.

In the case of atherosclerosis,

since there is no absolute proof that cholesterol causes

the disease, some investigators feel that therapy by re
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moval of this tentative causative factor would only

probably be beneficial but, at least, would not be harmful
(23-25),

This apparent confusion can be interpreted as

another illustration of the complexity of atherosclerosis
and that many factors acting together contribute to the
development of the disease.

Because of the large body of

experimental evidence, cholesterol can indeed be considered
to be intimately involved with atherosclerosis and its

removal may very well prove to be beneficial.

The correlation between cholesterol and atherosclerosis

is an old one; early investigators (26) used cholesterol

feeding to study the pathogenesis of the disease in rab
bits.

Cholesterol is known to accumulate in human arteries

and its deposition is a process which requires extended
periods of time.

The lipid composition of early lesions

is very similar to that of blood plasma (24), suggesting

that lipids found in these lesions are derived from the

blood.

As growth progresses the amount of cholesterol in

the plaque increases until, in the late stages, it is the

ma jor constituent.

This is further indirect evidence that

lowering serum cholesterol levels should inhibit athero

genesis.

A smaller body of evidence exists which indicates no

relationship between cholesterol and atherosclerosis.

an attempt to surmount the problem of not being able to

In

examine the human aorta before death Land� and Sperry (27)
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studied serum cholesterol levels and the severity of
atherosclerosis in victims of sudden accidents.

Their

graphical results showed no correlation between serum

cholesterol levels and severity of the disease at autopsy.
Similarly, a more recent study (28) showed that when the

expected positive correlation with age was removed there

was no significant relationship between lesion severity
and cholesterol levels.

Thus, there appears to be a

positive correlation between serum cholesterol levels and

the incidence and severity of atherosclerosis; although, as
shown, there is not complete agreement on this matter.
B.

Cholesterol Biosynthesis

The biosynthesis of cholesterol is a very complex

process of which most tissues are capable but which occurs

most actively in the liver.

The biochemical building unit

for this synthesis is acetyl coenzyme A (acetyl CoA)

which, through the series of initial reactions (Figure 1)
is converted to the key intermediate mevalonic acid.

This

early portion of the entire biosynthetic sequence is most
important to the present work.

Following its production

mevalonic acid is successively phosphorylated by ATP to

afford 5-pyrophospho-J-phosphomevalonic acid (Figure 2).
This compound decarboxylates and loses the J-phosphate

function to form 3-isopentenyl pyrophosphate which, in

turn, is rapidly isomerized to dimethylallyl pyrophosphate.

20

2 CH3-C-S-CoA
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Mevalonic Acid

Figure 1:

13-Hydroxy- (3 -methyl
glutaryl CoA

The biosynthetic conversion of Acetyl CoA to
Mevalonic Acid.

Nucleophilic attack on dimethylallyl pyrophosphate by another

molecule of 3-isopentenyl pyrophosphate leads to geranyl
pyrophosphate,

The repetition of this reaction with the

new substrate leads to farnesyl pyrophosphate, two mole
cules of which couple to form squalene.

The elegantly

designed cyclization of squalene- 2 , J-epoxide (Figure J)
leads to lanosterol which, after several steps, is con
verted to cholesterol,

By following the conversion of

1-c 14 -acetate

to cho

lesterol in fractionated rat liver homogenates, Bucher and

McGarrahan ( 2 9) found that neither mitochondrial, micro
somal, nor supernatant fractions alone were capable of
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23

Combination of the three fractions

showed that most of the synthesis took place in the micro
some, both in vitro and in vivo.

Further localization of

this process has shown that both the rough and smooth

endoplasmic reticulum are capable of cholesterol synthesis

from 2-c 14 -mevalonic acid (JO).

The earliest chemical studies of cholesterol biosyn

thesis were performed by Bloch and co-workers (31-34, 36).
Initial attempts to determine the biological precursors

of cholesterol consisted of feeding mice deuterioacetate,
isolation of the biosynthesized cholesterol, and deter

mination of its isotopic content by mass spectrometric
techniques (31, 32).

The first important result from

these experiments was that deuterium labeled sodium acetate
was incorporated into cholesterol.

In addition, the

quantity of label found made it possible to rule out fatty

acids as the biosynthetic intermediates in sterol biosyn
thesis (3 1 ).

These results stimulated fuFther feeding

experiments using various deuterium labeled acid salts.

Of all the salts examined only acetate was capable of par

ticipation in cholesterol biosynthesis (32), and since the
function of acetate as a metabolic intermediate was not

then known this provided the first clue that coupling of
very small molecules might be involved.

Conclusive proof that acetate is indeed the basic

biosynthetic unit awaited double labeling experiments.

Thus, incubation of rat liver slices with sodium acetate

labeled with deuterium in the methyl group and

c1 J
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in the

carboxyl position showed that the isolated cholesterol
c0ntained both isotopes (JJ) .

Having established the basic

unit, Bloch and his co-workers turned their attention to
the quantitative aspects of label incorporation.

Using

variations of the original double label technique it was

found that of the 27 carbon atoms of cholesterol, 15 were
derived from the methyl group and 12 from the carboxyl

carbon of acetate (J4).

Finally, using combinations of

both chemical degradation and radioisotopic labeling ex

periments, the work of several investigators led to the

elucidation of the origin of most of the carbon atoms in
cholesterol (J4-J6) as illustrated in Figure 4.

HO
Figure 4:

The chemical origin of carbon atoms of choles
terol (J4-J6) . Positions numbered 1, J, 5, 17,
18, 19, 21, 22, 24, 26, and 27 are derived from
the methyl group of acetate ; those numbered 2,
4, 6, 10, 20, 2J, and 25 are derived from the
acetate carboxyl carbon .
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The above discussion of cholesterol biosynthesis is

breif and emphasizes the early historical work and elu

cidation of the important function of acetate.

The re

maining aspects, especially conversion of lanosterol to

cholesterol, are very complex and all of the mechanistic

details are not clearly known.

Since the present work is

primarily concerned with the early portion of the biosyn
thetic pathway the remaining discussion will be centered

on those reactions which mediate the conversion of acetate

to mevalonic acid,

The early work of Bloch and other investigators

indicates that the basic precursor or building block is
acetate.

Succes sful use of sodium acetate in incorporation

studies using tis sue slices or homogenates as well as in

vivo experiments naturally led to the conclus ion that

acetate is probably employed without further biochemical

modification.

However, it is now known that intermediates

occurring early in cholesterol biosynthesis (up to and in
cluding J-hydroxy-J-methylglutaryl CoA) are all present
as thioesters with coenzyme A (CoA).

Light was shed on the

question of whether coenzyme A is neces sary in repeated
use of acetate during cholesterol biosynthesis by the
development of truly coenzyme A deficient rats (37),

Correlation of reduced plasma and liver cholesterol levels
with this deficiency proved the requirement for this co

factor in the conversion of acetate to cholesterol.

This

was the first indication that in acetate feeding experiments
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the initial step of the synthetic pathway consists of the

conversion of acetate · to its CoA thioester.

Under normal

physiological conditions this step may not be required

since the end product of other metab0lic sequences (such
as glycolysis and fatty acid degradation) is acetyl CoA.

Further investigation of the incorporation of labeled

compounds as p0ssible cholesterol precursors indicated the

role of a four carbon compound.

In vivo and in vitro ex

periments established that this compound was acetoacetate
(39, 41); it therefore appeared that the second step of

cholesterol biosynthesis was the condensation of two mole
cules of acetyl CoA to provide acetoacetyl CoA.

Con

siderable confusion was caused by radioactivity incor

poration data since some results were interpreted to show
that prior to incorporation acetoacetate was equilibrated
with a two carbon pool or was degraded in some other

manner (38).

This conclusion was based on the observation

that incorporation of radioactive acetoacetate afforded

cholesterol in which the labeled atoms were found widely
distributed over the entire molecule.

Similarly, the then

unknown reversible nature of acetate condensation to form
acetoacetate probably contributed to the confusion by

causing label dilution.

Other investigators (39) found

direct incorporation of intact acetoacetate with no prior
degradation to two carbon units.

The earliest indication of the nature of the third

step of cholesterol biosynthesis was related to the
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erroneous proposal that dimethylacrylic acid was a choles

terol precursor.

This compound was probably obtained as

an artifact by oxidation of dimethylallyl pyrophosphate
during isolation.

Rudney (4 0) proposed that this compound

could be the result of dehydration and decarboxylation of

µ -hydroxy- j3 -methylglutaric acid (HMG) as shown in equa

tion 1 .

To test this proposal HMG was biosynthesized from

2-c 14 -acetate using a rat liver homogenate.

Degradation

and measurement of radioactivity from each carbon atom of

the isolated compound showed very high c 14 content at C2,
C4, and C6.

The most important aspect of this study was

that HMG was correctly envisioned as being the product of

the condensation of acetyl CoA and acetoacetate.

Further

investigation of this reaction showed that the four carbon
precursor to HMG was definitely acetoacetyl CoA rather

than free acetoacetate (4 1 ).
0
II
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H
, 2
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"-....

4 3)

(eq.

revealed

several important features of this step of cholesterol
biosynthesis.

The stoichiometry of the reaction showed

that one mole of acetyl C0A reacts with one mole of

1)

acetoacetyl CoA to provide a single mole of both
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/3 -

hydroxy- � -methylglutaryl CoA (HMG CoA) and free coenzyme A
and that the dicoenzyme A thioester was not formed.

Ap

propriate labeling experiments (equation 2) conclusively

proved that the free coenzyme A produced in the reaction
was derived exclusively from acetyl CoA and not from
acetoacetyl CoA.

One of the most important aspects of this

investigation was the proposal, based on structural simi

larities, that HMG CoA may be biochemically reduced to

mevalonic acid which is an excellent substrate for choles
terol biosynthesis.

It should be emphasized that up to

and including biosynthesis of acetoacetyl CoA the pathways

for fatty acid and isoprenoid syntheses are identical.

Synthesis of HMG CoA is the branch point between these

pathways.

The biochemical alternatives for utilization

of HMG CoA are either cleavage to acetoacetyl CoA and

acetate and subsequent reentry into the two carbon pool or
reduction to mevalonic acid and continuation into sterol

biosynthesis.

+
CoA-SH

(eq. 2)
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Important contributions to the elucidation of the final

and most important early step of cholesterol biosynthesis

were made by Ferguson et al. (44).

Using yeast extracts

these investigators established that HMG CoA was indeed
reduced to mevalonic acid.

These experiments completed the

elucidation of the ectrly sequence of reactions of choles

terol biosynthesis as shown in equation J.

This reduction

(eq. J)

requires NADPH and the enzyme which mediates the reaction,

HMG CoA reductase, accepts only the CoA thioester of HMG

as substrate, not the free acid. · Using 1-c 14-HMG CoA as

substrate the resulting mevalonic acid was converted to its

barium salt and pyrolyzed.

The carbon dioxide generated

from the resulting barium carbonate was found to be highly

radioactive.

This result proves that the free carboxyl

group of HMG CoA remains intact during the reduction and

therefore, the reduction takes place at the thioester car

bonyl group (equation 4).

Incubation of the enzyme with

JO
2-c 1 4 -mevalonic acid, NADP, oxidized glutathione, and free

coenzyme A showed that the reaction is not reversible.

irreversibility of this reduction has important conse

The

quences on the entire series of reactions in early choles

terol biosynthesis.

Thus, once the two carbon precursors

have reached the mevalonic acid step they are not capable

of reentering the two carbon pool and their progress
toward incorporation into sterols becomes committed.

+

2 NADPH

>
+

(eq. 4)

CoA-SH

Since the reduction of HMG CoA to mevalonic acid

requires two moles of NADPH it is tempting to suggest that
the reaction takes place via an aldehyde intermediate.

However, addition of unlabeled mevaldic acid or semicar
bazide in an attempt to trap the aldehyde does not sig

nificantly lower incorporation of label into mevalonic acid

(44 , 62).

Therefore, if an aldehyde is an intermediate in

the reaction, it may occur as an enzyme bound species such
as the thiohemiacetal of coenzyme A (44).

Concurrent with these studies Knauss and co-workers

were investigating mammalian sterol synthesis.

They in

dependently discovered a rat liver preparation which was
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capable of synthesizing mevalonic acid from acetate (45),

These results established that the early steps of cholester

ol biosynthesis in this mammalian system were identical
with those shown in equation 3,

These early steps, from acetyl CoA to mevalonic acid,

are very important with respect to the overall control of
�holesterol biosynthesis.

Many of the physiological

phenomena known to alter sterol synthesis exert their

effects at one of these steps.

In this regard, HMG CoA

reductase is the ma jor site of action for several of these

metabolic controls (46).

For example, the detergent

Triton WR 1339 and X-irradiation exert a stimulating effect

on the conversion of acetyl CoA to both squalene and cho

lesterol but a much les s noticable effect on the conversion

of mevalonic acid to squalene or cholesterol (47) ,

This

suggests that the effect is exerted on one of the early

reactions prior to mevalonic acid.

The opposite is seen

in response to fasting or cholesterol feeding.

Conversion

of acetate to cholesterol is greatly reduced, but conver

sion of mevalonic acid to cholesterol is altered to a much

smaller degree.

Again, the early steps -are implicated as

the sites of action.

Studies of this type are the basis of

suggestions that the early reactions of cholesterol bio
synthesis include the rate limiting step for the entire

pathway and that this step is probably located between
acetoacetyl CoA and mevalonic acid (46, 47),

Since these

early hypotheses it has been found that the true rate

limiting step is the reduction of HMG CoA to mevalonic
acid.
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In the first example above, X-irradiation of rats

causes an increase of cholesterol biosynthesis in the

treated animals.

clearly defined.

The mechanism of this response is not

It is known, however, that this process

is not under adrenal control since adrenalectomized rats

respond to X-irradiation j ust as do control animals (48).
Similarly, hypophysectomy does not appear to alter the

response although the results are not clear since the less

drastic increase of cholesterol biosynthesis in these

animals could have been due to poor condition of the animal,

lack of pituitary hormones, or both (48).

The case of cholesterol feeding is more clearly illus

trated.

It is known that feeding cholesterol (0,5% of the

diet) is associated with a marked decrease of cholesterol
genesis as measured by the incorporation of radioactive

acetate (49),

This is a specific inhibition of cholesterol

synthesis and not a general metabolic liver depression
since fatty acid and carbon dioxide production do not

change.

Decreased cholesterol biosynthesis in response to

cholesterol feeding is complemented by an increase of bio
synthesis after biliary obstruction or diversion (50, 51).
Because cycloheximide administration blocks this rise in

synthetic activity it i£ probable that changes in protein
synthesis rates are responsible for these effects (50).

By analogy this also indicates that cholesterol itself is
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not a direct enzyme inhibitor.

As with cholesterol feeding, biliary diversion is a

specific stimulus since the conversion of radioactive

acetate to carbon dioxide or to fatty acids is not signifi
cantly changed.

Restoration of the enterohepatic circu

lation of biliary diverted animals by intravenous or intra
je junal infusion of taurocholic acid, glycocholic acid,

combinations of taurocholic and taurodeoxycholic acids,

cholic acid, deoxycholic acid, or phospholipids did not
block the increase of hepatic cholesterol biosynthesis

observed after biliary diversion (51),

Blockage of in

testinal lymph flow, which caused interruption of the

enterolymphatic circulation of endogenous cholesterol, also
caused an increase of hepatic cholesterol biosynthesis

which was quantitatively identical to that observed in re

sponse to biliary diversion.

It was therefore concluded

that the bile acids have no direct control on hepatic

cholesterolgenesis; rather, they control absorption of
cholesterol which is the true mediator (51).

Localization

of this effect shows that enhancement of HMG CoA reductase
is the mechanism by which the observed increase of sterol
synthesis takes place.

Thus, cholesterol appears to par

ticipate in control of cholesterol biosyrithesis by acting

at the level of HMG CoA reductase; although, as discussed
below, it does not interact directly with the enzyme.

Further support for this regulatory mechanism was provided

by the work of Bricker et al. (53)
- ,

Using a desmosterol
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suppres sion technique it was shown that cholesterol feeding

caused an effective in vivo regulation of cholesterol bio
synthesis.

This control has also been found to operate in

man (52) where the activity of the control system varied
with the levels of dietary cholesterol.

In feeding experiments of relatively short duration

the site of control which dietary cholesterol exerts upon
cholesterol biosynthesis is located at the reduction
mediated by HMG CoA reductase.

However, there are some in

dications that under varied feeding conditions other les s

important control sites . may exist after the formation of
mevalonic acid.

These additional sites are difficult to

detect under normal experimental conditions but if choles

terol feeding is extended for long periods of time they
become significant.

By appropriate labeling experiments

it has been shown that conversion of squalene is unaltered

but conversion of farnesyl pyrophosphate to cholesterol is

reduced to 3 to 35% of control values in response to long
term cholesterol feeding of rats (54).

This site alone

does not account for the magnitude of depression of con

version of mevalonic acid to chelesterol observed in the se
same experiments.

This suggests that an additional c0ntrol

site exists between mevalonic acid and farnesyl pyrophos

phate.

The contribution of these postmevalonate sites in

creases with feeding times until complete suppression of
cholesterol biosynthesis is achieved.

Thus, HMG CoA re

ductase is the most important regulatory site under normal

an1 most exper imental c ond i t i ons bn t when bloc kade ap
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proac hes c omple tene s s as w i th c hole s te r o l f e e d ing f or ex

tended pe ri ods, the p o s tmevalon i c ac i d s i te s b e c ome impor
tan t.

A l though m o s t s t ud i e s of c hole s te r ol b i o synthe s i s are

c onc e rned N i th hepa t i c synthe s i s, e x trahepat j c t i s sues are

als o c apable of c hole s te rol sy n the s i s.

In a c ompre hen:o ive

s tudy o f synthe s i s and c ontrol c harac ter i s t i c s of vari ous

rat t i s s ues, D i e tschy and S i p e r s te in ( 5 5 ) f ound that, per

gram of t i s s ue, the l iv e r, ileum, transve rse c olon, an:l

s t omac h e xh i b i t e d the h i ghe s t rate s of inc orporat i on o f

ace tate i n t o c h ole s te rol.

T h e e s o phagus, j e j unum, te s t i s ,

lung, adrenal, s k in, k idney, duod enum, and spleen s howed
2- 1 0% of the hepatic rate wh ile smo o th mu s cle, skele tal

musc le, and brain had inc orpora t i on rat e s le s s that 0. 6%
that of hepat i c ra t8 s.

Even th ough s everal organs are

c apable of c h o l e s te r o l b i o s ynthe s i s the ability to c on trol
the proc e s s by c h ole s terol feed ing rema i ns un ique to the

live r.

In the s e exper iments ( 5 5 ) c h ole s te r o l feed ing was

of s i x weeks durati on.

Add i t i onally, fas ting for 48 h ours

d e pre s s ed chole s t e r o l bi osynthe s i s only in the l i v e r.

Of a l l the extrahepat i c tis sues, c h ole s terol b i os yn

the s i s has been m o s t thoroughly examined in the gas tro
inte s t inal trac t.

The rate of synthe s i s var i e s al ong the

length of the i nte s t i ne, w i th ileum b e i ng h i gh e s t ( 5 6, 57 ) ,
Thi s vari a t i on extend s t o the type of t i s sue exam ine d ;

intestinal smo o th muscle and villi are p o o r i n c h ole s te rol
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biosynthetic ability and the highest rates are observed in
As in liver t biliary diversion increases

crypt cells.

intestinal sterol synthesis but does not alter other syn
thetic pathways.

This effect has been attributed to in

creased activity of HMG CoA reductase (56) ,

Restoration

of the enterohepatic circulation by infusion of whole bile
or solutions of bile acids suppresses synthesis; however,
infusion of bile from which bile acids have been removed

shows no effect.

This data can be interpreted to suggest

that either bile acids participate in control of intestinal

cholesterol biosynthesis or that bile acids play a secondary

role by facilitating entry of cholesterol into the intes
tinal mucosa where it is the true mediator of regulation.

The second possibility may be doubtful because cholesterol
feeding appears to have no effect on intestinal synthesis

(56).

Similarly, intestinal synthesis is relatively re

sistant to the effects of fasting seen in hepatic tissue.
It can be concluded that although liver and intestinal

sterol synthesis are physiologically controlled, the mecha
nisms of control in the two tissues are considerably dif

ferent.

In man, the results are similar to those found in

animals (58).

The ma jor difference is that fasting for 48

hours reduces human intestinal cholesterol biosynthesis to
50% of control values (58).

As with animals, cholesterol

feeding does not inhibit cholesterol biosynthesis in human

intestine.

The gastrointestinal tract is therefore
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probably an important s ourc e of endogenous choles terol

under c onditions of high c h ole s terol intake when liver
s ynthe sis is drastically d e c reas ed.

Finally , when the

enterohepatic circulation is inte rrup ted human inte s tinal
tis sue r e s p onds with an inc reased level of chole s te rol

biosynthe sis.

Thi s sugge sts that man has a bile acid as

s o c iated c ontrol sys tem similar to the one obs erved in

animals ( 58 ) •

Hepatic c hole s te r o l bios ynthe sis e xhibits a diurnal

rhythm with its maximum o c curring around midnigh t at levels
f our to ten tim e s highe r than the minimum, which oc curs at

n o on (59 - 6 1 ) .

Alth ough f e eding bile acids inhibits bio

s ynthe s i s in rats there is no c orrelation b e tween the di

urnal rhythm and hepatic bile acid c oncentrations.

There

fore , the bile ac ids are not the caus e of the rhy thm ( 59) ,

Rather, sinc e HMG C o A red'Jc tas e has b e en previously im

plicated as a ma j or c ontrol point for the ent ire sequenc e
of reac tions and s i n c e fac tors capable of altering the

rhythm appear t o ac t through this enzyme it is be lieved

that the c yclic c hange s are due to similar change s a t the

enzyme level.

Adminis trat i on of cyclohe ximide abolish e s

t h e diurnal ris e d uring the dark period ( 59 ) ,

This is c on

clusive e videnc e that the nature of this rhy thm is bas e d on
enzyme synth� sis rather than on c hange s of enzyme ac tivity .
Several experime ntal manipulations have effe c ts on

this c yclic rhy thm and , in vitro, the s e can b e s tudie d by

measuring the inc orporation of radioac tive ac e tyl CoA or
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mevalonic acid into cholesterol.

Fasting , which normally

reduces the magnitude of hepatic cholesterol synthesis ,

also effects the diurnal rhythm of synthesis (60).

Under

fasting conditions the cyclic nature of the rhythm is main
tained but the magnitude of synthesis is greatly reduced.

Also, after bilateral adrenalectomy the rhythm is abolished ,
but the level of cholesterol synthesis is maintained at
approximately the maximum level observed during dark

periods.

Adrenalectomy does not alter the biosynthesis of

cholesterol as measured from mevalonic acid incorporation.
This once again implicates the important enzyme HMG CoA
reductase as being the site through which synthetic al

terations are expressed (60).

The regulator of this

rhythm cannot be norepinephrine since this agent causes
enhancement of cholesterol synthesis.

A possible regulator

is corticosterone (60) since this adrenal steroid also is

sub ject to diurnal variations .

The diurnal variations of

corticosterone levels can be abolished by cutting the af

ferent nerves to the medial basal hypothalamus or by main
taining the experimental animal in continuous light.

If

corticosterone is the mediator it would be expected that
these condition� would destroy diurnal variations of
cholesterol synthesis also.

discussed in a later section.

A similar experiment will be

The diurnal rhythm has also been demonstrated under in

vivo conditions in rat intestinal tissue as well as in

liver (61).
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Reversal of light-dark cycles is accompanied

by a similar phase shift of the biosynthetic rhythm.

Since

rats consume most of their daily food ration during dark

periods and the 2, 5 hours preceding onset of darkness it is

suggested that the true stimulus of the rhythm is food

consumption rather than darkness.

To test this suggestion

rats were allowed access to food under normal lighting . con

ditions (lights on 6 AM to 6 PM) only from 9 AM to 1 PM.

This caused a shift of daily rhythm and the new maximum of

cholesterol synthesis activity occurred at 6 PM (61).
C.

/J -Hydroxy-,8 -methylglutaryl Coenzyme A Reductase

Early definitive studies on the reduction of HMG CoA

were done by Durr and Rudney - (62).

Using an enzyme prepa

ration derived from bakers • yeast these workers described

properties of the reaction which were later found to be in

common with the same enzyme derived from mammalian sources.

As the enzyme was purified beyond a specific activity of
1. 0 it became increasingly unstable and required thiol

protecting reagents to maintain the activity.

This, as

well as the subsequent finding that reduction of the sub

strate was completely inhibited by Q-hydroxymercuribenzoate,

demonstrated the enzymatic requirement for free thiol
groups.

For each mole of HMG CoA reduced two moles of

NADPH are consumed and one mole each of free coenzyme A and

mevalenic acid are produced (equation 4).

The enzyme was
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found to be specific for HMG C0A only and acyl transfer or
phosphate transfer were n0t required.

Additionally, the

reaction was demonstrated to take place irreversibly.

irreversible nature of the reaction is reasonable since

The

thioester bonds are high energy sources and their reductive

cleavage is accompanied by free energy loss of approxi

mately 8200 calories per mole (62).

The monodirectional

biosynthetic flow at this reaction is one of the early

stimuli which suggested the regulatory nature of this

enzyme,

Finally, the continuing question of the identity

of possible reaction intermediates was opened by this in
vestigation (62).

Inability to inhibit reduction of HMG

CoA by the addition of semicarbazide or the semicarbazone

of mevaldic acid was evidence that the free aldehyde was
not involved as an intermediate.

Reduction of HMG CoA to mevalonic acid is the first

unique step as well as the rate limiting step of polyiso
prenoid biosynthesis (6J, 64).

Early suggestions that this

unique position is related to possible regulatory functions

of the enzyme were made by Siperstein (64).

Using incor

poration experiments and a rat liver preparation it was

shown that chelesterol feeding exerted its effects on this

enzyme.

Conversion of squalene to cholesterol or of meva

l0nic acid t0 squalene were not depressed by cholesterol

feeding and therefore it was reasoned that the site of syn
thesis depression must be prior to mevalonic acid.

Acetoacetyl CoA is a precursor for the synthesis of long
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chain fatty acids as well as for cholesterol,

Similarly,

HMG CoA is a precursor not only of cholesterol but also

of ketone bodies, acetoacetate and P -hydroxybutyric acid.

Therefore, if cholesterol feeding exerts its effects at the

conversion of acetate to acetyl CoA, acetyl CoA to aceto
acetyl CoA, or of acetoacetyl CoA to HMG CoA a block of

fatty acid and ketone body synthesis would be observed

along with a block of cholesterol biosynthesis (Figure 5),
Since cholesterol feeding is known to alter only choles

terol biosynthesis it was concluded that the site of this

action must be HMG CoA reductase (64).

t
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Cholesterol �
<'--�- Squalene E<'--�- Mevalonic Acid
Alternate pathways for the early intermediates
in cholesterol biosynthesis, after Siperstein
(64).

The elegant efficiency of placing a regulatory site

at this position is striking; synthesis of mevalonic acid
is the first reaction subsequent to the final branching

point for alternate pathways of these early intermediates.

A regulatory site located closer to cholesterol would cause
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unnecessary synthesis of intermediates and would create the
problem of disposal of those intermediates.

With the regu

latory site located at mevalonic acid synthesis the latter
problem does not exist since the earlier reactions are

reversible and alternate synthetic pathways are available

to the intermediates.

On the other hand, if the regulatory

site is located prior t0 mevalonic acid synthesis, the pro
duction of other important metabolic products would be

altered along with the normal regulation of cholesterol

biosynthesis.

Mammalian hepatic HMG CoA reductase is bound to the

endoplasmic reticulum and therefore is found in microsomes
on isolation,

Centrifugal fractionation of rat liver micro

somes has shown that the smooth and "smooth" smooth endo
plasmic reticulum together contain the ma jority (81%) of

enzyme activity while the rough membrane fraction accounts
for only 14% of the activity (65),

The observation of a

small amount of enzyme activity in the polysome fraction
is reasonable since this is the most probable site of

enzyme synthesis,

The subcellular localization of this

reductase is important with respect ,to the location of
HMG CoA condensing and cleavage enzymes.

The latter two

enzymes, which catalyze the forward and reverse reactions

shown in equation 2, respectively, are located in rat liver
mit0chondria (66),

Since the cleavage enzyme is approxi

mately ten times more active than the condensing enzyme it
might appear that net cholesterol biosynthesis would be
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considerably hampered, if not impossible.

Compartmental

ization of these enzymes explains why liver tissue is
capable of overcoming this apparent anomaly.

Being con

fined to mitoch0ndria, the cleavage enzyme destroys only
mitochondrial HMG C0A.

Small amounts of condensing enzyme

attached to microsomal membranes allows all of its product,
as well as any HMG Co.A:"- which might leave the mitochondria,

to be available to the reductase (66).

Thus, it can be

seen that because of this compartmentalization the earliest
steps of cholesterol biosynthesis, where intermediates
are employed in alternate pathways, take place in the

mitochondria.

The unique step, mevalonic acid synthesis,

and reactions subsequent to it take place on the endo
plasmic reticulum.

Even though HMG CoA reductase is bound to the endo

plasmic reticulum membranes the enzyme has been solubilized
and refined to various degrees of purity (67-70) allowing
study of several of its properties.

The earliest suc

cessful attempt at solubilization provided an acetone

powder derived from rat liver (67) and was not an entirely
satisfactory preparation.

Using deoxycholate to remove

the enzyme frem membranes Kawachi and Rudney (68) obtained
a preparation from rat liver which allowed the determina
tion of some physical and kinetic properties.

The molecular

weight of the purified enzyme was measured in the range
217, 000 to 226, 000 and the previous report of a thiol

requirement (62) for the enzyme was substantiated and
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confirmed with this purified preparation.

Recent success in solubilizing the reductase from rat

liver microsomes illustrates the delicacy with which it
must be handled.

Taurocholic acid, pH change, presence or

absence of salts, and quick freezing methods all proved

unsuccessful in removing the enzyme from endoplasmic

reticulum membranes (69).

However, a slow freeze-thaw

cycle (8- 1 0 ° C per minute to -50 ° C) provided a soluble

enzyme preparation containing 80% of the activity of the
original rat liver microsomal pellet.

Further purification

of this preparation is possible by ammonium sulfate pre

cipitation followed by agarose gel chromatography (69).
Similarly, the most recent attempts also emphasize the

delicate nature of the enzyme.

Thus, incubation of rat

liver microsomal pellets with potassium chloride solutiGns
or suspension of a previously frozen pellet in glycerol
provided active reductase preparations (70).

These gentle

conditions removed only approximately 25% of the micr0somal

protein.

Also, the electron microscopic appearance of

microsomes after removal of the reductase showed that they
remained intact throughout the procedure.

This ease of

removing the enzyme without either disrupting the membrane
or apparently breaking covalent bonds indicated that the

reductase was peripherally located on the surface of,

rather than being an integral component of the microsomal

membranes.

This is in agreement with the observation that

HMG C0A reductase is synthesized and destroyed in vivo much

faster than the remaining microsomal protein (9 3 ),
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As with most other chemical reactions which take place

in living systems the reduction mediated by HMG CoA re
ductase is stereospecific.

Using HMG CoA and the hemithio

acetal of mevaldic acid as substrate for the yeast enzyme,

Dugan and Porter (71) demonstrated that only A-side, or

(4R)-4-H3 -NADPH, incorporated the tritium atom into mev
alonic acid.

If the two proton transfers involved in this

reduction took place with opposite stereochemistry, that

is, one transfer from the 4R side and one from the 4S side

of NADPH, the maximum theoretical yield of 5-H3 -mevalonic
acid would be 50% ,

However, with HMG CoA as substrate 78%

transfer of tritium was observed.

Similarly, using the

hemithioacetal of mevaldic acid as substrate showed a high

transfer of the isotope.

These data are conclusive evi

dence that both proton transfers from NADPH take place

stereospecifically and from the 4R side of the pyridine

ring.

Other investigators (72, 73 ) have confirmed this

finding.

Blattmann and Retey (72) found that the yeast

enzyme acted stereospecifically with respect to CJ and C5
of the substrate.

In each case reduction of the monothio

hemiacetals of (JRS)-mevaldate with coenzyme A and (JRS)

mevaldate with (R)-pantetheine as well as (JRS)-mevaldate

alone, using (4R)-4-H 3 -NADPH provided only (JR, 5S)-5-H3 mevalonic acid (Figure 6).

As discuss�g previousty, free mevaldic acid is probably

not an intermediate in this reduction (44, 62).
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this fact, the question of an intermediate for this two
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step reaction is clouded by conflicting experimental

results.

Brodie and Porter (74) were able to trap radio

active mevaldic acid after incubating a rat liver microsomal
preparation with

1 -c

14

-acetate, however, the amount of

mevaldic acid detected was not large enough to justify the

suggestion of a free aldehyde intermediate.

Therefore , it

was proposed that HMG CoA is first reduced to an enzyme

bound thiohemiacetal which is hydrolyzed to give enzyme
bound mevaldic acid.

This would explain the small amount

of mevaldic acid detected as being a result of leakage from
the surface of the enzyme.

These data are in accord with the later experiments

of Kirtley and Rudney (75),

From kinetic studies with a

yeast enzyme preparation these investigators found that

mevalonic acid is an uncompetitive inhibitor with respect to
NADPH.

Uncompetitive inhibition by the product was in

terpreted to mean that the product was bound to a different

form of the enzyme from that which bound the substrate.

possible mechanism was proposed which involves an enzyme
bound mevaldic acid (Figure 7),

A

Retey and co-workers investigated the possibility of

enzyme bound intermediates in the yeast system (76).

Using radioactive coenzyme A it was found that the reductase

did not participate in acyl exchange as illustrated in
equation 5,

This indicates that there is probably no

transfer of HMG to a free SH group on the enzyme surface

48

HMG CoA

+

ES-HMG

+

ES-MAL

+

ES-MVA
Figure

ESH

NADPH +

NADPH +

< >
�< >
� < >
>

ES-HMG

ES-MAL

ES-MVA
ESH

CoASH

+

NAD P

+

NAD P

+

MVA

+

Mechanism proposed by Kirtley and Rudney (75)
illustrating enzyme bound mevaldic acid, E =
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and, therefore, no formation of enzyme bound intermediates
as proposed by Kirtley and Rudney (75) and by Brodie and
Porter (74).

This enzyme preparation did not reduce

HMG-S-pantetheine, but (RS)-mevaldic acid-pantetheine hemi

thioacetal was readily reduced almost as fast as normal

substrate.

This observation indicates that conversion of

substrate to a hemithioacetal and reduction of this hemi

thioacetal to mevalonic acid occur at two different sites
on the enzyme surface.

The first proposed site would be

strictly specific for HMG CoA as substrate while the latter
site would accept mevaldate CoA hemithioacetal.

It is

clear that further experiments are necessary to fully

elucidate the true nature of possible intermediates in this

reaction, and specifically, whether these two sites

actually exist and, if so, whether they represent physically
distinct regions of the enzyme, conformational changes
taking place at the active site, or both.
HMG CoA

+

14
C 14-CoASH � HMG-C -CoA
�

+

CoASH

( eq . 5)
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The developmental pattern of HMG CoA reductase in rats

has been studied by Rodwell et al, (77, 78).

In general,

enzyme activity rises very rapidly just prior to birth then
sharply falls after birth to a level near that of adults.

This level is maintained for eight days then declines pre

cipitously.

On the third day after weaning enzyme activity

overshoots adult levels threefold and slowly declines until

adult levels are reached in the second week after weaning.
It is interesting to note that throughout development

cholesterol synthesis parallels these variations in enzyme
activity, indicating that the reductase is the rate deter

mining step of cholesterol biosynthesis during development.
The drastic fall of activity prior to weaning is not

due to cholesterol in suckling milk.

This was demonstrated

by the observation that hepatic cholesterol levels change
very little during suckling; both free and total hepatic

cholesterol levels remain within ± 1 0% of adult levels
throughout development (77),

Premature weaning caused a

rise in activity as did normal weaning and late weaning
prevented this rise.

Thus, it appears that the rise of

activity associated with weaning is due to dietary changes

which take place at weaning.

Evidence for the presence of an inhibitor of the

reductase in suckling rat liver was observed (77),

In

cubation of adult rat liver microsomal enzyme preparations

with the 7, 000 x g and 50, 000 x g supernatant from suckling
liver homogenates caused a 20% reduction of adult activity.

This depression was not observed with adult supernatant

solutions.
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The inhibitor could be precipitated by am

monium sulfate and was nondialyzable but has not been

characterized.

The initial rise of enzyme activity from

the low suckling values to adult levels was not blocked by

cycloheximide administration and therefore must be due to

relief of an inhibition of the enzyme which takes place at
weaning, rather than by alterations in protein synthesis.

Thus, the developmental pattern of this enzyme seems to be

controlled by dietary factors which appear to regulate

enzyme synthesis as well as by an uncharacterized hepatic
inhibitor of the reductase.

Most of the previ0usly discussed factors which alter or

regulate cholesterol biosynthesis have been shown to act
by exerting their influence on HMG CoA reductase.

As a

body, this work provides proof of the important rate
limiting and regulatory functions of this enzyme.

Many of

these studies have been approached by measuring changes in

the degree of incorporation of one intermediate into another

or into cholesterol itself in response to some physiological
or experimental condition.

A note of caution has been

raised concerning this method (79) since it assumes that

changes of incorporation rates directly reflect changes of
rates of biosynthesis.

Rates of incorporation of radioactivity into a spe

cific product are not necessarily equal to rates of syn
thesis of that product because of possible dilution of
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the radioactive precursor by endogenously synthesized
precursor .

For example, using rat liver microsomes White

and Rudney (79) found that the specific activity 0f labeled
acetoacetate was only 1 6% of what it should have been if

c 14 -acetyl

CoA were the only precursor.

This effect was due

to formation of acetoacetate by endogenous synthesis and
dilution of the labeled pool.

These results cast doubt on

experiments showing HMG CoA reductase to be the control

point for cholesterol biosynthesis since this work is based
on incorporation of labeled substrate into a product.

Changes of incorporation into a product are an accurate

measure of an alteration of the synthesis of that product

only if the specific activity of the precursors remains
unchanged.

Thus, in the present case of cholesterol syn

thesis when some experimental condition alters incorpo

ration of acetyl CoA but not of mevalonic acid into cho

lesterol the alternate explanation to considering HMG CoA
reductase as a regulatory reaction is that unlabeled sub
strate from endogenous sources may have entered the
pathway. _prior to mevalonic acid.

This would reduce the

specific activity of precursors and therefore make it
appear that synthesis has . been inhibited.

If the experi

mental condition enhanced fatty acid oxidation or gly

colysis, the pool size and therefore the specific activity
of acetyl CoA would change.

Possible solutions to this problem include removal of

endogenous substrate pools from the test system or using
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such large quantities of radioactive substrate that
endogenous contributions would be insignificant.

The former

solution is not feasible while the latter would be satis
factory only for single step reactions and the high �on

centrations of substrate necessary may inhibit other

reactions.

White and Rudney have solved this problem in a

general manner by developing a method for the direct

measurement of acetoacetate; pince this intermediate is

related to both HMG CoA and mevalonic acid, the necessary
specific activities could be calculated (79),

Similarly,

these investigators developed three systems for the direct

assay of HMG CoA reductase as well as a method which

cleanly separates and measures HMG and mevalonic acid.

results showed that for the early steps of cholesterol

The

biosynthesis the tacit assumption of equality of label in
corporation and synthesis rates was accurate; therefore

previous experiments indicating the regulatory nature of
the reductase remain valid.

Thus, after unveiling this

potentially serious problem White and Rudney (79) have
provided a satisfactory general solution.

Among all the experimental conditions used to study

this enzyme, cholesterol feeding is perhaps the best known.

As described previously, dietary cholesterol reduces choles
terol biosynthesis and it has been found that this regu

latory action takes place at the site of HMG CoA reductase
(63, 78, 80-8J).

The reductase is always the most important

site of inhibition, but if cholesterol feeding is of
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extended duration other sites also contribute to the

overall blockade.

The inhibition obtained by feeding cho

lesterol is drastic; short periods provide 80-90% or more

depression of cholesterol biosynthesis while extended

feeding periods are associated with complete suppression of
synthesis .

Most evidence indicating that HMG CoA reductase is the

true regulatory site for cholesterol biosynthesis is of

an indirect nature.

Siperstein and Fagan (81) developed

gas chromatographic analytical techniques which allowed
separation and measurement of HMG and mevalonic acid,

other systems cholesterol feeding caused depressi�n of
synthesis by more than 95% as measured from rat liver

As in

microsomes while there was no effect on the condensing
enzyme.

Direct measurement showed that HMG levels were

normal , but mevalonic acid · 1evels were severely depressed
in cholesterol fed animals.

The depression of mevalonic

acid levels was sufficient to account for the corresponding
depression of cholesterol synthesis .

These data substan

tiate previous indirect evidence that the reductase is the

site of action during cholesterol feeding and the analytical
technique used makes this work the first direct observation

of this fact.

Using the computational technique (79) which avoids

the assumption that incorporation rates are equal to syn

thesis rates White and Rudney also showed that in rat liver

microsome preparations cholesterol feeding caused depression
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of reductase activity by more than 90% ( 8 3 ) ,

When a

soluble system was used small degre es of depression of HMG
CoA condensing enzyme were observed under cholesterol

feeding conditions.

This work agrees with the fact that

the major effect is on HMG CoA reductase but also indicates

that under conditions where substrate availability for the

reductase is limiting the slight inhibition of condensing
enzyme may become important.

The mechanism of the clearly demonstrated lowering of

HMG CoA reductase activity caused by dietary cholesterol
has be en the object of much investigation.

mechanisms include (78, 82):

Possible

1) direct inhibition of the

enzyme, 2) allosteric inhibition of the enzyme, 3) changes

of the rate of enzyme synthesis by interfering with mRNA
synthesis, de stabilization of polysomes, or interference

with incorporation of the completed enzyme into the endo

plasmic reticulum, or 4) increasing the rate of disso

ciation of the enzyme from the endoplasmic reticulum or
enhancing the degradation rate of the enzyme, or both .

The first possibility may be excluded since cholesterol

or some other soluble compound does not act as a direct
inhibitor (82) ,

This conclusion was derived from the

observations that albumin or propylene glycol suspensions

of cholesterol, as well as cholesterol rich low and very

low density lipoproteins from livers of both normal and

cholesterol fed animals did not alter reductase activity

in vitro (78),

Similarly, mixing experiments where liver
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preparations from cholesterol fed animals were added to

normal preparations showed no alterations of activity and

therefore the absence of a soluble inhibitor,

possible mechanism may also be excluded.

The second

Although the total

activities of the enzyme derived from normal and cholesterol

fed animals are vastly different their kinetic properties

are so similar that the reductase cannot be an allosteric

enzyme (78),

It is therefore evident that dietary choles

terol is not a true feedback inhibitor of cholesterol
biosynthesis.

The apparent inhibitory effect of cholesterol on HMG

CoA reductase is actually one of altering the amount of

enzyme rather than the activity of the reductase (78, 82).

Experiments involving study of the diurnal rhythm of this

enzyme indicate that dietary cholesterol acts to alter the
rate of rise of enzyme synthesis while the normal rate of
degradation is maintained.

Thus, the true mechanism of

dietary cholesterol on cholesterol biosynthesis is an un
known effect which alters synthesis rates of HMG CoA

reductase.

As with cholesterol feeding, severe lowering of HMG

CoA reductase levels is caused by fasting (6J, 78, 80, BJ),

a physiological condition which is apparently opposite to
that of cholesterol feeding.

This effect is expressed at

the reductase step and appears to be associated with changes
of enzyme synthesis.

not understood,

The mechanism of this phenomenon is
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The ma jor site at which the effects of cholesterol

feeding and fasting are expressed is HMG CoA reductase.

an attempt to determine if other secondary regulatory

In

sites exist Slakey et al. (84) studied the effects of fast

ing and refeeding on the seven enzymes which mediate the

conversion of HMG CoA to squalene.
C

14

Sterol synthesis from

·
·
-ace ta te and c 1 4-meva 1 onic
acid
was depressed by fasting

and rose in response to refeeding.

For each enzyme examined

except mevalonic kinase and phosphomevalonic kinase, the

total activity fell during fasting; however, with respect

to HMG CoA reductase the magnitude of these depressions was

small.

It was concluded that during most of the fasting

and refeeding periods the overall rate of cholesterol bio

synthesis was controlled by the amount of HMG CoA reductase.
The time course for conversion of acetate to digitonin

precipitable sterols was parallel to that of reductase

activity ; and total activity of the reductase was considered

sufficient to account for the observed rate of sterol syn
thesis.

This conclusion was based on studies of only the

initial and final components of the entire sterol biosyn

thetic pathway.

Kinetic analysis indicated that the enzymes

in this seven membered segment of the pathway are not co

ordinately controlled and that the flux of material thr0ugh
this portion of the pathway was not well explained by con

sidering HMG CoA reductase as the sole regulatory step.

Thus, it was concluded that there may be two additional

regulatory sites between mevalonic acid and squalene.

57
This conclusion was in agreement with the work of Gould and
Swyryd (54) who postulated the existence of two secondary

regulatory sites between mevalonic acid and squalene.

additional sites detected by Slakey et al. (84) may be

The

identical to those proposed by Gould and Swyryd and, like

the latter, may become important only under certain con

ditions.

As previously discussed for cholesterol biosynthesis,

with very little emphasis placed on the role of the rate

limiting reaction, bile acids alter the conversion of

acetate to cholesterol, their presence being associated

with decreases and absence with increases.

It has been

shown that these effects are due to changes in the level
of HMG CoA reductase (78, 85, 86) although the exact

mediator of these changes is a sub ject of considerable dis

agreement.

Using rat liver microsomes Hamprecht et al.

(85) showed that bile acids inhibited the reductase in vitro
and taurochenodeoxycholate and taurodeoxycholate were the
most efficient inhibitors.

Since the total bile acid

concentration in rat liver is only approximately O. J mM,
in vitro inhibition of cholesterol biosynthesis by bile

acids is probably not due to actual inhibition of the enzyme
because the above experiments were done with concentrations

of bile acids greater than the physiological concentration.

Similarly, this inhibition was neither fully reversible nor
fully irreversible, indicating that bile acids were not

allosteric inhibitors of the reductase.

Therefore, it was
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proposed that in vitro effects of bile acids on this enzyme
were due to a nonspecific detergent action on the membrane
bound enzyme (85).

In vivo experiments (85) indicated that

bile acids altered synthesis of the enzyme and that their
in vitro activity did not accurately reflect in vivo ac

tivity.

Two possibilities for the mechanism of bile acid in

hibition of cholesterol biosynthesis were considered:

The

bile acids either altered synthesis, degradation, or both,

of HMG CoA reductase or they enhanced absorption of choles
terol which was the true mediator (86).

When absorbed in

the gut cholesterol must pass through the thoracic duct
before reaching the liver.

On the other hand, bile acids

reach the liver directly after absorption via the portal
vein.

For these reasons, in rats with cannulated thoracic

ducts cholesterol is eliminated after absorption and never

reaches the liver.

This allows the study of the effects

of bile acids independent of any effects related to choles
terol absorption.

Cholic acid feeding of rats with this

lymphatic diversion depressed hepatic HMG CoA reductase.

Thus, Hamprecht et al. (86) believe that bile acids exert

their effect on cholesterol biosynthesis by interfering
with the synthesis of HMG CoA reductase.

These results

are in direct disagreement with the work of Weiss and

Dietschy (51) who, by experiments with bile fistula rats,

claim that bile acids alter cholesterol biosynthesis only

by improving intestinal absorption of cholesterol.
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As with many biochemical processes, hormones influence

HMG CoA reductase but their effects have been studied to
a much less comprehensive extent than dietary and drug

effects.
levels.

Thyroid hormones were found to alter reductase

Using isolated perfused rat liver, Gries et al.

(87) studied the effects of these hormones on levels of the
reductase as well as of other enzymes and discovered that

the level of reductase present was a function of the con
It was observed

centration of thyroid hormone present.

that after perfusion with DL-thyroxine, enzyme levels in

creased and paralleled cholesterol biosynthesis.

After

thyroidectomy, HMG CoA reductase levels fell until activity
was barely detectable; however, this activity could be re

established by triiodothyronine. Similarly, with rat liver
.
.
.
.
microsome preparat ions, i n J. ect ion
of r 1J i to suppress

thyroid function of the test animal caused the reductase
activity to be lowered to 42% of control values (88).

Thyroidectomy caused a fall in reductase levels to 35% of

normal levels, in agreement with the experiments of Gries

et al, (87),

Finally, hypothyroid animals were injected

with 3, 3 ' , 5 ' -triiodothyronine, killed, and HMG CoA reduc
tase activity was assayed in the livers.

Until JO hours

after injection reductase activity remained in the range
typical of thyroidectomized animals.

Thereafter, activity

rose rapidly until 45 hours after injection when normal
reductase activity was achieved and maintained for the

remainder of the experiment.

The JO hour latent period in

these experiments indicated that triiodothyronine was
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stimulating enzyme synthesis rather than having a direct

effect on the enzyme itself (88).

It is possible that this

activity of thyroid hormones is due to their general stim

ulation of metabolic functions, although later experiments

show this to be unlikely.

Another hormone which alters HMG CoA reductase

activity is insulin.

It has been recently demonstrated

that rat liver microsomal reductase activity increased two
to threefold with respect to controls after subcutaneous

insulin administration (89) and diabetic rats exhibited
an even larger increase of activity.

For both the normal

and diabetic animals, the observed increases of activity
corresponded to increases of acetate incorporation into

cholesterol.

Glucagon, the physiological insulin antago

nist, completely blocked these enhancements when admin

istered two hours prior to insulin.

These experiments

are another case in which the effect of an experimental

condition on HMG CoA reductase is believed to have been

caused by increase of activity due to the stimulation of
synthesis of new enzyme.

In similar experiments it has

been found that the reductase activity of alloxan diabetic

rat liver microsomes is lower than the activity in healthy
animals (90).

As expected, insulin administration caused

an increase of enzyme levels to the normal range.

Contrary

to the results of the previous example, Huber et al.

observed an increase of activity in re sponse to glucagon
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in jection (90).

However, this effect was transient in

nature and was followed by depression of activity to below

control levels.

The mechanisms of these recently reported

effects are yet to be elucidated.

Finally, it has been suggested that norepinephrine

enhances HMG CoA reductase activity (91).

Within twelve

hours after norepinephrine in jection cholesterol biosyn

thesis had doubled, as assayed in rat liver tissue slices.
This increase was not a direct effect since addition of

norepinephrine to a tissue slice incubation had no effect.
Treatment with puromycin abolished this increase _but did

not inhibit conversion of labeled mevalonic acid to cho
lesterol.

On this basis stimulation of enzyme synthesis

was suggested as the mechanism of the norepinephrine

effect.

Very recent work has shown that addition of 3 ' , 5 ' 

cyclic AMP to rat liver microsomes, liver cells, and 5, 000
x g liver supernatant lowers the incorporation of acetate
and acetyl CoA into cholesterol but does not alter the

incorporation of mevalonic acid (92).

Similarly, addition

of ATP and Mg++ to rat liver microsome preparations was

shown to lower reductase activity.

However, if the micro

somal pellet was washed three times with buffer the ability
of ATP and magnesium ion to inhibit the reductase was lost.
This indicated that some soluble agent with inhibitory

capabilities was present.

On investigation of the nature

of this agent it was found that addition of 100, 000 x g
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supernatant to washed microsomes restored the ability of
ATP and magnesium ion to inhibit the enzyme.

Th� inhib

iting factor was found to be protein in nature since the

reductase activity was also decreased by preincubation

with material precipitated from 100 , 000 x g supernatant

by ammonium sulfate.

These experiments demonstrate the

presence in rat liver cytosol of a protein, perhaps a
kinase , which inhibits HMG CoA reductase activity.

A

possible mechanism for this inhibition may be an altera

tion of the conformation of the reductase by interaction
with this protein material.

The previously discussed diurnal rhythm of cholesterol

biosynthesis is caused by a diurnal rhythm of HMG CoA
reductase (63 , 78).

This cyclic variation of enzyme level

has been intensively studied but there remain several
aspects which are not clearly defined or agreed upon.

Maximum reductase levels occur at approximately midnight

while the minimum occurs close to noon (93) and the

difference in activity between these two points is five to
tenfold.

Study of the fine structure of the rhythm shows

that , in fact , there are two maxima occurring at midnight
and 1 : 45 AM (94).

There are several po£ sible explanations

for this pair of maxima.

A labile enzyme degrading system

could appear for short periods destroying a portion of the
increased levels of reductase present (78).

It is also

possible that there exists a metabolically programed limit
to enzyme levels and when this limit is exceeded cellular

controls act to decrease enzyme synthesis (78) ,
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If this is

true then it is reasonable to assume that both peaks are

due to the same rise of enzyme synthesis.

The decline

of activity between these maxima would then be caused by a

control overshoot and when the enzyme has reached low

enough levels for the control system to stop functioning
enzyme levels would begin to rise.

It should be noted that

these plausable explanations are speculative and their

confirmation or disproval awaits further experimentation.

Fasting is known to depress cholesterol biosynthesis

and therefore might be expected to alter the diurnal

rhythm.

Hamprecht et al. (95) showed that in fasted rats

the rhythm persists but at a much lower amplitude than in

fed controls.

This has been interpreted as evidence that

the rhythm is not a response to eating habits of the
animals.

Several investigators have probed the mechanism and

causative factors associated with the diurnal rhythm of
this enzyme.

One possible cause for the rhythm is changes

in the rate of enzyme synthesis, degradation , or both ,

Measurement of formation and destruction constants for the
reductase at various times during the cycle show that the
breakdown constant changes very little but the formation

constant increases seven to tenfold during the diurnal rise

over that observed during diurnal fall (96).

It therefore

appears that the rhythm is due to increased enzyme syn

thesis during the rise with almost constant degradation
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rate s throughout the cycle .

Othe r inve s t igators have also

implicated prote in synthe s i s as the ma j or rhythm c ontrolling

fac tor .

Unde r the assumption that amino acid inc orporati on

was a val id measure of pro t e in synthes is , H J -leuc ine in
c orporati on int o the enzyme has b e en s tud i e d ( 6 J , 97 ) ,

Variation of rad i oac tivi ty in the i s o lated enzyme accu

rate ly reflec ted the rise and fall of activity throughout
the cycle .

Inc rease of lab e l inc orporation pre c e d e s the

c yc l ic enzyme r i s e s by f our to s ix hours and thi s may be

the time ne c e s s ary for prote in synthe s i s to be re flec ted
in enzyme leve l s .

Higgins e t al . ( 97 ) c laim that the s e

data provide unequivocal evidence that the diurnal enzyme
variat i on is due to an increased rate of enzyme synthe -

s i s for s ix hours during c y c l i c r i s e followed by c ompl e te

c e s sation of enzyme synthe s i s for f ifteen hours during the
cyclic d e c l ine .

Add i t i onal evid enc e for the role of enzyme synth e s i s

was provided b y the work o f Edwards and Gould ( 93 ) .

Follow ing in j e c ti on of rats w i th cyc loheximide , HMG C oA
reduc tase act ivity always d e c l ined .

If a degradatory

prote in were the ac tual c ause of the rhythm , cycloheximide
adminis tration would have inhibited its synthesis and re
duc tase leve ls would have d e c l ined s l owe r than normal .

This was not observed and enzyme synthe s i s was onc e again
imp l i c ate d .

Shapiro and R odwe ll ' s experiments are in

c omplete d i s agre ement w i th this hyp othe s i s ( 9 8 ) .

They

found that cyc loheximide treatment c aused a c omplete block

of the normal diurnal rise of reductase levels; however,

enzyme levels remained elevated after cycloheximide treat

ment, indicating that the diurnal fall had also been
blocked.

These experiments are evidence that the diurnal

rise is due to enzyme synthesis but that the fall is caused
by synthesis of a degradatory protein rather than by ces

sation of reductase synthesis.

The relationship of feeding habits and light-dark

cycles to the diurnal rhythm of this enzyme have been in
vestigated.

When the light-dark cycle under which experi

mental animals were housed was shifted by twelve hours the

diurnal enzyme rhythm also exhibited a twelve hour shift

within seven days (99), maintaining peak activity in the
dark phase.

During this same period food consumption was

also shifted into the new dark phase, obscuring whether
light and dark cycles or feeding habits were important

factors.

Similarly, regardless of the magnitude of the

shift in light-dark cycles, maximum enzyme levels were

always observed very close to six hours after the onset of
darkness (9J), however, since rats normally feed during
darkness, food consumption always shifted also.

Strong

evidence for effects of food consumption was provided by

experiments where feeding was restricted to the period
8: JO AM to 10 1 JO AM (96).

Under these conditions enzyme

levels rose rapidly and peaked at approximately noon.

Rats maintained in continuous light for nine days exhibited
a diurnal rhythm of normal magnitude but the peak enzyme

levels occurred slightly later than normal and minimum

levels were slightly higher than control (100),
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Similarly,

rats kept in continuous darkness for nine days showed

normal rhythm where peak enzyme levels occurred slightly
earlier than normal.

Examination of the rhythm in continu

ous light conditions is the experiment suggested by

Hickman et al, (60), and preservation of the rhythm under

these conditions excludes corticosterone as a regulator of
these cyclic variations.

Finally, superior cervical

ganglionectomy did not abolish reductase rhythm (100), in
dicating lack of involvement of the pineal gland.

Adrenalectomized rats have been shown to maintain

normal diurnal rhythm of the reductase (101).

This means

that enzyme variations are not controlled by corticosterone,

which is produced in the adrenal cortex, supporting the
above results with continuous lighting, or by catechol
amines, which are produced in the adrenal medulla.

Con

sidering the rate limiting nature of the reductase, this

observation is contradictory to the experiments of Hickman
et al. (60) who found that adrenalectomy abolished the

diurnal rhythm of cholesterol biosynthesis but that the

rate of biosynthesis was maintained at high levels.

Clearly, an unknown factor appears to be related to both

rhythms.

Thus, in view of the contradictory nature of

much of the evidence concerning diurnal variations, it
appears that food consumption is a primary controlling
factor but that other factors may also be involved.
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Another aspect of the involvement of HMG CoA reductase

with cholesterol synthesis and regulation is presented by

hepatoma tissue.

Numerous investigators have shown that

cholesterol biosynthesis in several hepatomas does not

respond to fasting and cholesterol feeding as do normal

cells (63, 78, 102-106).

This apparent los s of regulation

has been observed in several types of hepatomas in rat

(102, 104, 105), mouse (102, 103, 106), and man (104).

Early investiga�ions of this phenomenon were done by

Siperstein and Fagan (102) who found that rat and mouse

hepatomas synthesize cholesterol and that the site of

dietary cholesterol effects, HMG CoA reductase, was indeed
present and functioning.

Their experiments showed that the

absence of cholesterol biosynthesis regulation by dietary

cholesterol was not caused by the rapid growth of tumor

tis sue, lack of HMG CoA reductase, or loss of the ability

of tumor tis sue to synthesize cholesterol; rather, it was

concluded that the los s of regulation was due to mal

functioning regulatory mechanisms.

Later studies of

kinetic properties of HMG CoA reductase isolated from both

tumor cells and normal liver cells demonstrated that the

tumor enzyme was not measurably different from the normal
enzyme (103),

It therefore appeared that failure of regu

lation in hepatomas was due to the inability of dietary

cholesterol to reach the site where it acts or to a defect
in the regulatory system itself.

In addition to the lack

of control by dietary cholesterol or fasting, tumor tissue
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exhibited no diurnal variations of cholesterol biosynthe

sis (107).

Attempts to experimentally define a defective regu

latory system in these hepatomas may not be necessary since
some investigators suggest the true defect to be inability

of dietary cholesterol to enter hepatoma cells (63, 78, 106,
108, 109).

Using mouse liver slices and mouse liver

homogenates, Sabine (108) studied the effects of bile acids
on hepatomas 512J C and BW7756 and found that cholesterol

biosynthesis was not affected in these hepatomas by removal

of bile acids.

However, in vitro addition of bile acids to

cell free hepatoma preparations caused inhibition of tumor
cholesterol biosynthesis as effectively as normal choles
terol synthesis.

On the other hand, addition of bile acids

to whole cells exhibited inhibition in normal liver but

not in hepatoma cells.

The inescapable conclusion is that

hepatomas do not exhibit regulation of cholesterol biosyn

thesis because the regulating agent is not able to enter the
cells.

Finally, using label uptake experiments, Harry et al.

(109) observed that administration of H J -cholesterol to

rats was followed by uptake of radioactivity into normal

liver cells but not into Morris hepatoma 7787 cells.

This

provided clear evidence that the lack of cholesterol regu

lation by tumor cells was due to the inability of choles

terol to enter the cell, not to a regulatory system defect.
The above discussion shows that cholesterol, its

biosynthesis, and HMG CoA reductase play important roles
in atherosclerotic diseases.

In at least one case, famil

ial hypercholesterolemia, HMG CoA reductase has been dem

onstrated to be the most important, if not causative,
disease factor (110).

Familial hypercholesterolemia is an

autosomal dominant trait which the heterozygote usually

carries for JO to 60 years in an asymptomatic condition.

Homozygotes for this gene develop (110) :

1) extremely high

plasma cholesterol levels, often exceeding 800 mg per 100

ml, 2) cutaneous planar xanthomas in early life, J) coro

nary, cerebral, and peripheral occlusive vascular diseases
in childhood.

These conditions are associated with ac

cumulation of cholesterol in atheromatous plaques.

Death

usually occurs in these individuals as a result of myo
cardial infarction often prior to the age of JO,

Goldstein and Brown (110) have recently studied HMG

CoA reductase obtained from fibroblasts of homozygotes for

familial hypercholesterolemia.

Normal human fibroblasts

maintained on fetal calf serum exhibited low levels of
reductase activity.

If the medium was replaced with

human lipoprotein deficient plasma, reductase activity in
creased.

When human low density lipoprotein was added,

enzyme activity declined in a manner which was both time
and concentration dependent.

This observation is remi

niscent of certain conditions which have regulatory effects

on this enzyme.

Under the same experimental conditions

HMG CoA reductase from human homozygote fibroblasts
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exhibited sixty times higher activity than normal human
cells when maintained on fetal calf serum.

Replacement of

the calf serum with human lipoprotein deficient plasma or

human low density lipoprotein was accompanied by no change
in enzyme activity.

This lack of regulation was shown to

be unrelated to added materials since incubation of low

density lipoprotein, derived from normal and homozygote
sub jects, with normal fibroblasts was able to depress
enzyme activity.

These experiments are a clear demon

stration of defective HMG CoA reductase regulation being
integrally related to a hypercholesterolemic disease

with atherosclerotic complications.

Because kinetic properties of the reductase from

normal and homozygote are nearly identical the genetic

determinant for the enzyme itself does not appear to con
tain the defect.

Further, a genetic alteration would cause

changes of enzyme structure which would be expressed as
changes of enzyme activity, not regulation.

It was con

cluded that the genetic mutation of familial hypercholes

terolemia causes a defect in the regulation of HMG CoA
reductase activity by lipoproteins (110).

It is possible

that this could occur by mutation of a gene which normally

specifies the elaboration of a protein which is critical
to enzyme regulation.

This regulatory defect results in

the extremely high rate of cholesterol biosynthesis ex
hibited by the homozygote.

Thus, the ability to inhibit

cholesterol biosynthesis, preferably at the reduction of
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HMG CoA to mevalonic acid with no other metabolic changes,
would provide an effective means of treatment of familial

hypercholesterolemia.
this time.

D.

Such an ability does not exist at

Hypocholesterolemic Agents

Treatment of atherosclerotic diseases is confronted

with a unique quandary.

siderations:

The problem arises from two con

first, the great difficulty of proving a

causal relationship between hyperlipidemia and hypercho

lesterolemia and the diseases and second, the multifaceted

nature of the several factors which evidently act together

to produce these diseases.

Thus, it is not possible to

positively state that lowering of serum cholesterol and

lipid levels will in fact aid in the prevention 0f athero

sclerosis.

This is emphasized by a statement from the

American Heart Association Study Group, "Primary Preven

tion of the Atherosclerotic Diseases" when referring to
drug treatment of atherosclerosis :

"What is yet to be de

termined is whether biochemical action of these or similar
drugs will exert any favorable effect on the cause of the

atherosclerotic diseases and whether long-term continued

use of these substances produces significant deleterious
effects" (117) ,

However, in spite of this uncertainty it

is generally accepted that even though lowering of blood

cholesterol and lipid levels may not provide an absolute
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cure for atherosclerosis, it certainly cannot be harmful
and might even be beneficial.

Therefore, an important

means of approaching atherosclerosis therapy is by attempt

ing to lower blood levels of these substances.

Several methods are known for lowering ch0lesterol

levels.

Dietary measures can be designed which limit the

consumption of cholesterol and other lipid substances

although the magnitude of lowering obtained with these

programs is often small.

Enhancement of cholesterol ex

cretion, metabolism, or both is a second method.

Like

dietary measures this program does not generally produce
dramatic results .

Furthermore, consumption of t�e _large

quantities of polymeric resins necessary to achieve these
effects often acts as a negative incentive for such a

therapeutic regimen.

Finally, the most extensively explored

method of lowering cholesterol levels is by inhibition of

its biosynthesis.

Several agents have been developed for

this purpose and varying degrees of success have been

achieved.

A discussion of the choice of the inhibition

site and the design of these agents will be found in a

later section .

Although a vast number of agents which

reduce serum cholesterol levels have been synthesized, only
a few of the more important examples _ will be considered

here.

The initial approach to treatment of hypercholes

terolemia and hyperlipidemia is dietary (25, 111).

An

early method of dietary management consisted of addition
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of sitosterol to the diet.

The rationale for this treat

ment was that sitosterol is not absorbed from the intes

tines but does form single crystals with cholesterol from
which neither component can be physically separated.

Pollak (112) found that feeding rabbits varying quantities

of sitosterol along with enough cholesterol to induce

atherosclerosis resulted in the lowering of blood choles
terol levels.

This was a graded response; the higher daily

sitosterol doses caused greater depres sion of cholesterol

levels.

In addition, sitosterol feeding protected against

atherosclerosis which normally developed in cholesterol fed

rabbits.

Extension of these studies to humans afforded

es sentially identical results (113),

In these experiments

it was noted that the cholesterol lowering effects were

greater for high initial blood levels than for low initial

levels.

One drawback of this method is that very high

consumption of sitosterol (up to 10 grams per day) is
required.

Dietary management of hypercholesterolemia can also

be accomplished by adoption of a modified diet.

These

diets are usually designed to reduce obesity and to depres s

blood lipids a s much as pos sible.

A diet designed for

moderate reduction of blood cholesterol levels eliminates
butter fats and vegetable oils, replaces meat with fish,
and employs skim milk and polyunsaturated fats.

This diet

has been shown to yield a 17% lowering of serum cholesterol

levels (114).

Similarly, strict cholesterol lowering
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diets completely eliminate butter and margarine fats,

drastically reduce meat consumption, and use high protein

vegatables such as peas and beans .

Strict observation of

this diet reduces serum cholesterol levels 29% (114).

Many methods of dietary lowering of blood lipid levels

replace saturated fats with unsaturated ones.

The lipid

lowering effects of unsaturated fats are not caused by

enhanced fecal sterol excretion or redistribution of lipids
to other body pools.

Several investigators believe that

these effects are due to changes in plasma lipoprotein

compositions caused by unsaturated fats taking the place of

saturated fats .

In light of the established lipid lower

ing properties of unsaturated fats it has been proposed

that these fats are incorporated into low density lipo

protein where, because of their unsaturation, they occupy

more area than the corresponding saturated fats (115, 116) .
This may cause eonformational changes of the lipoprotein

resulting in fewer lipid molecules being accomodated by

the protein portion of low density lipoprotein thin when

saturated fatty acids are incorporated.

The overall result

is that the total lipid content of lipoprotein is lowered.
Although this hypothesis has not been rigorously proved,

it is consistent with the finding that in unsaturated fat

diets lipid-protein ratios showed less lipid to be present
in low density lipoprotein than in saturated fat diets

(115),

A thought provoking caution against abuse of

polyunsaturated fat diets has been pointed out by Mead
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( 1 1 1 ) who expressed concern about the uncontrolled auto

oxidation of these fats.

Autooxidation is the spontaneous

oxidation of a compound by molecular oxygen.

This process

is usually very slow; however, unsaturated fatty acids are
known to undergo autooxidation very readily in a manner

similar to that shown in Figure 8,
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process can be a free radical or a metal.

It has been

pointed out that peroxidized fats are known to be toxic

materials and can form in biological tissues (111).

Thus,

drastically increasing the quantity of dietary polyun

saturated fats may be accompanied by a corresponding in

crease in opportunities for these lipid peroxide and free

radical reactions to take place.

If true, the result would

be possible increases of tissue damage in excess of that
which normally occurs.

To this caution was added the

suggestion that polyunsaturated fat diets should be

accompanied by adequate antioxidant supplementation, such
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as approximately JO mg of d- � -tocopherol per day (111),

A good source of these compounds is vegetable oils which

contain not only polyunsaturated fats but also the anti

oxidants required in nature to prevent the natural poly
unsaturated compounds from decomposing.

Perhaps the best example of reducing serum cholesterol

levels by enhancement of metabolism and excretion is the

use of cholestyramine.

Cholestyramine is the chloride

salt of a basic anion exchange resin composed of quater

nary ammonium groups attached to a polymeric styrene di

vinylbenzene skeleton with molecular weight in excess of
one million.

This resin lowers low density lipoproteins

and therefore lowers plasma cholesterol levels, but does
not affect very low density lipoproteins.

By binding bile

acids it prevents their reabsorption causing increased
metabolism of cholesterol to bile acids .

In addition,

bile acids are required for intestinal absorption of

cholesterol and therefore cholesterol reabsorption is also
decreased.

In in vitro experiments cholestyramine was capable of

removing large quantities of bile acids (118).

Similarly ,

using cockerels and dogs as experimental animals, 1%

cholestyramine in the diet prevented increases of blood
cholesterol levels caused by cholesterol feeding.

In

addition, the resin is capable of lowering blood choles

terol levels of normocholesterolemic animals , indicating
that the loss of cholesterol is greater than the
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compensatory increases of biosynthesis.
have been observed in man.

Similar results

Moore et al. (119) found that

12 grams of cholestyramine per day caused reduction of
human serum cholesterol levels to 80% of pretreatment

levels with a concurrent increase of fecal bile acid loss.
The loss of bile acids continued in spite of the fact

that serum cholesterol levels became constant at their low

point, indicating that man responds with a compensatory in

crease of cholesterol synthesis, mobilization of cholesterol
from extravascular depots, or both.

However, since the low

blood levels were maintained the compensatory mechanisms

were not sufficient to return them to pretreatment levels.

The ma jor drawbacks of cholestyramine therapy include

the large daily quantities of drug required for positive
results to be observed.

A more serious complication is

the anion exchange nature of cholestyramine.

Since it is

a basic resin it is capable of binding other drugs which
are sufficiently acidic.

It has been shown to bind chloro

thiazide , phenylbutazone, phenobarbital, and tetracycline
(154).

This nonselectivity for bile acids could seriously

compromise concurrent therapy.

Of the many compounds synthesized for the purpose of

lowering serum cholesterol levels ethyl

o(

-(4-chloro

phenoxy) isobutyrate, also known as clofibrate, has

received extensive study and application.

This compound is

a safe and effective agent for lowering serum cholesterol

and triglyceride concentrations in man and has been
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demonstrated to be useful in all types of hyperlipidemia
except the rare, fat induced hypertriglyceridemia (120).

In addition to lowering human plasma cholesterol and tri
glyceride levels , clofibrate also enhances excretion of

neutral sterols in the feces , increases mobilization of

cholesterol from tissue depots (120) ; but does not appear
to lower plasma triglycerides in rats or rabbits (121),

Other workers have confirmed the finding that both choles

terol and triglyceride levels are lowered in man , although

some patients do not respond at all (127),

The mo�t pro

found hypolipidemic effect is often seen in those indi

viduals who had the highest blood lipid levels prior to

treatment.

Furthermore , Byers and Friedman also observed

a 74% reduction of incorporation of HJ -acetate into cho

lesterol in the liver (121); however , the liver mass of
treated animals was considerably greater than that of

controls , causing cholesterol content per liver to increase.

.On the other hand , cholesterol content per gram of liver

was indistinguishable for treated and control experiments .
This led to the proposal that elofibrate reduees the rate
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of hepatic cholesterol biosynthesis and thereby lowers the

influx of cholesterol into the blood rather than increasing
The increase of liver

its efflux from the circulation.

mass has also been studied by Platt and Thorp who found

that when given 0. 25% clofibrate in the diet the liver mass

increased rapidly, remained constant for approximately

sixty days, then slowly returned to normal by the termina

tion of a two year regimen (122).

For up to 29 days the

dosage of clofibrate significantly increased protein content

in rat liver; this effect appeared to precede the increase

of liver mass and continued until total protein reached
an equilibrium level.

It is not known if the agent caused

an increase of synthesis of all liver proteins or of a
specific protein.

It was initially thought that clofibrate acted by po

tentiation of the metabolic effects of adrenal steroids and

was therefore claimed to have maximum efficiency when used

in combination with androsterone (126).

This combination,

known as Atromid, gained widespread clinical acceptance.

Other investigators (12J, 124) administered clofibrate to

large numbers of human subjects for extended periods both
with and without androsterone.

Under both dosage regimens

effects on serum proteins, side effects, and toxic effects

were minimal.

Both regimens were found to be equally

effective in ability to lower elevated serum cholesterol
levels, although 15-25% of the patients did not exhibit

adequate or sustained reduction of either cholesterol or

triglycerides.

80

The therapeutic effects were so similar to

each other that it was concluded that the addition of

androsterone to clofibrate was a therapeutically useless

tactic (123),

The only ma jor side effect of this drug is its inter

action with anticoagulant agents (124, 125),

Concurrent

clofibrate and anticoagulant therapy requires reduction of
the anticoagulant dose by 33-50% (125) in order to main

tain optimum anticoagulant activity.

No correlation was

observed between hypolipidemic effects which appeared

within two weeks and the alteration of coagulation proper

ties which became noticeable within four weeks.

Many investigators have studied the mechanism of

action of clofibrate and a large body of often contradic
tory evidence has resulted.

It was initially thought that

clofibrate was bound to serum albumin and other blood

proteins at the same sites which normally bind L-thyroxine
(122, 128).

In order to bind at these sites the drug dis

placed thyroxine which was then taken up by liver cells.
This hypothesis provided no function for the drug other

than physical displacement of thyroxine, and the effects

associated with clofibrate were actually thought to be due
to normal hepatic response to the thyroid hormone.

Sup

port for this proposal was provided by the work of Chang
et al. (128) who studied protein binding in vitro.

In man

the vast ma jority of thyroxine is normal ly bound to pre

albumin, albumin, and thyroxine binding o<. -globulin.

Addition of 6 mM clofibrate to these binding proteins
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lowered the amount of thyroxine bound to prealbumin

although higher concentrations were necessary to displace

thyroxine from albumin and no displacement from thyroxine
binding ot.. -globulin was observed (128),
were obtained in the dog.

Similar results

Thes� experiments suggest that

the drug acts by displacing the bound thyroid hormone, but
do not exclude other possible mechanisms.

Best and Duncan (129) observed that adrenalectomized

and gonadectomized rats responded to this agent with normal
reductions of serum cholesterol levels.

This experiment

showed that clofibrate did not act by enhancing the action

of endogenous steroid hormones.

If these animals were

made hypothyroid with thiouracil clofibrate caused no hypo

lipidemic effects.

Similarly, thyroidectomized animals

exhibited only a small reduction of serum cholesterol
concentration in response to the drug.

This work lent

further support to the thyroid hormone displacement mecha
nism of action.

On the other hand , administration of the

drug to humans with complete primary myxedema resulted in
lowered blood cholesterol and triglyceride concentrations

(127) indicating that in man displacement of thyroxine may

not be an important mechanism of action.

Early indications that clofibrate actually inhibits

cholesterol biosynthesis resulted from in vitro experiments
with cell free homogenates of bovine aorta (130).

system the drug inhibited the conversion of labeled

In this

mevalonic acid to nonsaponifiable material.
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Support for

the suggestion that inhibition of cholesterol biosynthesis

was involved came from the experiments of Avoy et al. (131).
Using a rat liver system these investigators showed that

clofibrate drastically lowered the incorporation of labeled

acetate into digitonin precipitable sterols, but when

labeled mevalonic acid was employed as the precursor in

corporation was not significantly inhibited.

Similarly,

in vivo experiments also showed that inhibition did not

take place late in cholesterol biosynthesis.

It was there

fore concluded that clofibrate acted by inhibiting mevalonic
acid synthesis from acetate but did not inhibit fatty acid
or ketone body synthesis.

Results of this type have also

been reported by Sodhi et al, (132) using human Type I I
and Type IV hyperlipidemias.

It should be noted that it

is in this portion of cholesterol biosynthesis that the

important regulatory reaction mediated by HMG CoA reductase
is located,

The recent, definitive experiments of White (133)

provided proof that a mechanism of action of clofibrate is
indeed inhibition of cholesterol biosynthesis.

At 0. 3%

in the diet it had no effect on food consumption or weight

gain but consistently reduced rat plasma cholesterol levels
by a mean of 35%,

Using rat liver slices and cell free

homogenates it was demonstrated that incorporation of radio
active acetate into cholesterol was decreased, but incor
poration of labeled mevalonic acid was not changed.

This
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was in complete agreement with previous results (131).

Furthermore, the incorporation of radioactivity into carbon

dioxide and fatty acids was not altered by the drug and

acetoacetate formation was increased in treated animals.

This narrowed the location of inhibition to being between

acetoacetyl CoA and mevalonic acid.

Finally , clofibrate

feeding was associated with no alteration of HMG CoA con

densing enzyme but did cause decreased incorporation of
radioactive HMG CoA into mevalonic acid.

Thus , the in

escapable conclusion (133) is that clofibrate acts , at

least partially , by inhibiting hepatic microsomal HMG CoA
reductase, the most appropriate site of action for max

imum inhibitory efficiency.

Although it was shown that

the drug also interferes with the soluble enzyme system

which activates acetate to acetyl CoA this is a secondary

mechanism of action.

The recent work of Witiak et al. (155) emphasizes the

fact that clofibrate has several modes of action.

These

investigators found that treatment of rats with clofibrate

caused a significant increase of hepatic microsomal
cytochrome P-450,

This was interpreted (155) as an indi

cation that another mode of action of clofibrate is in

creased catabolism of cholesterol due to the enhancement of
hepatic cytochrome P-450,

Triparanol or 1- [Q-( � -diethylaminoethoxy)pheny � -1-

(Q-tolyl)-2-(Q-chlorophenyl) ethanol (MER-29) is an agent

which was initially thought to be a promising inhibitor of
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Triparanol
cholesterol biosynthesis.

Although it does inhibit the

biosynthesis and reduce blood cholesterol levels, this

compound is an excellent example of the disadvantages which

accompany inhibition late in the biosynthetic sequence.

Much of the promise of triparanol was due to early reports
of its apparent ability to reduce total sterol synthesis .

It was found that after feeding the compound to rats, in

corporation of radioactive acetate into digitonin pre

cipitable material was essentially unchanged with respect
to untreated animals (134).

However, when cholesterol was

separated from the digitonin precipitate and purified it

was discovered that the conversion of labeled substrate

to cholesterol had been almost totally inhibited.

Further examination of the total digitonin precipitable

material provided results applicable to the mechanism of
action of triparanol.

As previously reported, separation

of cholesterol as its dibromide accounted for very small
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amounts of total radioactivity; the ma jority stayed in the
remaining digitonide.

Investigation of the noncholesterol

precipitate demonstrated that most of the labeled acetate

had been incorporated into 24-dehydrocholesterol (des
mosterol) (135),

The_s�_. �xp�_riments provided evidence that

the reaction inhibited by triparanol was the reduction of

24-dehydrocholesterol to cholesterol and that desmosterol

is a biosynthetic precursor of cholesterol.

Further sup

port for this mechanism was provided by the finding of

very large amounts of desmosterol in the serum and liver of
triparanol treated sub jects, and undetectable amounts in
control animals (136),

Thus, triparanol treatment was

associated with accumulation of desmosterol, and even

though eholesterol synthesis was inhibited, very little
reduction of the total sterol levels took place.

Final

proof of the biosynthetic relationship between desmosterol

and cholesterol was made by Steinberg and Avigan (137) who

conclusively demonstrated the precursor nature of des
mosterol both in vitro and in vivo.

The high levels of desmosterol found in triparanol

treated sub jects is a serious drawback to the use of this

agent to accomplish reduction of serum cholesterol levels

because of the possibility that desmosterol itself may con

tribute to the atherosclerotic process.

By experiments

with rabbits, Avigan and Steinberg (138) were able to show

that dietary desmosterol was indeed incorporated into
atherosclerotic lesions.

Examination of the grossly
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normal aorta and lesions of desmosterol fed and triparanol
treated rats showed that the ratio of desmosterol to cho

lesterol in these tissues was the same as the ratio of these
sterols in the serum.

Therefore, it appeared that tri

paranol inhibition of cholesterol biosynthesis was a�com
panied by at least partial replacement of cholesterol in

lesions by desmosterol.

From these studies it can be con

cluded that if desmosterol is present in the circulation
it will be incorporated into developing atherosclerotic

plaques at a rate which is proportional to its concentra

tion in the serum.

In view of these data, use of tri

than cholesterol.

In humans treated with the drug for

paranol as a hypocholesterolemic agent would depend upon
desmosterol being deposited in plaques - at a slower rate

two to nine months desmosterol has been found in both un

involved aorta tissue and in plaque, while no evidence of

it could be detected in these tissues of untreated patients
(1 J 9 ) ,

This accumulation took place over a period of

months while an entire plaque requires decades for de
velopment.

This suggests a more rapid deposition of des

mosterol than of cholesterol.

Because of the atherogenic properties of desmosterol

and its rapid accumulation in lesions, the use of tri

paranol is not a rational method of treatment for athero

sclerotic diseases.

This compound clearly illustrates the

ma jor disadvantage of inhibiting cholesterol biosynthesis
at one of the reactions close to the end product .

The
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result is the accumulation of cholesterol precursors which

have no metabolic purpose and for which there are no alter
nate metabolic pathways available.

In the case of tri

paranol, an additional danger is present because the ac

cumulated intermediate is an atherogenic compound.

Thyroid function and thyroid hormones have been shown

to have an effect on the development of atherosclerosis;

normal, healthy, or supplemented thyroid function appears

to lend protection against these diseases (20).

Hyper

thyroid individuals often exhibit low concentrations of
cholesterol in plasma.

Hypocholesterolemia is associated

with thyroxine administration partly because the hormone

causes increased conversion of cholesterol to bile acids
to a greater extent than it causes increased cholesterol
biosynthesis (146).

These and similar considerations have

been the basis of attempts to treat hypercholesterolemia
with thyroid hormones and their analogs.

In general, the

thyroid hormone L-thyroxine causes significant reductions
of serum cholesterol levels (140).

Other effects of this

compound include a general increase of metabolic rate,·

increase of heart rate, and increased oxygen consumption.
Even though the serum cholesterol lowering properties of

L-thyroxine are desirable the concurrent increase of heart
rate and oxygen consumption may precipitate an anginal

attack in a patient suffering from coronary heart disease.

Thus, the goal of using thyroid hormones and their analogs

as hypocholesterolemic agents is to separate the general
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metabolic stimulatory properties of the hormones from their
cholesterol lowering ability.

The dextrorotatory stereoisomer of thyroxine has been

found to possess a partial separation of these properties

(141-143) ,

Although L-thyroxine causes a greater reduction

of serum cholesterol concentrations it is also almost 100
times more potent than the D-isomer in causing cardiac

hypertrophy and increased heart rate (140).

This may be

due to the greater localization of L-thyroxine in cardiac
tissue while dextrothyroxine is localized mainly in liver

tissue (140, 144).

Similarly, the D-isomer causes much less

stimulation of the general metabolic rate than L-thyroxine.
Studies of D-thyroxine in human myxedematous patients

indicate that the separation of metabolic stimulation is so
pronounced that serum cholesterol levels are lowered with
ne observable increase of the basal metabolic rate (141).

Other human studies of longer duration- report similar suc
cess.

Patients with idiopathic hypercholesterolemia and

cardiovascular diseases are able to tolerate this agent

with no serious side e ffects.

Perhaps most significantly,

patients with angina pectoris exhibit cholesterol lowering
with no deterioration of the electrocardiogram and no
change in cardiac compensation (142).

This is important

because the increases of oxygen consumption and heart

rate caused by L-thyroxine aggravate this condition.

Finally, this study shows that those subjects with the

highest pretreatment blood cholesterol levels exhibit the

greatest lowering effects.
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Studies of the mechanism by which D-thyroxine acts

have produced some interesting results.

Early work by

Rabinowitz et al. (14J) showed that radioactive cholesterol
administered to humans was cleared from the serum two to

threefold faster by those treated with D-thyroxine than by

untreated subjects.

Further, the expired carbon dioxide

containing radioactive label was considerably increased in
treated patients.

These data led to the conclusion that

the observed reductions of serum cholesterol level may have
been due to enhanced metabolic destruction of cholesterol.
Other experiments indicate that thyroid hormones may

act as enzyme inhibitors rather than stimulators of cho

lesterol catabolism.

When examined in an in vitro system,

triiodothyronine was found to inhibit the incorporation of
labeled acetate into cholesterol more efficiently than
thyroxine or other iodinated tyrosine analogs (145),

labeled mevalonic acid was the substrate the thyroid

When

hormones provided much les s inhibition of incorporation of

the label into cholesterol.

The greater activity of tri

iodothyronine than thyroxine observed in this system has

been explained by the indication that thyroxine was bound
much more firmly to nonspecific proteins than was tri
iodothyronine.

This implies that the inhibitory activity

was in fact a function of the concentration of unbound

hormone rather than due to structural influences of the
compounds.

The ability to inhibit cholesterol biosynthesis

90

before but not after mevalonic acid is a familiar pattern
which has previously been the source of preliminary
suggestions that HMG CoA reductase was involved.

The hypothesis that HMG CoA reductase is a possible

site of action for thyroid hormones gained clear support
from the work of Eskelson et al , ( 1 46).

Thyroidectomized

animals exhibited low levels of HMG CoA reductase which

were increased by thyroxine administration resulting in

enhanced cholesterol biosynthesis.

It has also been shown

that the addition of L-triiodothyronine and L-thyroxine to
rat liver homogenates from rats with normal thyroid func

tion decreased cholesterol biosynthesis ( 1 45),

Using rat

liver homogenates Eskelson and co-workers observed 50%

inhibition of cholesterol biosynthesis from radioactive
acetate by 1 0 -4 M triiodothyronine but no inhibition when
labeled mevalonic acid was the substrate.

Similarly,

D-thyroxine inhibited the conversion of labeled acetate
to cholesterol but L-thyroxine did not ( 1 46).

By using

1 1 3 1 -triiodothyronine and 1 1 3 1 -thyroxine it was also shown

that the thyroid hormones were nonspecifically bound to
microsomal protein.

From these results it was concluded

that the rate limiting reaction of cholesterol synthesis,

catalyzed by HMG CoA reductase, is under thyroid hormone
control and that this reaction is inhibited by triiodo
thyronine.

The high concentrations of thyroid hormones

which were needed to inhibit the reductase and the protein

binding study suggest that these compounds actually inhibit
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the enzyme only after the protein binding sites have become
saturated.

These data make it tempting to postulate a dual func

tion of thyroid hormones in cholesterol biosynthesis:

very low hormone levels may control enzyme synthesis while
higher concentrations directly inhibit the rate limiting
step for the entire sequence of reactions .

This provides

an additional example of the importance of HMG CoA re

ductase and its central position in cholesterol biosyn

thesis.

An example of agents specifical l y designed to inhibit

HMG CoA reductase is the azasteroids prepared by Counsell
and co-workers (147-149),

Under the belief that choles

terol acted as a true feedback inhibitor of cholesterol

biosynthesis by inhibiting the reductase, it was reasoned

that if cholesterol was bound to the enzyme by means of van

der Waals forces and hydrogen bonding then this binding

as sociation could be strengthened by employing nitrogen iso
steres of cholesterol as inhibitors of the enzyme (147),

Several nitrogen isosteres of cholesterol were prepared

for this purpose.

Using the percent reduction of serum

cholesterol in the rat as a test system the most effective
inhibitors prepared were the 22, 25-diaza analogs, 20 � 

(2-dialkylaminoethyl)aminopregn-5-en-J � -ol (147),

Initial

attempts to define the site and mode of action of these

compounds yielded mixed results.

Although 22, 25-diaza

cholestanol (SC11952) was designed as, and would hopefully

act as, an inhibitor of HMG CoA reductase, in vitro in
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corporation of labeled acetate into cholesterol by rat

liver homogenates was only equal to or lower than that of

untreated animals (148).

However, labeled squalene, lan

osterol, and desmosterol all exce eded the corresponding

levels in untreated animals and labeled cholesterol was

considerably lowered with respect to controls.

It was

concluded that under in vitro conditions the aza analogs

of cholesterol were capable of inhibiting the desired enzyme

and little emphasis was placed on the build-up of the

steroid intermediates.

The observed accumulation of squalene, lanosterol,

and desmosterol indicated that the compounds inhibited

cholesterol biosynthesis at at least one additional site
late in the pathway.

Re examination of the inhibitory

properties under in vivo conditions showed that the goal
of inhibition of HMG CoA reductase was not achieved,

Rather, 22, 25-diaza cholestanol was conclusively shown to

inhibit the conversion of desmosterol to cholesterol (149,

150) as did triparanol and therefore cause accumulation of
desmosterol in rat liver and plasma.

It was later shown

that this compound is also capable of inhibiting the rat
. h are
liver � 7 as well as the � 24 reductases whic
necessary for sterol biosynthesis; the latter enzyme

catalyzes the conversion of desmosterol to cholesterol

(152), High concentrations are required to inhibit the
� 7 reductase and therefore no evidence of this action
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is observed in vivo.

A more potent diazacholesterol derivative is the 20,

25-diaza analog which lowered serum cholesterol and phos

pholipid concentrations to a greater degree than did tri

paranol (153),

In rats and in man this compound reduced

serum cholesterol but not total sterol concentrations.

As

in the case of the 22, 25-diaza derivative, subjects treated

with this compound exhibited an increased level of des

mosterol (152).

Thus, while these analogs of cholesterol

were rationally designed they are not useful hypocholes
terolemic agents because, like triparanol, they caused

accumulation of the potentially atherogenic cholesterol
precursor desmosterol.
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The previous discussion showed that a high serum cho

lesterol level is clearly one of the several factors which

contribute to atherosclerotic disease and its many com
plications.

Because much confusion surrounds the exact

role of cholesterol and its relationship to atheroscle

rosis it can only be assumed that lowering the serum cho

lesterol level is a profitable therapeutic approach to
treatment of the disease.

Regardless of the lack of rig

orous proof, it is believed that the vast literature con
cerning this aspect of the disease suggests the validity

of this central assumption.

The goal of this work is to

contribute to efforts designed to lower serum cholesterol
levels in mammals by defining some structural aspects of

a series of compounds designed to inhibit cholesterol bio

synthesis.

Several methods are available for the reduction of

serum cholesterol levels.

The currently favored initial

method is to reduce the quantity of ingested cholesterol
by strict dietary management.

This procedure affords only

fair results and may be accompanied by considerable
difficulty on the part of the patient.

This problem is

manifested in the inability or unwillingness of the

patient to adhere to the required dietary restrictions.

Another approach is to increase the oxidation of cho

lesterol to bile acids and thereby reduce cholesterol
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levels.

Bile acids act as feedback regulators of the con

version of cholesterol to the bile acids.

Cholestyramine,

a polymeric ion exchange resin, decreases the reabsorption
of the bile acids in the intestinal tract and therefore

removes the regulator of cholesterol conversion to bile
acids.

This results in an increased oxidation of choles

terol and lowers serum cholesterol levels.

A secondary

mode of action of this resin is the indirect decrease of
intestinal cholesterol absorption.

As noted previously,

because of their ion exchange properties these resins

may also remove other medicinal agents from the gastro

intestinal tract and therefore, they cannot be used with
many therapeutic regimens.

Finally, an extensively studied

method for lowering serum cholesterol levels is to inhibit

cholesterol biosynthesis.

The inhibition of cholesterol

biosynthesis is a delicate problem and requires careful

consideration but can provide rewarding results.

Cholesterol biosynthesis from acetyl CoA is a complex

process which consists of more than twenty known reactions.
At first, it might appear reasonable that inhibition at

any one of these steps would effectively lower the total

quantity of cholesterol biosynthesized and therefore safely

reduce serum levels.

Unfortunately, this is not true and

has been illustrated above, especially in the case of tri
paranol and the azasteroids.

The first step of cholesterol biosynthesis, conversion

of acetyl CoA to acetoacetyl CoA, is also an important part

of fatty acid synthesis.

Inhibition of this reaction
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would therefore inhibit fatty acid biosynthesis as well as
cholesterol biosynthesis and produce undesirable results

(147, 156-158).

Similarly, interference with formation of

acetyl CoA is undesirable since this compound is the well
known entrance into the tricarboxylic acid cycle.

The next

step in the biosynthetic pathway consists of condensation
of acetoacetyl CoA with acetyl CoA to produce HMG CoA.

This reaction is the branching point in fatty acid and

cholesterol biosyntheses from which ketone bodies are de

rived.

For this reason the inhibition of HMG CoA formation

might also inhibit the latter process and is therefore un
desirable (156, 157),

Thus, inhibition of any reaction in

cholesterol biosynthesis up to and including formation of

HMG CoA is not an acceptable approach to blocking the path
way, primarily because the additional metabolic processes
for which these intermediates are required would also

suffer inhibition.

Later steps in the biosynthetic sequence following

the cyclization of squalene might appear to provide poten
tial inhibition sites.

Unlike earlier steps, the biosyn

thetic reactions following squalene formation are not
reversible,

For this reason, efficient blockade of one of

these reactions would be expected to lead to accumulation

of the corresponding intermediate.

Since no alternate

metabolic pathways exist for these compounds this accumu
lation would continue unhindered.
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An excellent example of this problem is the hypocho

lesterolemic agent triparanol which inhibits reduction of
2 4-dehydrocholesterol (desmosterol) to cholesterol (135),
Blood levels of desmosterol under normal conditions are

not detectable; however, shortly after triparanol treatment

desmosterol concentration rapidly increases and its ac
cumulation is metabolically uninhibited.

An additicnal

danger associated with this example of inhibition late in
cholesterol biosynthesis is the observation of Herndon

and Siperstein (139) that desmosterol is incorporated into

atherosclerotic plaque and that this deposition takes place
at a more rapid rate than cholesterol deposition.

It is

reasonable that inhibition of any of the several reactions
in the later stages of cholesterol biosynthesis would

lead to similar results.

Since these intermediates appear

to have no function other than as cholesterol precursors
and since this portion of the pathway does not contain

any reversible reactions, the most likely method of dis

position of these compounds is their accumulation.

The

total quantity of cholesterol synthesized would be lowered
but the total sterol concentration would increase.

There

fore, it is believed that the inhibition of the reactions
between squalene and cholesterol does not provide a ra

tional approach to lowering serum cholesterol levels.

Similar views have been expressed by other investigators

(133, 156 , 157),

The above considerations severely limit but do not
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preclude the choice of a biosynthetic reaction on which

rational attempts to inhibit cholesterol biosynthesis may
be focused,

For the purposes of this work HMG CoA re

ductase , which mediates the reduction of HMG CoA to meva
lonic acid, is the reaction which is believed to provide

the most appropriate opportunity for effective inhibition

of cholesterol biosynthesis.

The properties which bestow

this unique quality on this enzyme are many.

All biosynthetic processes take place at a rate which

can be described and measured.

For those processes which

consist of a series of reactions leading to a final product
one of the reactions will be the slowest, or rate limiting,
step under a given set of conditions.

In cholesterol bio

synthesis the rate limiting step is mediated by HMG CoA

reductase (66, 63),

Because of this property, inhibition

of the reductase will cause a greater proportional decrease
in the total quantity of cholesterol synthesized than the

same degree of inhibition at any other reaction in the
entire pathway.

Since this is a general kinetic charac

teristic of the biosynthetic pathway, alterations of the
physiological condition should not interfere with the

relative efficiency of inhibition.

Although the rate limiting nature of HMG CoA reduc

tase is an important reason for its choice as the in

hibition target, several other positive aspects enhance its
desirability.

It will be noted that the formation of aceto

acetyl CoA and HMG CoA are reversible reactions.

The

biosynthesis of acetoacetyl CoA is directly reversible,

99

that is, both the formation and the cleavage of aceto

acetyl CoA are catalyzed by the same enzyme.

On the other

hand, the biosynthesis of HMG CoA is indirectly reversible

since the condensation and cleavage reactions .are mediated
by separate enzymes.

However, the following step, reduc

tion of HMG CoA to mevalonic acid, is the first irrever
sible reaction of cholesterol biosynthesis (62).

In

marked contrast to the later stages of the pathway where

sterols are abundant, inhibition of HMG CoA reductase will
cause no accumulation of intermediates by virtue of the

reversibility of the formation of its immediate precursors.
Any accumulation of HMG CoA in response to inhibition of

HMG CoA reductase will be disposed of through ketone body
synthesis.

Similarly, acetoacetyl CoA accumulation will

be disposed of through fatty acid synthesis.

Thus, the

irreversible reduction means that only cholesterol bio

synthesis will be inhibited with no concurrent accumulation

of intermediates.

The importance of this reductase is

emphasized by the fact that it is also the ma jor site of
physiological control of cholesterol biosynthesis under
both normal and experimental conditions.

This function

of the enzyme is discussed in detail in the preceding
section.

For these reasons HMG CoA reductase is believed to be

the ideal site for efficient inhibition of cholesterol

biosynthesis and was therefore chosen as the target enzyme

in the present work.
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Although this conclusion is in agree

ment with the work of other investigators (159, 160) this

view is not unanimous.

Holmes and DiTullio (156) have pointed out that

me valonic acid is a precursor not only of cholesterol but

also of coenzyme Q which is associated with electron trans
port .

Inhibition of HMG CoA reductase was therefore

claimed to be accompanied by inhibition of coenzyme Q bio
synthesis.

In order to avoid possible harmful effects these

investigators suggested that the best site for inhibition
of cholesterol biosynthesis lies betwe en mevalonic acid

and squalene (156).

Closer examination of the reductase

reveals these fears to be less serious than they originally
appeared to be.

Since cholesterol is a vital

steroid from

which many others are produced complete blockade of its

synthesis is not desirable.

Partial inhibition of HMG CoA

reductase should provide the greatest possible decrease of

total cholesterol synthesis while allowing some mevalonic
acid to be synthesized.

Partial, rather than complete,

inhibition of the enzyme therefore makes the mevalonic acid
formed available for both coenzyme Q and cholesterol bio
syntheses.

Serious blockade of electron transport w�uld be

rapidly expressed by metabolic deficiencies.

No investi

gations specifically concerning any relationship betwe en
coenzyme Q or electron transport and the inhibition of

HMG CoA reductase are available .

However, in studies of

the administration of clofibrate [an agent which acts, in
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part, by inhibiting HMG CoA reductase (133 � to animals

(122) and man (120) no indications of coenzyme Q deficiency

have been reported.

Therefore, it is believed that the

reasoning of Holmes and DiTullio (156) does not completely
describe the relationship of mevalonic acid to both co

enzyme Q and cholesterol biosyntheses,

Thus, HMG CoA

remains the ideal site for the inhibition of cholesterol
biosynthesis.

Pop j�k (161) has expressed the opinion that the in

hibition of HMG CoA reductase as a means of blocking cho
lesterol biosynthesis is a rational approach only on the
basis of preliminary considerations.

The ma jor ob jection

to this site of inhibition is one of selectivity.

Pop jak

argues that inhibition of HMG CoA reductase without con

current inhibition of dehydrogenase enzymes seems to be
" a remote possibility. " (161).

This assertion appears to

have been made on the assumption that the active sites of

these enzymes must be similar because of similar functions

of the enzymes and therefore an inhibitor of one would also
interfere with the normal functioning of the rest.

It

should be noted that this assumption is not necessarily
true.

Even though similar enzymes may mediate similar

chemical conversions, the geometry of the active site is

not solely dependent on the type of reaction taking place.
The structure of the substrate in regions remote from the

reaction site may be an important determinant of the

structure of the enzyme active site since the substrate

must be accomodated.

For this reason two enzymes which
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mediate very similar reactions could conceivably have very

different active sites.

An illustration of this is the

striking specificity of HMG CoA reductase for HMG CoA as

substrate (62); peripheral selectivity is seen in the ob
servation that HMG-S-pantetheine is not reduced by the

enzyme (76).

In presenting his ob jection to HMG CoA reductase as

the ideal site for the inhibition of cholesterol biosyn

thesis Pop jak proposed the inhibition of prenyl transferase

on the basis of alternate metabolic pathways for the allylic
phosphate precursors of farnesyl pyrophosphate (161).

hibition of prenyl transferase, which mediates farnesyl

In

pyrophosphate formation, would result in accumulation of
3, 3-dimethylallyl pyrophosphate.

It was suggested that

this compound would be hydrolyzed to the corresponding

free alcohol, which should be a good substrate for hepatic

alcohol dehydrogenases.

The coenzyme A thioester of the

resulting acid is known to be carboxylated to trans-J

methylglutaconyl CoA, which is reversibly hydrated to HMG
CoA (Figure 9),

Thus, the overall result of inhibiting

prenyl transferase is the production of more precursor
of the substrate for this enzyme.

It should be noted that if prenyl transferase is

chosen as an inhibition site several advantages of HMG
CoA reductase are lost.

Specifically, the site no longer

corresponds to the rate determining step of cholesterol
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biosynthesis which is represented by HMG CoA reductase.
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Rather, inhibitory efficiency will be lost to the many

slow reactions involved.

The above discussion shows that HMG CoA reductase is

clearly the most appropriate site for the inhibition of

cholesterol biosynthesis.

For these reasons this enzyme

has been chosen as the target enzyme for inhibitors designed
and synthesized in the course of the present investigation.
Palazzo et al. (162) reported that a series of aryl

alkyl hydrogen succinates and glutarates I exhibited in

vivo hypocholesterolemic activity in rats as well as the

ability to inhibit in vitro cholesterol biosynthesis from

labeled acetate.

This investigation included the first

report of the hypocholesterolemic and cholesterol biosyn
thesis inhibitory activities of the general class of

1-(4-biphenylyl)-rr-alkyl hydrogen succinates and hydrogen
glutarates.

However, the effects of structural changes in

these compounds on the hypocholesterolemic activity were
not adequately explored by these workers.

For this reason

the only conclusion which can be drawn from this investi
gation is that esters I are capable of lowering serum

cholesterol levels in the rat.

These results suggested to Boots et al. (158) that

considerable information concerning the structural re

quirements for activity could be obtained by the incor

poration of structural alterations into c0mpounds similar

to esters I.

These investigators also noted the structural

X
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similarities between esters I and HMG CoA (I I).

Both

contain free carboxyl and ester groups and for the series
of hydrogen glutarates the distance between these two

functional groups in the substrate and in the inhibitors

can be identical.

This led to the suggestion that these

compounds might adopt similar conformations at their active

sites and that these sites are located on HMG CoA reductase.

In an extensive investigation of the inhibitory properties
of some esters I in a yeast HMG CoA reductase system it

was found (158) that as the alkyl group R was increased

from hydrogen to rr-hexyl in a series of compounds where

X = £-phenyl, the activity reached a maximum when R was

rr-butyl or rr-pentyl.

This indicates that the R group of

I contributes to binding by participating in hydrophobic
interactions with the enzyme and that the hydrophobic

binding area on the enzyme is large enough to accept an

rr-pentyl group.

A similar investigation was carried out to study the

effects of substituents X on the binding of esters I (158).
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While maintaining R as rr-butyl, the substituent X was varied
in such a manner that the electronic properties of the

aromatic ring were known.

Since these compounds exhibited

no significant alteration of inhibitory activity, no elec

tronic effects on inhibitor binding were observed,

How

ever, it was found that as the hydrophobic nature of the

group X increased inhibition activity also increased; the
most active compound contained X

=

Q-phenyl.

The excellent

inhibition observed when the aromatic group was 2-fluorenyl

showed that when X = Q-phenyl the two aromatic rings were
probably coplanar when bound to the enzyme.

These ex

periments indicated that the aromatic rings also partici

pate in binding by hydrophobic association with the target

enzyme.

Part of the site at which these compounds bind can

therefore be envisioned as including a hydrophobic area

which accomodates an rr-alkyl group and a planar hydrophobic

area at least large enough for bonding of a 4 -biphenylyl
moiety.

�he location of these areas relative to each

other is a matter of surmise and is limited only by the

conformations which inhibitors I can assume.

The acid-ester portion of these inhibitors also con

tains functional groups which may contribute to enzyme
inhibitor binding.

Two such groups are the free carboxylic

acid (-COOH) and the ester

( - o-8- ) function.

In a study of

possible distance requirements between these two functional

groups during binding, Boots et al. (164) prepared a series
of esters I I I in which the distance between the acid and
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the ester groups was varied while the remainder of the

molecule was maintained constant.

Although a distance

corresponding to one to four methylene groups betwe en the
ester and the acid moieties provided the most active in

hibitors, no consistent increase or decrease of activity

was observed throughout the series; only slight differences

in activity were observed as the chain was lengthened.

If the distance between the carboxylic acid group and the

alcohol moiety of the ester was required to me et very

demanding conditions in order to contribute to binding

it would be anticipated that one member of this series

would show a distinct maximum of inhibition while the

other compounds would gradually increase to and/or decrease

from maximum activity as the chain length was altered,

However, the oxalate ester I I I (m = 0) exhibited very poor
activity, indicating that when the distance betwe en the
ester and carboxylic acid groups was too small, proper

binding of the carboxylic acid and alcohol moiety of the
ester could not take place.

These experiments lead to the

conclusion that the carboxylic acid group does contribute
P H2-CH2-CH2-CH3
C-H
0-C-(CH 2 )-CO
m 2H
II

III (m = 0-6)

to binding and that as the chain length between the car
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boxylic acid and the ester group increased, the chain

became sufficiently flexible to allow the carboxylic acid
group and the alcohol moiety of the ester to reach their

respective binding points.

Another potential binding point of inhibitors I is the

ester group.

By replacing each atom of this functional

group the several possible modes of binding of which it

is capable may be individually examined.

Using succinate

III (m = 2) as a reference inhibitor Boots et al. (164)

prepared ester analogs for this purpose.

Replacement of

the carbonyl group of the ester with a methylene group

afforded an ether which exhibited activity nearly identical
to that of the reference ester.

Similarly, replacement

of both the carbonyl group and the ether oxygen of the ester
with a pair of methylene groups caused a slight decrease

in the inhibitory activity.

These experiments suggest

that the ester group is not necessary for binding.

Finally, the previously noted structural similarities

between these inhibitors and the enzyme substrate (158)

caused Boots et al. (164) to prepare the direct substrate
analog IV.

This compound was found to be an extremely

active inhibitor and exhibited an elevenfold increase

of inhibition over the corresponding unsubstituted ester
III (m = J),

This showed that the 3-hydroxy group par

ticipated in binding to the enzyme.

It should be emphasized that all of the structural
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influences on inhibition activity discussed above have

been a measure of reversible interactions with some region

of the enzyme surface.

When an enzyme and its normal sub

strate interact, an enzyme-substrate complex (ES) forms.

Similarly, in the case of the above inhibitors an enzyme

inhibitor complex (EI) is formed which decreases the ability

of the enzyme to properly catalyze the reaction,

In both

cases, these complexes (ES and E I) are reversible in nature ;
that is, they may dissociate and form the unchanged enzyme

and substrate or inhibitor species.

One of the immediate goals of the present work was to

contribute to elucidation of some potential enzyme binding
points of the above arylalkyl hydrogen succinates and

hydrogen glutarates.

The initial phase of this study was

centered around the previously prepared substrate analog
IV.

Having suggested that the J-hydroxy group of ester IV

actively participates in binding to the enzyme, the question
of the nature of this binding naturally followed.
possibilities exist :

Two

A) the hydroxyl hydrogen could func

tion as a hydrogen donor in hydrogen bonding with the enzyme
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or B) the hydroxyl oxygen could act as a hydrogen acceptor
in hydrogen bonding with the enzyme.

These possible modes

of binding are illustrated in Figure 10.

It was therefore

proposed to structurally modify inhibitor IV in such a

manner to determine which, if either, of these binding
modes was operating.

The compound 1-(4-biphenylyl)-n

pentyl hydrogen 3-methyl-J-methoxyglutarate (V) was designed
for this purpose.

Replacing the 3-hydroxyl hydrogen with a methyl

group results in a compound which is not capable of acting

as a hydrogen donor during hydrogen bonding (possibility A,
above and Figure 10) but retains the ability to function

as a hydrogen acceptor for hydrogen bonding (possibility B,
above and Figure 10).

If the first possibility accurately

describes the contribution of the 3-hydroxy group, inhibi

tor V would be expected to exhibit decreased inhibition

with respect to ester IV.

Conversely , if the second pos

sibility holds , little change of activity would be antici
pated.

The first phase of the present work consisted of

synthesis of the J-methoxy ester V which is described in

the experimental section.
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The s e c ond pha s e of thi s work involving s truc tural
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change s of p o s s ible b ind ing p o ints c onc erned the e s te r

func tion .

As d is cu s s e d above , replac ement of the c arbonyl

group and e the r oxygen of the e s ter m o i e ty with me thylene

groups did not s ignif i c antly alter ac tivity of I I I ( m = 2 ) .

Unde r usual c ond i t i ons the e s ter group can act as a hydrogen
acc eptor in hydrogen bonding by virtue of the fre e pairs
of e l e c trons on oxygen .

As ind i c ated above , thi s d o e s not

take p lac e in thi s sys tem .

Even though the above expe riments show that the e s ter

group is not ne c e s sary for bind ing of the inhibitor to

the enzyme , it i s p o s s ible that the enzyme surfac e c ontains
unused func t i onal groups c apab l e of a binding c ontributi on
in the region where the e s ter mo i e ty is normally located .

The mo s t l ike ly character of such a group would be a hydro 

gen ac c eptor for hydrogen bonding s ince other s imi lar p o s 
s i bi l i t i e s have b e e n exc lude d .

To d e te rmine if such an

enzyme surfac e exists the e s ter group of the inhibitor

mus t be rep lac e d w i th a func t i onal group wh ich maintains

as much as p o s s ible the s i z e , shape , and e l e c tronic pro

pert i e s of an e s ter but which also inc lud e s the abi l i ty
to act as a hydrogen donor for hydrogen bonding .

The

c l o s e s t approximation of the s e requirements is the amide .

Amides V I and V I I were prepared in an effort to probe thi s
region of the enzyme and perhaps inc rease binding .

Pre s enc e

of a properly p o s i t i oned enzymic hydrogen ac c eptor would

be d e t e c ted by an inc rease of inhibi tion by amides V I and
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VI, m = 2
V I I, m = 3

V I I with respect to the corresponding ester, ether, and

carbon analogs.

Synthesis of these compounds is described

in detail in the experimental section.

It has been noted that the previously prepared com

pounds and, in all probability, the compounds proposed for
the present investigation are reversible inhibitors.

In

addition, it has been shown that succinate I I I exhibits
noncompetitive kinetics and there is reason to suggest

that a stable ternary complex of enzyme, substrate and in
hibitor is formed (158).

The kinetic behavior of these

compounds indicates that they probably bind to HMG CoA
reductase at some site other than the binding site for

substrate and may therefore form an enzyme-substrate-in

hibitor complex (ESI) which is not able to reduce HMG CoA

to mevalonic acid,

For this reason the mechanism of in

hibition may be explained in a number of ways including

alteration of enzyme conformation and interference with

possible enzyme subunit interactions.

Regardless of where

on the enzyme these inhibitors bind, the reversible nature

of the interaction means that inhibition will be temporary
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and limited by availability of the inhibitor to the bio
phase.

The elegant work of Baker (163) provided an alter

native to the transient nature of reversible inhibitors.

an inhibitor can be designed which has the ability to form
covalent bonds with the enzyme inhibition will become ir

If

reversible and more effective than reversible inhibition.
The ma jor portion of the present investigation consisted

of the synthesis of structural analogs of esters I which
contain a functional group which could be attacked by a

nucleophile located on the surface of the enzyme.

Such

an attack would result in irreversible binding of the in

hibitor to the enzyme surface.

The design aspect of incorporating into the inhibitors

a functional group which is susceptible to nucleophilic
attack is important.

Many amino acids contain groups

capable of acting as nucleophiles including the thiol
group of cysteine , the hydroxyl group of serine and
threonine, and the nitrogen of histidine.

Since it is

known that HMG CoA reductase requires free thiol groups

for activity (62) an important nucleophile is certainly

present on the enzyme surface and may attack the inhibitors.

Even though these compounds presumably do not interact
with the enzyme at its active site a covalently bound

enzyme-inhibitor complex could do severe damage to cata

lytic efficiency since the attacking nucleophile may

normally function as an aid to maintain the proper catalytic
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conformation of the enzyme.

The compounds designed for this purpose were intended

for examination of both reversible and irreversible inhibi

tion properties.

To maintain maximum reversible binding,

as determined from previous investigations, the potential
irreversible inhibitors contained the 4-biphenylyl group

for its hydrophobic characteristics and the succinic or

glutaric acid-ester groups.

The epoxide function was

chosen as the alkylating group.

A major reason for the

choice of the epoxide group as the alkylating moiety is

the ease with which it is known to open when attacked by

nucleophiles.

A reasonable mechanism for opening the ring

b� an enzymatic nucleophile is shown in Figure 11.

Ad

ditionally, this group is small and therefore would hope
fully cause a minimum of steric hinderance problems with

respect to approach of the inhibitor to the enzyme surface
and subsequent reversible binding.

The position at which

the epoxide group was incorporated was the terminal point
of the alkyl group R of esters I.

In this manner the chain

length can be increased and the area over which the epoxide

can "search" for a nucleophile becomes considerable
(Figure 12).

In this manner it was hoped that an enzymic

nucleophile at or near the inhibitor binding site could be

found.

The compounds proposed for this investigation

include the alkenyl esters VIII which are reversible in

hibitors and from which the potential irreversible inhibit
ing epoxyalkyl esters IX were prepared.

The synthesis of
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A mechanism by which irreversible inhibition might take place.
The reversible enzyme-inhibitor comples (IX-R) forms, then the
epoxide is attacked by an enzyme bound nucleophile ( : x-)
affording an irreversible covalently bound enzyme-inhibitor
complex (IX-I).
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Under the assumption that the aryl and ester
moieties always bind at the same location the
shaded area represents the volume in which the
epoxide group of inhibitors IXa-f may react
with a nucleophile, The actual area over which
the epoxide may alkylate is, of course, limited
by the shape of the enzyme surface in the
designated volume.
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VIIIa-f, n = 1, 2, J
m = 2, 3

IXa-f, n = 1, 2, 3
m = 2, 3
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these compounds is described in the experimental section.

Finally, it was also desired to examine compounds of

the type X I and X I I containing the alkene function located

at an internal position of the alkyl chain,

This would

allow stereochemical examination of the enzyme surface

in the hydrophobic region where the alkyl group binds.

From these compounds the corresponding internal epoxides
could be prepared.

Similarly, alkyne X, from which al

kenes XI and XII could be synthesized, is structurally
locked into linearity about the triple bond and could

provide further information concerning the geometry of

the enzyme in this binding region.

As described in the

discussion of the experimental section, synthetic dif

ficulties precluded preparation of the unsaturated esters

X-XII.

However, it was possible to prepare alkynyl ester

XIII which should provide similar information to that
desired from X-XII

The most desirable system for evaluation of the above

compounds is a pure preparation of the enzyme HMG CoA
reductase.

Such a preparation would assure that the altera

tions of inhibitory activity are accurate reflections of
structural changes of the test compounds.

In this manner

interactions between the inhibitor and the enzyme could be

studied without interference from effects due to absorption,
distribution, or. metabolism.

However, a pure enzyme test

system is not feasible because the enzyme is attached to
the endoplasmic reticulum (65),

Additionally, once it has
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been removed from the endoplasmic reticulum, HMG CoA
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reductase is extremely fragile (69, 70) and may present

handling problems if the solubilized preparation is used

regularly for testing purposes.

These difficulties contributed to the decision to

employ rat hepatic microsomal preparati0ns of the target
enzyme for inhibitor evaluation.

A limitation to the use

of microsomal preparations is the presence of other enzymes,

some of unknown function.

These enzymes represent possible

sites of metabolic and absorption loss for the inhibitor.

Even though the microsomal test system presents some dis
advantages with respect to pure preparations it is not

entirely without merit.

Any inhibitor which proves to be

especially promising will be examined in a whole animal
system.

Microsomes are a close approximation to the whole

animal system because numerous enzymes are present in any
whole animal system and in order to be effective a drug

must be capable of evading possible deleterious effects of
these enzymes.

Therefore , the loss of the ideality

inherent in pure enzyme systems is _ more than compensated

for by a closer resemblance of microsomal systems to actual

in vivo conditions.
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EXPERIMENTAL
General

A.

Reaction solvents were stored over the appropriate

size molecular sieves (194) except dimethylformamide which
was distilled from barium oxide prior to storage over

molecular sieves and pyridine which was distilled from and
stored over barium oxide ,

Tetrahydrofuran was stored over

molecular sieves until the alkynyl systems were investigated.
Following that time, this solvent was stored over lithium
aluminum hydride and distilled immediately prior to use.
Petroleum ether used for column chromatography was dis

tilled prior to use, the 60-70 ° C fraction being collected.
Removal of solvents under reduced pressure was done with

a Buchler Flash Evaporator at water aspirator pressure and

was followed by drying under a vacuum of less than one

mm Hg.

Melting points are uncorrected and were determined on

a Thomas Hoover melting point apparatus.

Combustion

analyses were performed with a Perkin-Elmer Model 240

Elemental Analyzer , or by Galbraith Laboratories, Knoxville,
Tennessee.

Infrared spectra were determined on a Perkin

Elmer Model 257 spectrophotometer either neat or as a

solution in the indicated solvent. The strong, sharp band
of p olystyrene film at 1601. 4 cm - 1 was used as a reference

marker for infrared spectra.

Nuclear magnetic resonance
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(nmr) spectra were measured on a Perkin - Elmer Model R-24
spectrometer or on a Varian A-60 spectrometer.

Chemical

shifts are given in units of parts per million (S), in .

the indicated solvent, downfield frem tetramethylsilane
which was used as an internal standard.

Liquid scintil

lation counting was performed on a Nuclear-Chicago Mark I
Liquid Scintillation System and counting was corrected

for efficiency by· the external standard quench correction

method.

All compounds are numbered with roman numerals.

The

S-benzylthiuronium salts are denoted by the number of the

parent carboxylic acid followed by a capital S.

For

example, the salt of acid number VIIIc is denoted VIIIc-S.

B.
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Compounds Synthesized

4-Hydroxy-4-methyl-1,6-heptadiene (XIV) . - The method

of Tschesche and Machleidt (165) was used.

To a three

necked flask fitted with a magnetic stirrer, pressure com

pensating dropping funnel, reflux condenser, and drying tube
was added 19,05 g (0, 78 g-atom) of magnesium turnings.

The

system was then flame-dried under a stream of dry nitrogen .

When the system had cooled, JO ml of dry ether, JO ml of

tetrahydrofuran and a crystal of iodine were added to the

flask.

To the magnesium mixture was added, in a dropwise

manner over a period of 2-2. 5 hours, a solution of 19. 5 ml

of ethyl acetate (0. 198 mole), 57 ml of allyl bromide

(0. 66 mole), 75 ml of ether, and 225 ml of tetrahydrofuran.
During the addition the reaction mixture was maintained

at a gentle reflux and when the addition was complete the
mixture was stirred at reflux for 2. 5 hours.

The mixture

was poured onto an ice-water slurry and the aqueous phase

was ad justed to pH 2 with 5% hydrochloric acid solution and

extracted twice with ether.

The combined organic phases

were washed with water until the aqueous phase was pH 6,
then .�ith 5% sodium hydroxide solution, water, and then
with a saturated sodium chloride solution, and dried

over anhydrous sodium sulfate.

Removal of the solvent

under reduced pressure afforded an orange liquid which was

distilled to give 24. 8 g (89%) of XIV as a clear, colorless

liquid bp 51 ° (15 mm), literature (165) bp 50-51 ° (12 mm).
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at
-1 (s ro
The infrared spectrum showed A ne
t ng, 0-H),
max 3360 cm
1645 cm-1 (strong, C=C). The nmr spectrum (CDc 1 3) showed

maxima for 2 protons as a multiplet at 5,60-6,37 ppm

(-CH=C�)2, 4 protons as a multiplet at 4,83-5,16 ppm
(�C=CH2)2, 1 proton as a singlet at 2. 38 ppm (R- 0-H), 4

protons as a doublet at 2,1 7 ppm (-CH2-C=)2, and 3 protons
as a singlet at 1, 15 ppm (R3C-CH3).
4-Methoxy-4-methyl-1,6-heptadiene (XV). - The method

of Anderson and Cree (166) was used.

To a three-necked

flask fitted with a gas inlet tube, drying tube, pressure
compensating dropping funnel, and magnetic stirrer was

added 3,7 g of sodium hydride as a 57% oil dispersion
[2. 1 g (0. 088 mole) as sodium hydride] •

The powder was

washed three times by mixing with dry ether and allowed to

settle, the supernatant being decanted after each wash,
and dried by sweeping the vessel with dry nitrogen.

Fifty

ml - of dry dimethylsulfoxide was then added with stirring to
the system.

To the stirred suspension was added at room

temperature and in a dropwise manner a solution of 7,76 g

(0. 062 mole) of the previously prepared diene X IV in 25 ml

of dry dimethylsulfoxide and the reaction mixture was
stirred until gas evolution ceased.

The flask was placed

in an ice bath and to the system was added in a dropwise
manner 26 g (0. 18 mole) of methyl iodide.

The mixture was

stirred at room temperature for 18 hours, then the opaque

orange solution was poured into ether and water.

The

organic phase was washed 7 times with water, followed by a

saturated solution of sodium chloride and dried over

anhydrous sodium sulfate.
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Removal of the solvent under

reduced pressure afforded a brown liquid which was d istilled

to give 5,64 g (65%) of XV as a clear , colorless liquid ,

bp 149-151° at atmospheric pressure. The infrared spectrum
showed l �!� t 1645 cm -1 (strong , C=C). The nmr spectrum
(CDClJ) showed maxima for 2 protons as a multiplet at 5 , 506. 16 ppm (-CH=C:) 2 , 4 protons as a multiplet at 4. BJ-5,16

ppm (:c=CH2)2 , J protons as a singlet at J. 2 0 ppm (R- OCH3) ,
4 protons as a doublet at 2. 2 5 ppm (=C-CH2 -) 2 , and J protons
as a singlet at 1. 10 ppm (R-CH3).
Anal. Calcd. for c 9H16 o : C , 77,1 ; H , 11,5,
C , 77,2; H , 11. 6,

Found:

3-Methyl-3-methoxyglutar ic acid (XV I ). - The method

of Tschesche and Machleidt (165) was used,

To a vacuum trap

was added a solution of 7,36 g (0. 05J mole) of previously

prepared 1 , 6-heptad iene XV , 7,0 ml of glacial acetic acid ,

and 85 ml of methylene chloride.

The system was put into

a Dewar flask containing an acetone-dry ice slurry and

cooled for 0 , 5 hour; then ozone (Welsbach ozone generator ,

Model T-408; 0. 4 1. /min , 0. 562 kg/cm2 , 110 volt) was passed
through the solution for J,5 hours ,

The blue solution was

removed from the acetone-dry ice slurry and allowed to
warm to room temperature.

To the resulting clear , color

less solution was added 50 ml of glacial acetic acid and

the methylene chloride was removed under reduced pressure.

To the residue was added 50 ml of glacial acetic acid , and
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50 ml of JO% hydrogen peroxide; then the resulting solution

was heated at reflux for 8 hours .

Removal of the acetic

acid under high vacuum afforded 7, 39 g of a colorless oil
which crystallized on standing under high vacuum .

Re

crystallization from ether-petroleum ether (60-70° ) gave

7,08 g (76%) of XVI as a white solid, mp 78-80° , The infra') CHCl
red spectrum showed .A max 3 2500-2700 cm-1 (strong, broad,
0-H), 1710 cm-1 (strong , C=O), The nmr spectrum (acetone
d 6) showed maxima for 2 protons as a broad singlet at 9, 93

ppm (-COOH)2, 4 protons as a singlet at J . 26 ppm (-CH2-)2,
3 protons as a singlet at 2 . 76 ppm (R-OCH3), and J protons

as a singlet at 1.40 ppm (R-CH3) . This material was used
as an analytical sample with no further preparation.
Anal.

Calcd . for

C, 47,7; H, 7,0,

c7H12o5:

C, 47, 7; H, 6,9,

Found:

1-(4-Biphenylyl)-pentan-1-ol (XVI I), - The method of

Palazzo et al, (162) as modified by S. G . Boots (personal
communication) was used .

To a three-necked flask fitted

with a gas inlet tube, magnetic stirrer, reflux condenser,

and pressure compensating dropping funnel was added 2. 20 g
(0 . 09 g-atom) of magnesium turnings.

The system was then

flame-dried under a stream of dry nitrogen .

When the

system had cooled a crystal of iodine was added to the

mixture; then, with stirring and cooling in an ice bath,

a solution of 7,2 g (0 . 052 mole) of n-butyl bromide in 70

ml of dry ether was added in a dropwise manner over a
period of 1 hour while maintaining a gentle reflux.

The
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ice bath was removed and to the reaction mixture was added,
in a dropwise manner with stirring, a solution of 9,2 g

(0. 05 mole) of 4-biphenylcarboxaldehyde, mp 52 - 55 ° (Aldrich),
in 125 ml of dry ether while maintaining the system at a
gentle reflux .

The reaction mixture was stirred at reflux

for 1 hour , cooled to room temperature and filtered to

remove residual magnesium turnings.

To the filtrate was

added , in a slow dropwise manner with stirring, a saturated

solution of ammonium chloride which had been ad justed to
pH 7 with concentrated ammonium hydroxide solution.

When

no further precipitate formed the mixture was filtered, the
solid was washed thoroughly with ether and the organic
phase was dried over anhydrous sodium sulfate .

Removal of

the solvent under reduced pressure afforded 12. 2 g of a

yellow solid which was recrystallized from ether-petroleum

ether (60-70° ) to give 7, 17 g (60%) of alcohol XVII as a

white solid, mp 79-80 ° , literature (158) mp 78-79 ° , The
CHClJ J590 cm - 1 (medium, free
infrared spectrum showed A
, max
0-H), J240 cm-1 (medium, broad, hydrogen bonded 0-H). The
nmr spectrum showed maxima for 9 aromatic protons at 7,207, 70 ppm , 1 proton as a triplet at 4, 57 ppm (R3C-H), 1
proton as a singlet at 2,87 ppm (R-0-H), and 9 protons as

a multiplet at 0, 85-1, 77 ppm (R-C4H9).
1-(4-Biphenylyl)-n-pentyl Hydrogen J-Methyl-J-methoxy

glutarate (V), - The ester was prepared by the procedure of
Biichi et al, (167),

To a solution of 880 mg (5, 0 mmoles)

of the previously described J-methyl-J-methoxyglutaric acid

(XVI) , mp 78-80 ° , in 25 ml of dry chloroform was added
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1 . 20 g (5 . 0 mmoles) of alcohol XVII , mp 79-80° , and 1. 59 g

of N , N-dimethylformamide dineopentyl acetal (Aldrich);

then the clear, yellow solution was stirred at room tem
perature for 68 hours.

The solvent was removed under

reduced pressure and the residue was dissolved in ether and

washed with water followed by 5% sodium hydroxide solution.
The alkaline aqueous phase was acidified to pH 1 with 5%

hydrochloric acid and extracted with ether; then the

organic phase was washed with water, saturated sodium

chloride solution, and dried over anhydrous sodium sulfate.

Removal of the solvent under reduced pressure afforded 1. 18

g (59%) of V as a viscous, clear brown oil. The infrared
CHClJ 1713 cm-1 (strong, C= O), 1740 cm-1
spectrum showed A max
· (strong , C= O). The nmr spectrum (CDC1 3) showed maxima for
1 proton as a singlet at 10. 0 ppm (-C OOH), 9 aromatic pro
tons at 7. 00-7. 79 ppm, 1 proton as a triplet at 5,71 ppm

(R3C-H), J protons as a singlet at J, 15 ppm (-OCH3), J pro
tons as a singlet at 2. 72 ppm (R-CH ), and 1J protons as
3
multiplets at 0. 67-2. 00 ppm (methylene and g-C4H9). The
compound was analytically characterized as described below.
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-n-pentyl

Hydrogen J-Methyl-J-methoxyglutarate (V-S). - The salt was
prepared by the precedure of Donleavy (168) as modified by
Boots et al. (158).

To a solution of J06 mg (0,77 mmole)

of the aforementioned hydrogen glutarate V in 15 ml of 95%

ethanol was added 2. 56 ml (0. 77 mmole) of O. J N sodium
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hydroxide solution followed by a solution of 1. 1 g (5,0

mmoles) of S-benzyl-2-thiopseudourea hydrochloride (Eastman)

in 8 ml of hot 95% ethanol.

The resulting cloudy suspen

sion was made up to 100 ml with distilled water and re
frigerated for 12 hours.

The mixture was filtered, the

precipitate washed thoroughly with water and air dried.

Two recrystallizations from ethyl acetate-petroleum ether

(60-70° ) afforded an analytical sample of the S-benzyl
thiuronium salt V-S as a white solid, mp 94, 5-96 ° .
Anal.

N, 5,0.

Calcd. for

Found :

c32tt40N2o5s :

C, 68. 0; H, 7,1;

C, 68. 2; H, 7,1; N, 5,1.

Preparation of the Jones Reagent. - The method of

Bowden et al. (169) was used to prepare the reagent.

a solution of 28 g (0. 28 mole) of chromium trioxide in

To

150 ml of distilled water was added slowly with stirring

25 ml of concentrated sulfuric acid.

The resulting red

solution was diluted to a total volume of 200 ml with

distilled water to give a solution of 14 mmoles of the Jones
reagent per 10 ml of solution.

1-(4-Biphenylyl)-pentane-1-one (XV I I I ). - The ketone

was prepared by the procedure of Bowers et al. (170).

To

a , solution of 1. 02 g (4. 2 mmoles) of alcohol XVI I, mp 79-

80 0 , in 10 ml of dry acetone was added 9 ml (12. 6 mmoles)
of Jones reagent in a dropwise manner with stirring and

cooling in an ice bath to maintain the temperature below .

10° .

at o 0 .

The resulting brown mixture was stirred for 0,5 hour
Ten ml of iso-propyl alcohol was added to destroy
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excess Jones reagent, and the mixture was stirred for 1

hour at room temperature.

The green reaction mixture was

extracted with ether and water, and the combined organic

phases were washed with a saturated solution of sodium

chloride and dried over anhydrous sodium sulfate,

Removal

of the solvent under reduced pressure afforded 1. 11 g of
ketone XVIII as white plates, mp 74-77 ° , which was re

crystallized from absolute ethanol to give 802 mg (80%) of

large white plates, mp 79,5-80. 5 ° , The infrared spectrum
13 1669 cm -1 (strong, C=O). The nmr spectrum
showed

A ���

(CDC1 3) showed maxima for 9 aromatic protons at �.27-

7, 93 ppm, 2 protons as a triplet at 2,78 ppm (-g - CH2-),

and 7 protons as a multiplet at 0, 67-1, 83 ppm (-CH2-CH2 -ctt3).
Anal. Calcd. for c 17tt18 o : C, 85,7; H, 7,.6. Found:
C , 85,6; H, 7, 5,

1-(4 - Biphenylyl) -pentane-1 - methoxylimine (X IX). -

The method of Feuer and Braunstein (171) was used.

To a

solution of 1. 19 g (5. 0 mmoles) of the previously described
ketone XVIII, mp 79, 5-80. 5 ° , in 50 ml of absolute ethanol
and 50 ml of pyridine (distilled from and stored over

barium oxide) was added 431 mg (5,0 mmoles) of methoxyl
amine hydrochloride (Eastman).

The solution was stirred at

reflux for 24 hours, cooled to room temperature and then

poured onto a slurry of ice and

5% hydrochloric acid.

The

mixture was extracted with ether and the organic phase was

washed with water, saturated sodium chloride solution, and

dried over anhydrous sodium sulfate.

Removal of the
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solvent under reduced pressure afforded 1. 21 g of viscous,

yellow oil which solidified upon cooling and was recrys

tallized from ether-petroleum ether (60-70 ° ) to give 610

mg (53%) of methoxylimine X IX as white needles, mp 43,5-45,5° ,
neat
The infrared spectrum showed J max
1610 cm-1 (weak, C=N-).
The nmr spectrum (CDC1 3) showed maxima for 9 aromatic
protons at 7,23-7,90 ppm, 3 protons as a singlet at 3,97

ppm (-OCH3), 2 protons as a triplet at 2. 75 ppm (-S-cH2- ),
and 7 protons as multiplets at 0. 67-1. 67 ppm (-CH2-CH2-cH3).
for c 18H21NO:
C , 80,7; H, 8. 1; N, 5,4,

Anal.

Found:

Calcd.

C , 80,9; H , 7,9; N, 5,2,

1-(4-Biphenylyl)-1-aminopentane Hydrochloride (XX). -

The method of Boots et al. (172) was modified.

To a solution

of 1. 83 g (6. 85 mmoles) of the aforementioned methoxyl-

imine XIX, mp 43,5-45,5, in 25 ml of 1, 2-dimethoxyethane

(DME; distilled from lithium aluminum hydride) in a three
necked flask fitted with reflux condenser, pressure com

pensating dropping funnel, acetone bubbler, and magnetic

stirrer was added 660 mg (17,2 mmoles) of sodium borohydride

(Fisher).

To the resulting mixture was added, in a drop

wise manner, with stirring and cooling in an ice bath, 3,2 g
(22 . 6 mmoles) of boron trifluoride etherate (Eastman) at
a rate which controlled gas evolution and foaming .

The

reaction solution was stirred at room temperature for 1

hour, at reflux for 2 hours; then with stirring and cooling
3,0 ml of water was added in a dropwise manner followed by

15 ml of 5% hydrochloric acid solution.

The resulting

solution was stirred at reflux for 1 hour then at room
temperature for 14 hours.
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Removal of the DME under reduced

pressure afforded a slurry which was ad justed to pH 12

with 5% sodium hydroxide solution and extracted with ether.
The organic phase was washed with water, saturated sodium

chloride solution, and dried over anhydrous sodium sulfate.

Removal of most of the solvent under reduced pressure

afforded . a solution to which was added, with stirring at
room temperature, 50 ml of ethereal hydrogen chloride

[prepared (195) from addition of 5 ml of concentrated

hydrochloric acid to 50 ml of ether followed by drying

with 15 g of anhydrous magnesium sulfate and filterinaj .
Filtration of the resulting mixture afforded a white

solid which on drying gave 1. 60 g (85%) of amine hydro
chloride XX as a white solid, mp 250-253 ° .

The nmr spectrum

(DMSO-d6) showed maxima for 9 aromatic protons at 7,307,63 ppm, 3 protons as a singlet at 4. 60 ppm (-NH + ) which
3
was destroyed by the addition of sodium deuteroxide solu

tion, and 9 protons as multiplets at 0. 62-1,53 ppm (n-C4H9 ).
Recrystallization of this material from ethyl acetate
afforded an analytical sample of XX as a white powder, mp

252-253,5 ° .
Anal.

Found:

Calcd.

for

c 17H22NC1:

C, 74,4; H, 8. 2; N, 5,4,

C, 74,0; H, 8. 0; N, 5,1,

Succinic anhydride (XXI). - The procedure of Fieser

and Martin (173) was used.

To a flask fitted with a reflux

condenser and gas trap leading to a solution of sodium

13 3

hydroxide was added 100 g (1.0 mole) of succinic acid, mp
182° (Fisher), and 315 ml (4,5 moles) of acetyl chloride.

The reaction mixture was heated at reflux for 4 hours,

cooled to room temperature and then refrigerated for 14

hours.

The mixture was f iltered and the solid was washed

with ether.

Concentration of the mother liquor afforded

13 g of white solid.

The combined solids were dried under

reduced pressure to give 79,4 g (79%) of succinic anhydride

as white needles, mp 118, 5-120 , 5 ° , literature (173) mp,
1 3 1785 cm-1
118-119 ° , The infrared spectrum showed A
( strong, C=O), 1862 cm-1 (strong, C=O).

���

The nmr spectrum

(DMSO-d 6 )��h�wed a maximum as a singlet at 2,97 ppm

(-CH2-CH2-).
N- [i- (4-Biphenylyl )-n-pentyl] -succinamic Acid (VI), -

The method described by Vogel (174) was used.

A solution

of 0. 50 g (1. 82 mm0les) of the aforementioned amine hydro

chloride XX, mp 250 - 253 ° , in 18 ml of ice-cold 5% sodium

hydroxide solution was extracted with 50 ml of benzene.

The organic phase was washed with water, a saturated sodium

chloride solution, and dried over anhydrous sodium sulfate.

Filtration of the mixture afforded a solution of 435 mg
(1. 82 mmoles) of the desired 1- (4-biphenylyl)-1-amino

pentane (XLIII) in dry benzene.

To the solution was added

200 mg (2. 0 mmoles) of the previously prepared succinic

anhydride (XXI), mp 118. 5-120. 5 °, and the resulting solu

tion was stirred at room temperature for 3 hours, then

extracted with 5% sodium hydroxide solution.

The alkaline
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aqueous phase was ad justed to pH 2 with ice-cold 5% hydro

chloric acid solution, and the acidic material was extracted

with ether.

The organic phase was washed with water,

saturated sodium chloride solution, and dried over anhy

drous sodium sulfate.

Removal of the solvent under re

duced pressure gave 573 mg of a white solid, mp 165-170° ,

which was recrystallized from ethyl acetate-petroleum ether

(60-70 ° ) to give 2 59 mg (40%) of succinamic acid VI as

white needles, mp 176, 5-178 ° .

Thin layer chromatography

of this material on neutral silica gel plates (Mallinkrodt)
developed with 80% benzene- 2 0% ethanol and visualized with
both iodine vapor and bromcresol green showed the acid-

amide to be pure within limits of detection with an R f
value of 0. 65. The infrared spectrum showed
3250 cm -1
(strong, N-H), 17 2 5 cm -1 (strong, C=O), and 1640 cm -1

J !!�

(strong, C=O amide).

The nmr spectrum (DMSO-d6) showed
maxima for 1 proton as a singlet at 8. 44 ppm (-COOH), 1

proton as a singlet at 8. JO ppm (-CONH), 9 aromatic protons
at 7, 34-7, 84 ppm, 4 protons as a singlet at 2 ,54 ppm (suc
cinamic acid methylenes), and 9 protons as multiplets at

0. 67- 2 . 00 ppm
Anal.

Feund:

(n-c4tt9).

Calcd.

for

c 2 1tt 2 5N o 3 :

C, 74, 1; H, 7, 4; N, 4, 2 ,

C , 74, J; H, 7, 4; N, 4. 1 .

N- [j.-(4-Biphenylyl)-n-penty� -glutaramic Acid (VII). -

The method described by Vogel (174) was used.

To a solu

tion of 1. 03 g (4. J mmoles) of 1-(4-biphenylyl)-1-amino
pentane (XLIII) in 7 5 ml of dry benzene, prepared as

previ ous ly d e s c r ibed f o r succ inamic acid V I , was added
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5 0 0 mg ( 4 , 3 mmo l e s ) of glutar ic anhydride , �P 5 2 - 5 6 °
( Aldri c h ) .

The r e s u l t ing s o lut i on was s t irred at room

temperature f o r 7 2 h ours and then extracted w i th 5% s od ium

hydroxide s o lut i o n .

The alkaline aque ous phase was ad j usted

t o pH 1 w i th i c e -c o ld 5% hydrochloric acid s o lution and
the ac idic mat e r ial was extrac ted w i th e t he r .

The organic

pha s e was dried ove r anhydrous sod ium sulfate and removal
of the s o lvent at reduc e d pre s s ure afforded 1 , 2 7 g of a

°
wh i t e s o l id , mp 1 3 1 . 5- 1 3 3 , 5 , which was r e c rys tall i z e d from

e thanol�wa t e r to give 7 54 mg ( 50%) o f glutaramic ac id V I I

a s a whi t e s o l id , mp 1 3 6 - 1 3 7 ° . The infrared spec trum
showed
3 2 4 0 cm- l ( s trong , N-H ) , 1 7 0 5 cm - l ( s trong ,
C= O ) , and 1 63 0 cm -1 ( s tr ong , C=O amide ) . The nmr spec trum

A �!�

( DMS O-d 6 ) s howed maxima f or 1 proton as a s ingl e t at 8 . 44

ppm ( -C O O:-I ) , 1 proton as a s ingl e t at 8 . 3 0 ppm ( -C ONH ) ,

9 aroma t i c pro tons at 7 , 34 - 7 , 7 5 ppm , 1 proton as a broad

doub l e t at 4 , 9 2 ppm ( R C -H ) , 6 protons as a mul t ipl e t at
3
1 , 58 - 2 . 42 ppm ( glutaram i c ac id me thylene s ) , and 9 pro tons
as a mul t iple t at 0 , 67 - 1 , 50 ppm ( rr-C 4 H 9 ) .
Ana l ,

Found :

C a l c d . f or

c 2 2 H 2 7 N o3 :

C , 74 , 6 ; H , 8 . 0 ; N , 3 , 9 ,

C , 74 , 8 ; H , 7 , 7 ; N , 4 . o .

1 - (4 -Biphenylyl ) -J-buten-1 - o l (XX I I ) . - The proc edure

of Tschesche and Machle idt ( 1 6 5 ) was us ed .

To a thre e 

necked flask f i t te d w i th a mechanical s t irre r , r e flux c on
dens e r , pre s s ure c ompensat ing dropp ing funne l , and dry ing

tube was added 0 . 97 g ( 0 . 04 g-atom ) of magnes ium turnings .
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The system was flame-dried under a stream of dry nitrogen,

and when it had cooled 10 ml of dry ether, 10 ml of dry

tetrahydrofuran, and a small crystal of iodine were added

to the flask.

To the magnesium mixture was added in a

dropwise manner over a period of 0. 5 hour a solution of 3. 46

ml (0. 04 mole) of allyl bromide (Fisher), 3,64 g (0. 02

mole) of 4-biphenylcarboxaldehyde (Aldrich), 25 ml of dry
ether, and 7 5 ml of dry tetrahydrofuran.

During the ad

dition the reaction mixture was maintained at a gentle

reflux and when the addition was complete the mixture was
stirred at reflux for 1 hour.

To the mixture was added in

a slow, dropwise manner with cooling and stirring a satu

rated solution of ammonium chloride which had been ad justed
to pH 7 with concentrated ammonium hydroxide solution.

no further precipitate formed the mixture was filtered

and the white solid was washed with ether.

When

The resulting

solution was washed with a saturated sodium chloride
solution and dried over anhydrous sodium sulfate.

Removal

of the solvent under reduced pressure afforded 4. 05 g of

a light tan solid, mp 60. 5-62 ° , which was recrystallized
from hexane to give 3,09 g (69%) of butenyl alcohol XX I I

as white plates, mp 63. 5-65 ° . The infrared spectrum
CHCl3 3590 cm-1 (medium, 0-H), 1640 cm-1 (medium,
showed '1A max
C=CH 2). The nmr spectrum (CDc 1 ) showed maxima for 9
3

aromatic protons at 7. 20-7. 70 ppm, 1 proton as a multiplet
at 5. 48-6. 18 ppm (-CH=), 2 protons as multiplets at 4, 87-

5. 27 ppm (=CH 2), 1 proton as a triplet at 4. 65 ppm (R3C-H),
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1 proton as a singlet at 2,68 ppm (0-H), and 2 protons as

a triplet at 2,47 ppm (-CH2-).
Anal. Calcd. for c 16H16o :
C, 86,0; H , 7,2,

C , 85,7; H, 7,2,

F0und:

1-(4-Biphenylyl)-3-butenyl Hydrogen Succinate · (\f I I Ia).

The method of Steglich and Hoffle (175) was modified.

To

a solution of 546 mg (2. 44 mmoles) of the aforementioned

butenyl alcohol XXII, mp 63, 5-65 ° , in 10 ml of N , N-dimethyl
formamide (DMF) , which had been distilled from barium oxide,

was added 244 mg (2. 44 mmoles) of succinic anhydride (XX I),
mp 118,5-120. 5 ° , and 297 mg (2. 44 mmoles) of 4-dimethyl

aminopyridine , mp 108-110 ° (Aldrich).

The resulting solu

tion was stirred at room temperature for 72 hours and then

poured into a slurry of ice and 5% hydrochloric acid and

extracted with ether.

The organic phase was washed with

water, saturated sodium chloride solution and dried over
anhydrous sodium sulfate.

Removal of the solvent under

reduced pressure afforded 624 mg (79%) of hydrogen succinate

V I I Ia as a viscous, clear, yellow oil. The infrared
CHClJ 1715 cm - l (strong, C=O), 17J8 cmspectrum showed ) max
l
(strong, C= O) , and 1642 cm-1 (weak, C=C). The nmr spectrum

(CDC1 3) showed maxima for 1 proton as a singlet at 9, 47 ppm
(-COOH) , 9 aromatic protons at 7, 17-7, 56 ppm, 2 protons as
a multiplet at 5,34-5, 90 ppm (=CH2) , and 6 protons as a
singlet (succinate methylenes) superimposed on a triplet
(butenyl methylene) at 2. 55 ppm.
analytically characterized

a£

This compound was

described below.
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S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-3-butenyl

Hydrogen Succinate (VIIIa-S). - To a solution of 2 33 mg

(0, 72 mmoles) of hydrogen succinate VIIIa in 15 ml of 95%
ethanol was added 2 ,56 ml (0. 77 mmole) of 0. 3 N sodium

hydroxide solution and a solution of 1. 1 g (5, 0 mmoles) of
S-benzyl- 2 -thiopseudourea hydrochloride (Eastman) in 8 ml

of hot 95%- ethanol.

The volume was made up to a total of

100 ml with distilled water and the resulting opaque

white mixture was cooled in an ice bath, filtered, and the
precipitate was washed thoroughly with water .

Two recrys

tallizations from ethyl acetate-petroleum ether (60-70 ° )

afforded an analytical sample of S-benzylthiuronium salt
VIIIa-S as a white solid, mp 143-144 °.
Anal,

N, 5, 6,

Calcd. for

Found:

c 2 8H30N 2 o4s • !H 2 0:

C , 67. 4; H, 6. 2 ; N, 5,6.

C , 67, 3; H, 6. 2 ;
After drying

under a pressure of 1 mm Hg for 8, 5 hours at 110 ° the one

half mole of water was successfully removed.
elemental analyses were as follows:
5,7,

Anal.

Found:

Calcd. for

c 2 8H30N 2 o4s:

The resulting

C, 68. 6; H, 6. 2 ; N,

C , 68, 5; H, 6. 1; N, 6. 1.

1-(4 - Biphenylyl)-3-butenyl Hydrogen Glutarate(VIIIb). -

The method of Steglich and Hoffle (175) was modified.

To a

solution of 896 mg (4. 0 mmoles) of butenyl alcohol XXII, mp

63,5-65 °, in 10 ml of N , N-dimethylformamide were added

456 mg (4. 0 mmoles) of glutaric anhydride (Aldrich), mp 5 2 56 0 , and 488 mg (4 . 0 mmoles) of 4-dimethylaminopyridine

(Aldrich), mp 108-110 ° .

The resulting solution was stirred

1J9

at room temperature for 48 hours, then poured onto a slurry

of ice and 5% hydrochloric acid and extracted with ether .
The organic phase was extracted with a cold 5% sodium

hydroxide solution; then the alkaline aqueous phase was
ad justed to pH 2 with ice-cold 5% hydrochloric acid.

The

acidified material was extracted with ether and the organic

phase was washed with water, saturated sodium chloride
solution, and dried over anhydrous sodium sulfate.

Re

moval of the solvent under reduced pressure afforded 417

mg (26%) of hydrogen glutarate VIIIb as a viscous, light
CHCl J 17JO cm-1
brown oil. The infrared spectrum showed A max
(strong, C=0), . 1715 cm-1 (strong C=O), and 1645 cm-1 (weak,

C=C).

The nmr spectrum (CDC1 3 ) showed maxima for 1 proton
as a broad singlet at 9. 20 ppm (-C OOH), 9 aromatic protons

at 7,17-7,60 ppm, 2 protons as multiplets at 5,37-5,94 ppm

(R 3 C-H and -CH=), 2 protons as a multiplet at 4. 80-5,24 ppm
(=CH2), and 8 protons as multiplets at 1 , 17-2, 74 ppm
(glutarate and butenyl methylenes).

This compound was

analytically characterized as described below.

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-J-butenyl

Hydrogen Glutarate (V I I Ib-S). - The salt was prepared by
the method of Donleavy (168) as modified by Boots et al.

(158) from the aforementioned hydrogen glutarate VI IIb in

the same manner as previously described using 260 mg (0,77
mmole) of the ester.

Two recrystallizations of the crude

salt from ethyl acetate-petroleum ether (60-70 ° ) afforded
an analytical sample of S-benzylthiuronium salt VIIIb-S,
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°
mp 146 . 5-147 .

5. 6.

Calcd. for c 29H 32N2 o4s : C, 69,0 ; H , 6. 4 ; N,
Found : C, 69,2 ; H , 6. 5 ; N , 5,5 ,

Anal.

1-(4-Biphenylyl)-3,4-epoxybutan-1-ol (XXV) . - The

method described by Fieser and Fieser (176) was used.

a solution of J,36 g (15,0 mmoles) of the previously

To

described butenyl alcohol XX I I, mp 63. 5-65° , in 25 ml of

dry chloroform was added in a dropwise manner with stirring

and cooling in an ice bath a solution of 5, 06 g (25,0

mmoles) of 85% fil-chloroperbenzoic acid (Eastman) in 100
ml of dry chloroform.

The clear, colorless reaction solu

tion was stirred at room temperature for 18 hours and then
with 7 5 ml of a 10% solution of sodium sulfite until the

starch-potassium iodide test was negative.

The organic

phase was washed with a 5% solution of sodium hydrogen

carbonate, then with water, saturated sodium chloride
solution, and dried over anhydrous sodium sulfate,

Removal

of the solvent under reduced pressure gave J,50 g (97%) of

epoxyalcohol XXV as a brown oil. The infrared spectrum
CHClJ 3600 cm-1 (medium, free 0-H), J450 cm-1
showed A max
(medium, broad, hydrogen bonded 0-H), and 835 cm-1 (epoxide).
The nmr spectrum (CDc 1 3) showed maxima for 9 aromatic pro
tons at 7, 27-7 ,66 ppm, 1 proton as a triplet at 4. 84 ppm

(R3C-H), 1 proton as a singlet at 3. 48 ppm (R-0-H), 3

protons as a multiplet at 2. 32-3. 22 ppm (-CH-CH2), and 2
protons as a triplet at 1. 90 ppm (-CH2-). Molecular

A

distillation using a Hickman still provided an analytical
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sample of this compound as a clear, colorless oil,
Anal.

Calcd. for

C, 79,8; H, 6,5,

c 16H16 o2 :

C , 80,0; H, 6,7,

Found:

1- (4-Biphenylyl)-3,4-epoxybutyl Hydrogen Succinate

( IXa).

- The ester was prepared from _the aforementioned

epoxybutanol as previously described for the butenyl hydrogen
succinate V IIIa to give 896 mg ( 57%) of epoxybutyl hydrogen

succinate IXa as a viscous, yellow oil. The infrared
CHClJ 1740 cm-1
spectrum showed 'lA max
( strong, C= O), 1719 cm -1
( strong, C= O), and 840 cm-1 ( strong, epoxide). The nmr
spectrum ( CDC1 3) showed maxima for 1 proton as a singlet

at 8,55 ppm ( -COOH), 9 aromatic protons at 7, 2 1-7,64 ppm,

1 proton as a triplet at 5,94 ppm ( R3C-H), 4 protons as a .
singlet at 2 . 60 ppm ( succinate methylenes) superimposed
/o,
upon 5 protons as a multiplet at 1,8J-J. 1J ppm ( -CH 2 -CH-CH 2 ) .
This compound was analytically characterized as described

below.

S-Benzylthiuronium Salt of 1-(4- Biphenylyl)-3,4-

epoxybutyl Hydrogen Succinate ( IXa-S). - The salt of the

aforementioned epoxybutyl hydrogen succinate IXa was pre

pared in the previously described manner using 2 61 mg ( 0,77

mmole) of the hydrogen succinate.

Two recrystallizations

of the crude salt from ethyl acetate-petroleum ether ( 6070 0 ) afforded an analytical sample of S -benzylthiuronium

salt IXa-S as a light brown solid, mp 114-116 ° .
Anal.

N , 5,4,

Calcd. for

Found:

c 2 8H30N 2 o5s • !H2 0 :

C, 65,J; H , 6. 0; N, 5,4,

C , 65, 2 ; H , 6. 0;
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1-(4-Biphenylyl)-3,4-epoxybutyl Hydrogen Glutarate

( IXb). - The ester was prepared from the aforementioned

epoxybutanol XXV as previously described for the butenyl

hydrogen succinate VIIIa to give 3 2 5 mg (47%) of hydrogen

glutarate IXb as a viscous, clear, yellow oil. The infraCHC1 3
red spectrum showed ') max
1735 cm-1 (strong, C= O), 1715
cm-1 (strong, C= O), and 835 cm -1 (strong, epoxide), The

nmr spectrum (CDC1 3 ) showed maxima for 1 proton as a broad
singlet at 8. 39 ppm (-COOH), 9 aromatic protons at 7,187, 6 2 ppm, 1 proton as a triplet at 5, 95 ppm (R 3 C-H), and
8 protons as multiplets at 0, 93-3, 00 ppm (methylenes).

This compound was analytically characterized as described

below,

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-3,4-·

epoxybutyl Hydrogen Glutarate ( IXb-S). - An analytical

sample of the S-benzylthiuronium salt of the aforementioned
hydrogen glutarate was prepared as previously described

using 2 59 mg (0,73 mmole) of the ester.

Recrystallization

of the crude salt twice from ethyl acetate-petroleum ether

(60-70 ° ) afforded an analytical sample of S-benzylthiur�nium

salt IXb-S as a white solid, mp 13 2 -13 3 ° .
Anal.

N, 5,3,

Calcd. for

Found:

c 2 9H3 2 N2 o5s, !H 2 0:

C, 65,6; H , 6. 2 ; N, 5 , 3 ,

C, 65, 8; H, 6. 2;

1-(4-Biphenylyl)-4-penten-1-ol (XX III). - To a three

necked flask fitted with a reflux condenser, .drying tube,

pressure compensating dropping funnel, and mechanical

stirrer was added 486 mg (0. 0 2 g-at0m) of magnesium turnings

14 3
and the system was flame-dried under a stream of dry

nitrogen.

To the cooled system was added, in a dropwise

manner with heating and stirring, a solution of 2,74 g

(0. 02 mole) of 4-bromo-1-butene (K&K Laboratories) in 50
ml of ether.

To the resulting Grignard reagent was added

a solution of 1. 82 g (0. 01 mole) of 4-biphenylcarboxaldehyde,

mp 57-59° (Aldrich), in 50 ml of ether in a dropwise manner
with stirring and heating at reflux over a period of 1,5

hours, followed by stirring at room temperature for 3 hours .
To the reaction mixture was added in a slow, dropwise

manner with stirring and cooling a saturated solution

of ammonium chloride which had been adjusted to pH 7 with
concentrated ammonium hydroxide solution.

When no more

precipitate formed the mixture was filtered, the solid was
washed with ether, and the solution was dried over an

hydrous sodium sulfate.

Removal of the solvent at reduced

pressure afforded 2,27 g (94%) of pentenyl alcohol XXIII

as a white solid, mp 66. 5-67,5 ° .

Thin layer chromatography

on silica gel (Eastman Chromotogram Sheet 6060) developed
with 50% benzene-50% methanol and visualized with iodine

vapor showed this material to be pure within the limit£ of
CHCl3 3600 cm-1
detection. The infrared spectrum showed 'lA max
(medium, free 0-H), 3443 cm-1 (weak, broad, hydrogen
bonded 0-H), and 1641 cm-1 (medium, C=C) . The nmr spectrum
(CDC13) showed maxima for 9 aromatic protons at 7,21-7,68

ppm, 1 proton as a multiplet at 5,53-6,10 ppm (-CH=), 2

protons as a multiplet at 4. 81-5, 20 ppm (=CH2), 1 proton
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as a triplet at 4, 63 ppm (R3C-H), 1 proton as a singlet
at 2 . 50 ppm (0-H), and 4 protons as a multiplet at 1. 67-

2. 34 ppm (-CH2-CH2-). Recrystallization of this compound
from petroleum ether (60-70 ° ) afforded an analytical
specimen of alcohol XX III as white needles, mp 68-68. 5° ,
Anal.

Calcd. for

C, 85, 6 ; H, 7, 7,

c17H18o :

C , 85,7; H, 7, 6,

Found:

1-(4-Biphenylyl) -4-pentenyl Hydrogen Succinate (VI I Ic).

The ester was prepared from the aforementioned pentenyl

alcohol XXI I I as previously described for the butenyl

hydrogen glutarate V I I Ib to give 1. 05 g (57%) of hydrogen

succinate V I I Ic as a viscous yellow oil . The infrared
CHCl3 1718 cm -1 (strong, C= O), 1730 cmspectrum showed
l
max
(strong, C= O). The nmr spectrum (CDC1 3) showed maxima for

1

1 proton as a singlet at 9, 94 ppm (-COOH), 9 aromatic pro
tons at 7, 25-7, 71 ppm, 2 protons as a broad multiplet at

5 , 50-6 . 0 9 ppm (R3C-H and -CH=), 2 protons as a multiplet

at 4. 84-5, 22 ppm (=CH2), 4 protons as a singlet at 2, 58 ppm
(succinate methylenes), and 4 protons as a broad band
centered at 2. 04 ppm (butenyl methylenes) .

This compound

was analytically characterized as described below.

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-4-pentenyl

Hydrogen Succinate (VI I Ic-S). - The salt of the aforemen

tioned hydrogen succinate V I I Ic was prepared as previously
described from 270 mg (0, 37 mmole) of the ester.

Two re

crystallizations of the crude salt from ethyl acetate
petroleum ether (60-70 ° ) gave an analytical sample of
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S-benzylthiuronium salt V I I Ic-S as a white solid, mp 118-

119 0 .

5, 6,

Anal.

Found:

Calcd. for

c 2 9H32 N 2 o4S :

C , 69, 0; H , 6. 4; N,

C , 68. 8; H , 6.4; N , 5, 6,

1-(4-Biphenylyl)-4-pentenyl Hydrogen Glutarate (VIIId).

The ester was prepared from the aforementioned pentenyl
alcohol XXII I as previously described for the butenyl

hydrogen glutarate VII Ib to give 7J5 mg (JS%) of hydrogen

glutarate V II Id as a viscous, yellow oil. The infrared
CHClJ 1712 cm-1 (strong, C= O), 17 2 9 cm-1
spectrum showed ""IA max
(strong, C=O). The nmr spectrum (CDClJ) showed maxima for

1 proton as a single t at 9, 90 ppm (-COOH), 9 aromatic pro
tons at 7, 17-7, 66 ppm, 2 protons as a broad band at 5, 45-

6. 0J ppm (R3C-H and -CH=), 2 protons as a multiple t at
4, 78-5, 19 ppm (=CH2 ), and 10 protons as multiple ts at 1, 672. 67 ppm (glutarate and butenyl me thylenes).

This compound

was analytically characterized as described below.

S-Benzylthiuronium salt of 1-(4-Biphenylyl)-4-pentenyl

Hydrogen Glutarate (VII Id-S). - The salt of the aforemen

tioned hydrogen glutarate VII Id was prepared as previously

described from 128 mg (O. J6 mmole) of the ester.

Two re

crystal l i zations of the crude salt from e thyl ace tate

pe troleum e ther (60-70 ° ) afforded an analytical sample of
the S-benzylthiuronium salt V I I Id-S as a light brown

solid, mp 12 2-1 2 J 0 •
Anal.

N , 5, J,

Calcd. for

Found:

c 30H34N 2 o4s • !H2 0:

C , 68. 4; H , 6, 5 ; N , 5, 4,

C , 68. J; H , 6. 4;
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1-(4-Biphenylyl)-4,5-epoxypentan-1-ol (XXVI ). - The

method described by Fieser and Fieser (176) was used.

To

a flask fitted with a magnetic stirrer, pressure compen

sating dropping funnel, and drying tube was added a solution

of 1,19 g (0. 05 mole) of the previously prepared pentenyl

alcohol XXIII, mp 66. 5-67, 5° , in 25 ml of dry chloroform.

To the flask was added in a dropwise manner with stirring

and cooling over a period of 1 hour a solution of 1. 41 g
(0. 07 mole) of 85% m-chloroperbenzoic acid (Eastman) in

75 ml of dry chloroform.

The reaction solution was stirred

at room temperature for 20 hours, and then with 50 ml of a
10% solution of sodium sulfite until the starch-potassium
iodide test was negative.

The organic phase was washed with

a 5% sodium hydrogen carbonate solution, water, saturated
sodium chloride solution, and dried over anhydrous sodium

sulfate.

Removal of the solvent at reduced pressure af

forcled 1. 23 g (96%) of epoxyalcohol XXVI as a brown oil.
·
•
The infrared spectrum showed I"\A CHCl3 3595 cm -1 (medium, free
0-H), 3430 cm -1 (medium, broad, hydrogen bonded 0-H), and
835 cm -1 (medium, epoxide). The nmr spectrum showed maxima
max

for 9 aromatic protons at 7,24-7,67 ppm, 1 proton as a

triplet at 4. 66 ppm (R3C-H), 1 proton as a singlet at 3,25
ppm (0-H), and 7 protons as multiplets at 1,17-2,79 ppm
(epoxybutyl).

Several attempts were made to prepare an analytical

sample of this compound.

Molecular distillation with a

Hickman still at temperatures up to 180 ° and pressure below
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1 mm Hg afforded a clear, colorless oil which exhibited

carbon analysis which was consistently approximately 1. 6%

below the theoretical value .

Infrared and nmr spectra of

this compound were satisfactory.

In addition, the infra

red and nmr spectra as well as elemental analysis for

pentenyl alcohol XX I I I, from which epoxyalcohol XXVI was

synthesized, and for esters IXc and IXd which were syn

thesized from epoxyalcohol XXVI were all .completely satis
factory.

On this basis it was concluded that the desired

epoxyalcohol XXVI had been obtained.

1-(4-Biphenylyl)-4, 5-epoxypentyl Hydrogen Succinate

( IXc). - The ester was prepared from the aforementioned

epoxypentanol XXVI as previously described for the butenyl

hydrogen glutarate VIIIb to give 924 mg (73%) of hydrogen

succinate IXc as a viscous, yellow oil. The infrared
1 3 1720 cm -1 (strong, C=O), 1735 cm-1
spectrum showed
(strong, C=O), and 835 cm-1 (medium, epoxide). The nmr

A ���

spectrum (CDC13 ) showed maxima for 1 proton as a singlet
at 9. 22 ppm (-COOH), 9 aromatic protons at 7,06-7,67 ppm,

1 proton as a broad band at 4,98 ppm (R3C-H), 4 protons as
a singlet at 2. 62 ppm (succinate methylenes), and 7 protons
as multiplets at 0,77-2,17 ppm (epoxybutyl).

This compound

was analytically characterized as described below.

S- Benzylthiuronium Salt of 1-(4-Biphenylyl)-4,5-

epoxypentyl Hydrogen Succinate ( IXc-S). - The salt of the

aforementioned hydrogen succinate was prepared as previously
described from 272 mg (0, 77 mmole) of the ester.

Two

148

recrystallizations of the crude salt from ethyl acetate

petroleum ether (60-70 ° ) afforded an analytical sample of
S-benzylthiuronium salt IXc-S as a light brown solid, mp
97-99 ° ,

Anal,

N , 5,3,

Calcd . for

Found:

c 2 9H32N 2 o5s · tH 2 0 :

C, 65, 7; H , 6. 1; N , 5,4,

C , 65,8; H , 6. 0;

1-(4-Biphenylyl)-4, 5-epoxypentyl Hydrogen Glutarate

( IXd), - The ester was prepared from the aforementioned

epoxypentanol XXVI as previously described for the butenyl

hydrogen glutarate VIIIb to give 707 mg (42 %) of hydrogen

glutarate IXd as a clear, viscous yellow oil. The infra
red spectrum showed A ��� 1 3 1730 cm-1 (strong, C= O), 1720
cm-1 (strong, C=O), and 835 cm- l (weak, epoxide), The nmr
spectrum (CDC1 3) showed maxima for 1 proton as a singlet
at 7,86 ppm (-C OOH), 9 aromatic protons at 7, 14-7,64 ppm,

1 proton as a broad band at 4, 96 ppm (R 3C-H), and 10
protons as multiplets at 0. 80- 2 . 80 ppm (glutarate methylenes

and epoxybutyl).

This compound was analytically charac

terized as described below.

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-4, 5-

epoxypentyl Hydrogen Glutarate ( IXd-S). - The salt of the

aforementioned hydrogen glutarate IXd was prepared as pre
viously described using 176 mg (0. 48 mmole) of the ester.

Two recrystallizations of the crude salt from ethyl acetate

petroleum ether (60-70 ° ) afforded an analytical sample of

S-benzylthiuronium salt IXd-S as a tan sol id, mp 115-11 7 °.
Anal.

Calcd. for

c 30H33 N2 o5 s,tH20:

C , 66,3; H, 6. 3;

14 9
N , 5, 2.,

Found:

C , 66. 1; H , 6. 4; N , 5, 0,

1-(4-Biphenylyl)-5-hexen-1-ol (XXIV). - To a three

necked flask fitted with a reflux condenser , mechanical

stirrer, drying tube, and pressure compensating dropping

funnel was added 607 mg (0. 025 g-atom) of magnesium turnings

and the system was flame-dried under a stream of dry nitrogen,
To the cooled system was added a small crystal of iodine

and, in a dropwise manner with stirring over a period of

15 minutes, a solution of 2. 98 g (0. 02 mole) of 5-bromo-

1-pentene (K&K Laboratories) in 50 ml of dry ether and the
resulting mixture was stirred at reflux for 20 minutes.

the resulting Grignard reagent was added a solution of

J, 09 g (0. 017 mole) of 4-biphenylcarboxaldehyde, mp 52-

To

55 0 (Aldrich), in 75 ml of dry ether and 15 ml of tetra

hydrofuran in a dropwise manner over a period of 1 hour with
stirring and heating at reflux, followed by stirring at
room temperature for 2 hours.

To the reaction mixture was

added in a slow, dropwise manner with cooling and stirring
a solution of saturated ammonium chloride which had been

ad justed to pH 7 with concentrated ammonium hydroxide

solution.

When no more precipitate formed, the mixture

was filtered, the solid was washed with ether, and the
solution was dried over anhydrous sodium sulfate.

Rem�val

of the solvent under reduced pressure gave J. 01 g of a

soft , brown solid which was recrystallized from petroleum

ether (60-70 ° ) to give 1,99 g (46%) of hexenyl alcohol XXIV

as a white, fluffy solid, mp 54-57 ° ,

The infrared spectrum
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showed Ji ��� 13 3599 cm - 1 (medium, free 0-H), 3435 c m - 1
(weak, broad, hydrogen bonded 0-H), and 1641 cm-1 (medium,

The nmr spectrum (CDC1 3) showed maxima for 9 aromatic
protons at 7. 16-7. 67 ppm, 1 proton as a multiplet at 5, 45

C=C).

ppm (-CH=), 2 protons as a multiplet at 4, 7 7 -5, 21 ppm

(=CH2), 1 proton as a triplet at 4. 61 ppm (R3C-H), 1 proton
as a broad singlet at 3, 02 ppm (0-H), and 6 protons as

multiplets at 1, 15-2, 25 ppm (-CH 2-CH2-CH2 -). Recrystal
lization of this compound from petroleum ether (60-70 ° )
provided an analytical specimen, mp 55-58° .
Calcd. for c 18H20 o :
C, 85. 5; H, 7, 6,
Anal.

C, 85, 7 ; H , 8. 0.

Found :

1-(4-Biphenylyl)-5-hexenyl Hydrogen Succinate (V I I Ie),

The ester was prepared from the aforementioned 5-hexen-1-

ol XX IV as previously described for the butenyl hydrogen

glutarate V I I Ib to give 612 mg (58%) of hydrogen succinate

V I I Ie as a beautiful, golden, viscous, clear oil. The
CHCl 3 1730 cm -1 (strong, C=O),
infrared spectrum showed A max
1720 cm -1 (strong, C=O). The nmr spectrum (CDC1 3) showed
maxima for 1 proton as a singlet at 8. 55 ppm (-COOH), 9

aromatic protons at 7, 18- 7, 74 ppm, 1 proton as a multiplet

at 5, 45-6. 08 ppm (-CH=), 2 protons as a multiplet at 4. 805, 20 ppm (=CH2), 1 proton at 4. 65 ppm (R3C-H), 4 protons
as a singlet at 2. 60 ppm (succinate methylenes), and 6

protons at 1. 08-2, 25 ppm (-CH2 -cH2 -CH2 -). This compound
was analytically characterized as described below.

S-Benzylthiuronium Salt of 1- (4- Biphenylyl)-5-hexenyl
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Hydrogen Succinate (VIIIe-S). - The salt of the aforemen
tioned ester VIIIe was prepared as previously described

from 168 mg (0. 48 mmole) of the ester.

Two recrystal

lizations of the crude salt from ethyl acetate-petroleum

ether (60-70 ° ) provided an analytical sample of the S

benzylthiuronium salt VIIIe-S as a white solid, mp 125-

127 0 ,

Anal.

N , 5, 2,

Calcd. for

Found :

c 30H34N2o4s • 1H20 :

C , 67, 3 ; H, 6, 5 ; N, 5, 3,

C , 67 , 2 ; H , 6, 3 ;

1- (4-Biphenylyl)-5-hexenyl Hydrogen Glutarate (VIIIf).

The ester was prepared by the method of Steglich and

Hoffle (175) from the aforementioned hexenyl alcohol XXIV

as previously described for the butenyl hydrogen glutarate
VIIIb.

This afforded 457 mg (42%) of hydrogen glutarate

VIIIf as a clear, viscous brown oil. The infrared spectrum
CHCl 3 1730 cm -1 (strong, C=O), 1725 cm -1 (strong,
showed '"\A max
The nmr spectrum (CDC1 3) showed maxima for 1 proton
as a broad singlet at 10. 0 ppm (-COOH), 9 aromatic protons
C=O).

at 7 , 30-7,75 ppm, 2 protons as multiplets at 5,46-6. 07

ppm (-CH= and R3C-H), 2 protons as a multiplet at 4. 675. 20 ppm (=CH 2), and 12 protons as multiplets at 1. 17-

2. 62 ppm (-CH 2 -CH 2 -CH 2 - of hexenyl and glutarate moieties).
This compound was analytically characterized as described
below.

S- Benzylthiuronium Salt of 1-(4- Biphenylyl)-5-hexenyl

Hydrogen Glutarate (VIIIf-S). - The salt of the previ0usly
described 5-hexenyl hydrogen glutarate VIIIf was prepared

as previously described using 174 mg (0 . 48 mmole) of the

ester.
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Two recrystallizations of the crude salt from ethyl

acetate-petroleum ether (60-70 ° ) afforded an analytical

sample of S-benzylthiuronium salt VI IIf-S as white plates,

mp 100-101. 5 ° .
Anal.

N, . 5. 2.

Calcd. for

Found :

c31tt 36N 2o4s :

C , 68, 7 ; H , 6. 6 ;

C , 68 , J; H, 6. 5 ; N, 4, 8.

1-(4-Biphenylyl)-5,6-epoxyhexane-1-ol (XXV II). -

The method described by Fieser and Fieser (176) was employed.

To a flask equipped with a pressure compensating dropping

funnel, magnetic stirrer and drying tube was added a

solution of 1. 00 g (4. 0 mmoles) of the previously described
hexenyl alcohol XXIV, mp 54-57 ° , dissolved in 25 ml of dry

chloroform.

To the resulting solution was added in a

dropwise manner with stirring and cooling over a period

of one hour a solution of 1. 21 g (6. o mmoles) of 85%

m

chloroperbenzoic acid (Eastman) dissolved in 75 ml of dry
chloroform.

On completion of the addition , the clear,

colorless reaction solution was stirred at room temperature
for 24 hours, then stirred at room temperature with 50

ml of 10% sodium sulfite solution until a negative starch
iodide test was observed.

The organic phase was then

washed with 5% sodium hydrogen carbonate solution, water,

saturated sodium chloride solution, and dried over an
hydrous sodium sulfate.

Removal of the solvent under

reduced pressure afforded 989 mg (92%) of epoxyalcohol
XXVII as a clear, light brown oil.

The infrared spectrum
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-1 ( mediu
CHCl
m, free 0-H), and 3440 cm-1
showed ) max 3 3595 cm
( medium, broad, hydrogen bonded 0-H). The nmr spectrum
( CDC1 3) showed maxima for 9 aromatic protons at 7,17-

7,70 ppm, 1 proton as a triplet at 4. 60 ppm ( R3c-H), 1
proton as a singlet at 3,1 7 ppm ( 0-H), 3 protons as a

multiplet at 2. 24-2. 90 ppm ( -CB�H2), and 6 protons as a
broad band at 1 . 22-2. 00 ppm ( -CH2-CH2-CH2-).

This compound

was used as an analytical specimen with no further pre

paration.

Calcd. for c 1 8H20 o2:
C , 80. 6; H , 7. 2.
Anal.

C , 80. 6; H , 7,5,

Found:

1-(4-Biphenylyl)-5,6-epoxyhexyl Hydrogen Succinate

( IXe). - The ester was prepared from the aforementioned

epoxyalcohol XXVI I as previously described for the butenyl

hydrogen glutarate VIIIb.

This provided 560 mg of clear,

golden, viscous oil which was composed of a mixture of the

desired ester and starting epoxyalcohol XXVII as determined
by infrared and nmr spectra.

A 1 57 mg portion of this oil

was dissolved in 1 ml of dry chloroform and chromatographed

on 1 0 g of washed silicic acid ( 1 96).

The starting epoxy

alcohol ( 51 mg) was removed from the column by elution

with 20% ether in petroleum ether.

Further elution.with

50% e ther in petroleum ether afforded 78 mg of hydrogen

succinate IXe as a clear, colorless oil, The infrared
-1 ( strong , C= O), and
spectrum showed 'lA CHCl
max 3 1 720 cm
1 730 cm-1 ( strong, C=O). The nmr spectrum ( CDC1 3) showed

maxima for 1 proton as a broad singlet at 8. 38 ppm ( -COOH),

.,
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9 aromatic protons at 7,23-7,74 ppm, 1 proton as a triplet

at 5,83 ppm (R 3C-H), 4 protons as a sharp singlet at 2. 64
ppm (succinate methylenes) superimposed on 3 protons as a

multiplet at 2,37-2,98 ppm (-CB� H2), and 6 protons as a
broad band at 1. 27-2, 12 ppm (-CH2-CH2-CH2-). This compound
was analytically characterized as described ·below.

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-5,6-

epoxyhexyl Hydrogen Succinate (IXe-S), - The salt of the

aforementioned hydrogen succinate IXe was prepared as pre
viously described from 283 mg (0,77 mmole) of the ester.

Two recrystallizations of the crude salt from ethyl acetate

petroleum ether (60-70 ° ) afforded an analytical sample of
S-benzylthiuronium salt IXe-S as a white solid, mp 105-

1070 .

Anal.

N , 5, 2,

Calcd, for

Found 1

c30H34N2o5 s :

C, 67 , 39; H, 6. 4;

C, 67, 5; H, 6. 4; N, 5,2,

1- (4-Biphenylyl)-5,6-epoxyhexyl Hydrogen Glutarate

(IXf). - The ester was prepared from 891 mg (3. 31 mmoles)

of the aforementioned epoxyalcohol XXVII as previously

described for the butenyl hydrogen glutarate VIIIb to give

340 mg (27%) of hydrogen glutarate IXf as a clear, yellow
-1
""\ CHCl
viscous oil. The infrared spectrum showed A max 3 1715 cm
(strong, C=O), 1730 cm-1 (strong, C=O). The nmr spectrum
(CDC13) showed maxima for 9 aromatic protons at 7,16-7, 71
ppm, 1 proton as a broad singlet at 6. 66 ppm (-COOH), 1

proton as a singlet at 4,67 ppm (R3C-H), and 15 protons as
broad intermingled multiplets at 0,83-3,00 ppm (epoxyalkyl

and glutarate methylenes).
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This compound was analytically

characterized as described below .

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)- S,6-

epoxyhexyl Hydrogen Glutarate ( IXf-S) . - The salt of the

aforementioned hydrogen glutarate IXf was prepared as pre
viously described from 165 mg (0 . 4J mmoles) of the ester .

Two recrystallizations of the crude salt from ethyl acetate

petroleum ether gave an analytical sample of S-benzyl

thiuronium salt IXf-S as a white solid, mp 79-82 ° .
Anal .

N � 5,0,

Calcd . for

Found:

c31tt36N2o5s • !H20 :

C , 66 , 9; H, 6 . 4; N, 5,J,

1-Bromo-2-butyne (XXVIII) .

C , 66 . 8; H, 6 . 4;

Method A. - The method of

Sharifkanov and Skhmedova (177) was used .

To a round

bottomed flask fitted with a magnetic stirrer, pressure

compensating dropping funnel, and drying tube was added 8 . 9
g (JJ mmoles) of phosphorous tribromide and 0 . 1 ml of

pyridine .

To the resulting solution was added in a drop

wise manner with stirring and cooling in an ice-sodium

chloride bath over a period of 1 hour a solution of 7,0

g (0 . 1 mole) of 2-butyn-1-ol (Research Organic/Inorganic
Chemical Corporation) and 0 . 1 ml of pyridine .

Following

the addition, the cloudy brown reaction solution was stirred
at room temperature for 1, 5 hours, then distilled to give
5,90 g (44%) of 1-bromo-2-butyne (XXVIII) as a clear,

°
colorless liquid, bp 84-87 (150 mm), literature (177) bp
1 CHCl
80 ° (1JO mm) . The infrared spectrum showed A max J
The nmr spectrum (CDClJ) showed maxima
22J5 cm 1 ( -C=C).
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for 2 protons as a quartet at J ,94 ppm (=C-CH2-Br) and
J protons as a triplet at 1. 89 ppm (ctt 3-c=),
1-Bromo-2-butyne (XXV II I).

Method B. - Slight modi

fications in the method of Black et al, (179) and of Coe
et al. (180) were used.

Thus, to a round-bottomed flask

equipped with a magnetic stirrer, pressure compensating

dropping funnel, and drying tube were added 1 6. o g (0,05
mole) of triphenylphosphite (Aldrich) and 50 ml of dry

ether.

To the resulting solution was added in a drop-

wise manner over a period of 0,5 hour with stirring and

cooling in an ice bath 8. 00 g (0. 05 mole) of liquid bromine

(Matheson, Coleman and Bell) and the resulting mixture was
stirred at room temperature for 20 minutes.

To the above

solution of triphenylphosphite dibromide was added, in a

dropwise manner with stirring and cooling in an ice bath,

over a period of 1 hour a solution of J,50 g (0. 05 mole)
of 2-butyn-1-ol (Research Organic/ Inorganic Chemicals
Corporation) and J,95 g (0. 05 mole) of pyridine.

On

completion of the addition, the reaction mixture was stirred
at room temperature for 21 hours, filtered, and the white

solid was washed with ether.

The filtrate was poured into

an ether-water mixture, the phases separated, and the
aqueous phase extracted twice with ether.

The combined

organic phases were washed with 5% sodium hydroxide solu

tion, water, saturated sodium chloride solution, and dried
over anhydrous sodium sulfate.

Removal of the solvent

under reduced pressure and distillation of the residue

afforded 3,83 g (58%) of 1 - bromo-2-butyne (XXVIII) as a
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clear, colorless liquid, bp 84 - 88° (1 53 mm), literature

(1 77) bp 80 ° (1 30 mm). The infrared spectrum showed
� CHCl3 2235 cm-1 (strong, C=C).
The nmr spectrum (CDc 1 )
� max
3
showed maxima for 2 protons as a quartet at 3,94 ppm
(Br-CH2-C=C-) and 3 protons as a triplet at 1 . 88 ppm
(-C =C-CH3).

Attempted preparation of 1-(4-Biphenylyl) -J-pentyn-

1 -ol (XXIX) ,

Method A. - To a three-necked flask fitted

with a mechanical stirrer ; reflux condenser, gas inlet

tube, pressure compensating dropping funnel, and drying

tube was added 21 5 mg (0. 009 g-atom) of magnesium turnings

and the system was flame-dried under a constant stream of
dry nitrogen.

When the system had cooled, a small crystal

of iodine and 0 , 5 ml of dry ether were added to the flask.
To the resulting mixture was added over a period of 1 8

minutes, with stirring, a solution of 961 mg (7. 2 mmoles)

of previously prepared 1 -bromo-2-butyne (XXV III) dissolved
in 1 ml of ether.

To the Grignard reagent was added in a

dropwise manner, at a rate sufficient to maintain gentle

reflux, a solution of 1 . 27 g (7. 0 mmoles) of 4-biphenyl

carboxaldehyde, mp 57-59 ° (Aldrich), dissolved in 5 ml of

dry ether and 5 ml of dry tetrahydrofuran; then the reaction

mixture was stirred at room temperature for 1 , 5 hours.
the mixture was added in a slow dropwise manner with

stirring at room temperature a solution of saturated am

monium chloride which had been ad justed to pH 7 with

To

concentrated ammonium hydroxide solution.

When no more
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precipitate formed, the mixture was filtered, the solid

washed with ether and the cloudy, yellow filtrate was washed
with 5% hydrochloric acid solution, water, saturated sodium

chloride solution, and dried over anhydrous sodium sulfate.

Removal of the solvent under reduced pressure afforded

1 �24 g of a viscous red-brown oil. The infrared spectrum
.
CHCl3 2825 cm-1 (med ium,
showed �� max
aldehyde C-H), 2730 cm-1
(medium, aldehyde C -H), and 1695 cm-1 (strong, C=O) and
was identical to the infrared spectrum of an authentic
sample of 4-biphenylcarboxaldehyde (Aldrich).

Attempted preparation of 1-(4-Biphenylyl)-3-pentyn-

1-ol (XXIX) .

Method B. - The method of Henbest et al.

(178) was used.

To a flask equipped with a magnetic stirrer

were added 1. JO g (0. 02 g-atom) of zinc powder (Fisher) and
10 ml of a 5% hydrochloric acid solution.

The zinc powder

was etched by stirring the resulting mixture for 15 minutes
at room temperature, then washed J times with water, twice

with absolute methanol, and J times with ether by allowing
the zinc powder to settle after a brief period of stirring

and decanting the resulting supernatant solution before
the next wash.

Finally, the zinc was covered with dry

benzene which was evaporated under a gentle stream of dry

nitrogen until a total volume of 0. 5-1,0 ml was obtained.
The flask was fitted with a reflux condenser, pressure

compensating dropping funnel, and to the system were added

over a period of 15 minutes, with stirring initially at

room temperature, a solution of 798 mg (6. o mmoles) of
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the previously described 1-bromo-2-butyne (XXVIII), 1. 09 g

of 4-biphenylcarboxaldehyde (6. 0 mmoles), mp 57-59 °
(Aldrich), and 3, 8 ml of dry tetrahydrofuran.

After ap

proximately 1 ml of the above solution had been added to

the zinc slurry a trace of mercuric chloride was added

and· the remainder of the add ition was completed at a rate
which allowed maintenance of steady reflux.

After completion

of the addition, the reaction mixture was refluxed for 0,5

hour then poured onto 50 ml of ice-10% acetic acid slurry.
The resulting mixture was extracted with ether and the

organic phase was washed with water, 5% sodium hydroxide

solution, water, saturated sodium chloride solution, and
dried over anhydrous sodium sulfate.

Removal of the sol

vent under reduced pressure afforded 905 mg of a light

yellow liquid which was not completely characterized since

it proved to be an undesired product as shown below by the
.
spectral data. The infrared
spectrum showed �A COCl
max 3
3590 cm

-1 (
.
.
medium, free 0-H ) , 34 10 cm 1 (broad, medium,

hydrogen bonded 0-H), and ·1963 cm-1 (medium, allene).

The conspicuous absence of infrared absorption in the 21002300 cm -1 region and the presence of the sharp 1963 cm-1

absorption indicated that an allene was obtained rather
than the desired alkynyl alcohol.

1-Phenyl-3-butyn-1-ol (XXX).

A Model System. - The

method of Lauger et al. (181) was used.

To a three-necked

flask equipped with a magnetic stirrer, pressure compensating
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dropping funnel, and drying tube were added 1. 78 g (0. 066
g-atom) of aluminum, 25 ml of dry tetrahydrofuran, and a
trace of mercuric chloride,

The aluminum was prepared by

cutting 0,13 mm thick aluminum sheet into 0. 5 cm X 4. 0 cm
strips which were rolled into small cylinders.

To the

above mixture was added in a dropwise manner with stirring

over a period of 0 , 5 hour a solution of 11. 9 g (0. 10 mole)

of 1-bromo-2-propyne (Aldrich) dissolved in 25 ml of tetra

hydrofuran.

During the addition the reaction mixture was

maintained at 25-30 ° and on completion of the addition it

was stirred at 35-40 ° for 0.5 hour.

To the resulting

black mixture was added, in a dropwise manner over a

period of 40 minutes while stirring at 3 0 ° , a solution of

10. 6 g (0. 10 mole) of benzaldehyde (Matheson, Coleman and
Bell) dissolved in 50 ml of dry ether.

The resulting

opaque, brown mixture was stirred at 35-40 ° for 0 . 5 hour,

then poured onto 200 ml of an ice-water slurry and stirred

until the mixture reached room temperature.

The phases

were separated and the aqueous phase was washed with ether.
The organic phase was washed with water until the washings

were pH 6, then with saturated sodium chloride solution and
dried over anhydrous sodium sulfate.

Removal of the solvent

under reduced pressure provided a brown liquid which was

distilled to afford 8. 08 g (55%) of alcohol XXX as a clear,
colorless liquid, bp 77-80 ° (0. 8 mm), literature (181) bp
CHCl
85-87 ° (0,5 mm). The infrared spectrum showed
max 3
3 590 cm-1 (strong, free 0-H), 3420 cm-1 (strong, broad,

1
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hydrogen bonded 0-H), JJOO cm - 1 (strong, alkyne C-H),
and 2110 cm-1 (weak, C=C). The nmr spectrum (CDClJ)

showed maxima for 5 aromatic protons at 7, 47 ppm, 1 proton

as a triplet at 4,75 ppm (R 3C-H), 1 proton as a singlet at
J, 52 ppm (R-0-H), 2 protons as a pair of doublets centered

at 2,52 ppm (-CH2-), and 1 proton as a triplet at 1,97 ppm
(-C=C-H),
Attempted preparation of 1-(4-Biphenylyl)-3-Eentyn-

1-ol (XX IX).

Method C. - The method of Lauger (181) as

previously described for the model system 1-phenyl-J

butyn-1-ol (XXX) was followed using 189 mg (0. 007 g-atom)

of aluminum in 10 ml of tetrahydrofuran and 1,JJ g (0. 01

mole) of the previously described 1-bromo-2-butyne (XXVIII)
in 10 ml of tetrahydrofuran to generate the alkynyl
aluminum complex.

Failure of the complex to form was in

dicated by the almost complete lack of degradation of the

aluminum surface after four hours at 45 °.

After a total

of 20 hours at 45 ° evidence of aluminum degradation was

observed and to the resulting mixture was added over a

period of 15 minutes, while stirring at room temperature,

a solution of 1. 82 g (0. 01 mole) of 4-biphenylcarboxaldehyde

mp 52-55 ° (Aldrich), dissolved in 10 ml of tetrahydro
furan.

The resulting mixture was stirred for J hours at

room temperature then poured onto an ice-water slurry and
stirred until the mixture reached room temperature.

The

phases were separated and the aqueous phase was washed
with ether.

The combined organic phases were washed with

r,
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water, saturated sodium chloride solution, and dried over

anhydrous sodium sulfate.

Removal of the solvent under

reduced pressure afforded 1. 84 g of an opaque, black liquid.
The infrared spectrum of this material showed ) neat
max
-1
-1
cm
27JO
C-H),
aldehyde
,
(medium
aldehyde
(medium,
2825 cm
C-H), and 1700 cm-1 (strong, C=O) indicating that the
desired alkynyl alcohol had not been obtained.

Trimethylsulfoxonium Iodide (XXXI). - The method of

Kuhn and Trischmann (182) was used ,

To a one-necked,

round-bottomed flask equipped with gas inlet tube, reflux

condenser, heating mantle and magnetic stirrer were added
96 g (1. 2J moles) of dimethylsulfoxide (Fisher) and 410 g

(2, 9 moles) of methyl iodide (Columbia Organic Chemicals

Co. ) and the resulting solution was maintained at reflux
for 72 hours under a nitrogen atmosphere.

The reaction

mixture was then cooled to room temperature , filtered, and

the solid was washed with chloroform.

The resulting white

powder was recrystallized twice from hot water to give
large, white needles which were crushed and dried in a

vacuum desiccator to provide 52,9 g (19,5%) of trimethyl

sulfoxonium iodide (XXXI) as a light brown solid, mp 195 °
(dee), literature (182) mp 200 ° (dee).

The infrared

spectrum was identical to that published by Kuhn and
Trischman ( 182).

1-Phenyl-1,2-epoxyethane (XXXI I).

A Model System. -

The method developed by Corey and Chaykovsky (18J) was used.

To a three-necked flask fitted with reflux condenser,
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pressure compensating dropping funnel, magnetic stirrer and
gas inlet system (184) was added 1. 26 g (0. 03 mole) of
sodium hydride as a 57% oil dispersion.

The sodium hydride

was washed 3 times with petroleum ether (30-60 ° ) by stir

ring and allowing the powder to settle while the system
was flushed with a continuous stream of dry nitrogen.

After each wash the petroleum ether was decanted and finally
the sodium hydride was dried by alternately evacuating and
flushing the system with dry nitrogen.

To the remaining

powder there was added 30 ml of tetrahydrofuran; then,

while the system was maintained under positive nitrogen

pressure, 6. 66 g (0. 03 mole) of the previously described

trimethylsulfoxonium iodide (XXXI) was added as a solid
over a period of 15 minutes while stirring at room tem

perature.

The resulting mixture was heated at reflux for

2 hours; then, to the opaque white suspension was added,
while stirring at reflux, over a period of 1,5 hours a

solution of 2. 86 g (0. 027 mole) of benzaldehyde (Matheson,
Coleman and Bell) in 30 ml of tetrahydrofuran.

The

resulting mixture was stirred at reflux for an additional
1 hour followed by removal of the solvent under reduced
pressure until approximately 15 ml remained.

The residue

was poured into 75 ml of water and extracted with ether .
The combined ether extracts were washed with saturated

sodium chloride solution and dried over anhydrous sodium

sulfate.

Removal of the solvent at reduced pressure

provided an orange liquid which was distilled to give

0 , 9 5 g (29%) of 1-phenyl-1, 2-epoxyethane (XXXII) as a

clear, colorless liquid, bp 26-28 ° (1 mm) ,
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The infrared

spectrum was identical to that of an authentic sample of

The nmr spectrum (CDc 1 3 )
showed maxima for 5 aromatic protons at 7,21 ppm, 1 pro

the desired epoxide (Aldrich).

ton as a pair of doublets centered at 3,77 ppm (H e Figure
13, . R = H), 1 proton as a pair of doublets centered at

3 , 08 ppm (H b Figure 13, R = H), and 1 proton as a pair of
doublets centered at 2,74 ppm (Ha Figure 13, R = H). The
nmr spectrum was identical to the spectrum of an authentic
sample of styrene oxide (Aldrich).

Figure 13:

Proton positions in styrene oxide.

1-(4-Biphenylyl)-1,2-epoxyethane (XXXIII),

Method A. -

The method of Corey and Chaykovsky (183) as previously

described for the model system 1-phenyl-1, 2-epoxyethane
(XXXII) was employed.

The ylide was generated from 1. 29 g

of sodium hydride as a 56% dispersion in oil (0. 03 mole)
and 6. 60 g (0. 03 mole) of trimethylsulfoxonium iodide
(Aldrich).

To the resulting ylide suspension was added,

in a dropwise manner, with stirring over a period of 45

minutes at reflux temperature a solution of 5 , 46 g (0. 03

mole) of 4-b iphenylcarboxaldehyde, mp 52-55 ° (Aldrich),

dissolved in 35 ml of tetrahydrofuran.
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Following the ad

dition, the reaction mixture was stirred and maintained

at reflux for 1 , 25 hours; then the solvent was removed

under reduced pressure until approximately 25 ml of the

mixture remained.

The residue was poured into 100 ml of

water, extracted 3 times with ether and the combined

organic phases were washed with water, saturated sodium

chloride solution, and dried over anhydrous sodium sulfate.
Removal of the solvent under reduced pressure afforded

5,25 g of an oily, yellow solid, mp 39-45 ° , which resisted

recrystallization attempts.

A 1. 02 g portion of this

material was dissolved in 1 , 5 ml of chloroform, and

chromatographed on 25 g of 60-100 mesh Florisil (Fisher).

Elution with 600 ml of petroleum ether afforded 3 6 9 mg
(representing an overall reaction yield of 32%) of the

desired epoxyethane XXXIII as a white solid, mp 86 -89 ° .
CHCl3 1245 cm-1 (medium,
The infrared spectrum showed ')A max
·
The nmr spec trum
epoxide ) and 107 2 cm - 1 ( medium, epoxide
).

(CDC1 3) showed maxima for 9 aromatic protons at 7 , 20-7,70
ppm, 1 proton as a pair of doublets centered at 3,85 ppm

(H

Figure 13, R = phenyl), 1 proton as a pair of doublets

centered at 3, 14 ppm (Hb Figure 13, R = phenyl), and 1
proton as a pair of doublets centered at 2. 80 ppm (Ha
C

Figure 13, R = phenyl).

This material was employed as

an analytical sample with no further preparation.
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C , 85,7; H , 6. 4.

Preparatien of Diethylaluminum Chloride Stock Solu

tien. - The method of Nagata and Yoshioka (185) was

employed.

A cylinder of diethylaluminum chloride (Alpha

Ventron) was connected with tygon tubing to a two-way

stopcock which was connected with tygon tubing to a straight

drying tube.

The drying tube was fitted to a straight

vacuum take-off adapter which was fitted to a round

bottomed flask which had been equipped with a magnetic
stirrer (Figure 14).

To the flask was added 150 ml of

petroleum ether (60-70 ° ) and the system was alternately
evacuated and flushed with dry nitrogen.

The reagent

cylinder valve was opened and J8. J g (O. J2 mole) of di

ethylaluminum chloride was slowly drained into the stirred
petroleum ether at room temperature.

The cylinder valve

was closed and the system was alternately evacuated and

flushed with dry nitrogen, then the flask was disconnected

from the system and a rubber septum was quickly inserted

and wired onto the neck of the flask.

The resulting clear,

colorless solution contained approximately 2J4 mg (1, 94
mmoles) of diethylaluminum chloride per ml of solution.

Attempted Synthesis of 1-Phenvl-3-pentyn-1-ol (XXXV) .

A Model System. - The methods of Fried et al. (186) and of

Hooz and Layton (187) were modified.

To a round-bottomed

flask equipped with a magnetic st irrer, straight vacuum

take-off, and pressure compensating dropping funnel equipped
with a rubber septum were added 1. 84 g (40 mmoles) of
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T

diethylaluminum chloride
cylinder
two-way
stork
straight

---? to vacuum
and N2

ing tube

�

straight vacuum
take-off

round-bottomed
flask

Figure 14:

Aparatus for preparation of diethylaluminum
chloride stock solution.
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propynyllithium (Alpha-Ventron) and 25 ml of dry petroleum
ether (60-70 ° ).

The system was alternately evacuated and

flushed with dry nitrogen and then 21 ml (approximately 41
mmoles) of the previously described stock solution of di

ethylaluminum chloride (XXXIV) was transfered to the drop
ping funnel by means of · a nitrogen filled syringe.

The

alane was added to the propynyllithium suspension in a

dropwise manner over a period of 20 minutes with stirring

and cooling in an ice bath; then the reaction mixture was

stirred at room temperature for 1 hour.

To the resulting

solution was added, in one portion, 10 ml of ether followed
by the addition, over a period of 15 minutes with stirring

and cooling in an ice bath, of a solution of 2. 40 g (20

mmoles) of styrene oxide (Aldrich) dissolved in 10 ml of
dry petroleum ether (60-70 ° ).

The resulting mixture was

stirred at room temperature for 19 hours, then added to an
Erlenmeyer flask and, with stirring and cooling in an ice
bath, a saturated solution of ammonium chloride which had

been ad justed to pH 7 with concentrated ammonium hydroxide

solution was added in a dropwise manner until no further
precipitation was observed.

The resulting mixture was

poured into a mixture of ether and water, the phases

separated and the aqueous phase was extracted with ether.

The organic phase was washed with water, saturated sodium

chloride solution, and dried over anhydrous sodium sulfate,
Removal of the solvent under reduced pressure gave 2. 64 g

(81%) of clear, golden yellow mobile oil.

The infrared

.
-1 (medium,
1 CHCl
free 0-H),
spectrum showed A max 3 3585 cm
3450 cm-1 (medium, broad, hydrogen bonded 0-H) and 2235
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cm-1 (weak, -C=C-).

The nmr spectrum (CDc 1 ) showed
3
maxima for 5 aromatic protons at 7,26 ppm, 2 protons as

a sharp singlet at 3,67 ppm (-CH2 - 0-) superimposed on 1
proton as a multiplet at 3,37-3,96 ppm (R3C-H), 1 proton
as a singlet at 2,17 ppm (0-H), and 3 protons as a doublet

at 1,83 ppm (-G=C-CH3). These spectral data are not
consistent with the structure of the desired alkynyl alcohol

XXXV and suggest that the reaction product was probably
2-phenyl-J-pentyn-1-ol (XXXVI).

2-Phenyl-1-pentanol (XXXVII). - To a Parr hydrogena

tion bottle was added 960 mg (6. 0 mmoles) of the previously
described compound suspected to be 1-phenyl-J-pentyn-1-ol

(XXXV), 70 mg of 5% palladium on charcoal (Englehard

Industries), and JO ml of absolute ethanol and the mixture

was shaken on a Parr hydrogenator under 2, 11 kg/cm

2

hydrogen pressure for 18 hours at room temperature.

The

mixture was filtered through a Celite pad and the pad was

washed with ten ml of absolute ethanol.

Removal of the

solvent under reduced pressure afforded 852 mg of dark
brown, mobile oil.

Molecular distillation of 242 mg of

this material provided 154 mg (an overall yield of 55%) of

alcohol XXXVII as a clear, colorless mobile oil. The
·
.
CHCl3 36 00 cm-1 (medium,
free
infrared spectrum showed 'iA max
0-H), and 3460 cm-1 (medium, broad, hydrogen bonded 0-H).
The nmr spectrum (CDC1 ) showed maxima for 5 aromatic
3

protons at 7,20 ppm, 2 protons as a doublet at 3. 68 ppm
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(-CH2-o-) , 1 proton as a multiplet centered at 2. 74 ppm

(R 3C-H), 1 proton as a singlet at 1. 82 ppm (-0-H), and 7

protons as multiplets at 0,63-1,78 ppm (-CH -CH -ctt ).
2
2
3
Anal. Calcd. for c 11tt 16 o : C, 80. 4; H, 9, 8, Found:
C, 80, 0; H, 9, 7,

1-Phenyl-3-pentyn-1-ol (XXXV).

A Model System.

Method B. - Minor modifications were made in the method of
Fries (188),

To a round-bottomed flask equipped with

magnetic stirrer, pressure compensating dropping funnel

and nitrogen atmosphere were added 966 mg (21 mmoles) of

propynyllithium (Alpha-Ventron) and 15 ml of dry dimethyl

sulfoxide.

To the resulting suspension was added in a

dropwise manner with stirring at room temperature over a

period of 20 minutes a solution of 1. 28 g (10,7 mmoles) of

the previously described 1-phenyl-1, 2-epoxyethane (XXXII),

dissolved in 5 ml of dry dimethylsulfoxide.

The opaque,

black reaction mixture was stirred for 15 hours at room
temperature, then slowly poured into 150 ml of stirred

ice-water slurry and the resulting mixture was extracted

with ether.

The organic phase was washed with water,

saturated sodium chloride solution and dried over anhydrous
sodium sulfate.

Removal of the solvent under reduced

pressure afforded 659 mg (38%) of pentynyl alcohol XXXV as
a clear, yellow liquid. The infrared spectrum showed
-1 (medium, free 0-H), 3450 cm -1 (medium,
A CHCl
max 3 3600 cm
broad, hydrogen bonded 0-H), and 2220 cm-1 (weak , alkyne).
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The nmr spectrum (CDC1 3) showed maxima for 5 aromatic
protons at 7, 27 ppm, 1 proton as a triplet at 4, 75 ppm

(R3C-H) , 1 proton as a moderately broad band at 2. 67 ppm

(0-H) which was partially obscured by 2 protons as a

multiplet at 2. 42-2, 65 ppm (-CH2-), and J protons as a
sharp triplet at 1, 75 ppm (-CH3). Several attempts to

prepare an analytical specimen of this compound by molecular
distillation with a Hickman still were unsuccessful,
1-(4-Biphenylyl)-3-pentyn-1-ol (XXIX).

The method of Fries (188) was employed.

Method D. -

To a round-bottomed

flask fitted with a magnetic stirrer, pressure compensating

dropping funnel , and nitrogen atmosphere were added 184 mg

(4. 0 mmoles) of propynyllithium (Alpha-Ventron) and 10 ml
of dry dimethylsulfoxide,

To the resulting mixture was

added , in a dropwise manner, with stirring at room temperature
over a period of 10 minutes a solution of 392 mg (2. 0

mmoles) of the previously described 1-(4-Biphenylyl)-1, 2epoxyethane (XXXIII) dissolved in 5 ml of dry dimethyl

sulfoxide.

The reaction mixture was stirred at J6-�2 ° for

48 hours, then slowly poure d onto 100 ml of an ice-water

slurry and extracted with ether.

The organic phase was

washed with water, a saturated sodium chloride solution,

and dried over anhydrous sodium sulfate.

Removal of the

solvent under reduced pressure provided 219 mg of clear,

dark brown oil which was not structurally clearly defined
by spectral means.

A portion of this material (164 mg) was

dissolved in 0, 75 ml of chloroform and chromatographed on
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1 8 g of 60-100 mesh Florisil (Fisher) and eluted in 100 ml

fractions.

The fractions eluted with 10% ether in petro

leum ether afforded 57 mg (16%) of a white solid, mp 1 09111 0 .

Recrystallization of this material from petroleum

ether (60-70 ° ) provided 4J mg of pentynyl alcohol XXIX as

The nmr spactrum (CDC1 3)
showed maxima for 9 aromatic protons at 7,15-7� 65 ppm, 1

a white solid, mp 1 10,5-1 1 1,5 0 .

proton as a triplet at 4. 82 ppm (R3C-H), 3 protons as a
multiplet at 2, 40-2,72 ppm (0-H and -CH2-C=), and J

protons as a sharp triplet at 1 ,77 ppm (-C=C-CH3) . This
material was used as an analytical sample with no further
preparation .
Anal,

Calcd. for

C, 86, 2; H, 6, 8,

c 1 7H16o :

C, 86. 4; H, 6. 8.

Found:

Triphenylmethylphosphonium Bromide (XXXV III) . - The

method of Wittig and Schoellkopf (189) was followed.

Approximately 8 ml (0. 1 45 mole) of methyl bromide (J. T.
Baker) . .was distilled into a three-necked round-bottomed
flask fitted with a dry ice condenser, gas inlet tube,

drying tube, and iso-propyl alcohol-dry ice cooling bath.
The clear, colorless liquid was added in one portion to

a pressure bottle which contained a solution of 26. 2 g

(0. 10 mole) of triphenylphosphine (Aldrich) dissolved in

28 ml of benzene and was cooled in an ice-salt bath.

The

stopper was wired into place and the reaction mixture was

allowed to reach room temperature and then allowed to

remain at this temperature for 48 hours.

The resulting
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white cake was crushed, slurried with 400 ml o f hot benzene,
filtered, and air dried for 0,5 hour.

Drying in a vacuum

oven (water aspirator) at 100 ° for 20 hours provided 35. 0 g

(98%) of triphenylmethylphosphonium bromide (XXXVIII) as a
white solid, mp 230-231° , literature (189) mp 232-233° .

(4-Biphenylyl)ethene (XXXIX). - The method of Greenwald

et al. (190) was used.

To a three-necked round-bottomed

flask fitted with a gas inlet tube and magnetic stirrer was

added 471 mg (11 mmoles) of sodium hydride (Alpha-Ventron)

as a 56% dispersion in oil which was washed three times
under a nitrogen atmosphere by stirring with petroleum

ether (60-70 ° ) .

After each wash, the powder was allowed

to settle and the supernatant solution was decanted.

After

the final wash the flask was fitted with a reflux condenser

and pressure compensating dropping funnel and the system

was alternately evacuated and flushed with dry nitrogen

until the sodium hydride was dry.

In one portion, 25 ml

of dimethylsulfoxide was added to the residue and the re

sulting suspension was heated to 75° while stirring for 50

minutes to give a clear, brown solution of methyl sulfinyl
carbanion.

The system was cooled in an ice bath and a

solution of 3,57 g (10 mmoles) of the previously described

triphenylmethylphosphonium bromide (XXXVIII) in 25 ml of
dimethylsulfoxide was added in a dropwise manner with

stirring over a period of 5 minutes.

The resulting ylide

was stirred at room temp�rature for 15 minutes f0llowed
by the dropwise addition over a periQd of 5 minutes of
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1. 82 g (10 mmoles) of 4-biphenylcarboxaldehyde, mp 57-59

(Aldrich), dissolved in 10 ml of dimethylsulfoxide.

The

dark green reaction solution was stirred at room tempera
ture for 2 hours, at 65 ° for 1 hour, then cooled to room

temperature and poured onto 150 ml of an ice-water slurry.
The resulting mixture was extracted with 200 ml of petro

leum ether (60 - 70 ° ) and the emulsion which formed was
extracted in 25 ml port ions with 200 ml of ether.

The

organic phase was washed with water, saturated sodium

chloride solution and dried over anhydrous sodium sulfate.

Removal of the solvent under reduced pressure provided

2. 02 g of light yellow solid which was dissolved in J. O

ml of chloroform and chromatographed on 50 g of neutral

alumina (80-200 mesh , Brockman Activity I).

Elution with

two liters of petroleum ether afforded 725 mg (40%) of

alkene XXX IX as a white solid, mp 118,5-119,5 ° , literature

(191) mp 120-122 ° ,

The nmr spectrum showed maxima for 9

protons of aromatic nature at 7,18-7,65 ppm, 1 proton as

a pair of doublets centered on 6,74 ppm (Ar-CH=) , 1 proton

as a doublet at 5,70 ppm (trans =C-H , J = 18 Hz), and 1

proton as a doublet at 5,21 ppm (cis =C-H , J = 10 Hz).

This material was used as an analytical specimen with no

further preparation.
Anal.

Calcd. for

C, 93 , 5; H, 6. 8.

c 14H12 :

C , 93,J; H, 6. 7.

1 -(4-Biphenylyl)-1 1 2-epoxyethane (XXXIII).

Found :

Method B. -

The method described by Fieser and Fieser (176) was used,
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To a round-bottomed f lask equipped with a pressure compen

sating dropping funn e l and magnetic st irrer and whic h c on
tained 520 mg (2 . 87 mmoles) of the previously d escribed
(4-biphe nylyl)ethene (XXXIX), mp 118, 5-119,5° , in 20 ml

of dry chloroform was add ed, in a dropwise manner ove r a

period of 1 hour with stirring and cooling in an ice bath,

a solution of 875 mg (4,3 mmoles) of 85% m-chloroperbenzoic
acid dissolved in 45 ml of c hloroform.

The resulting c lear,

colorless solution was stirred at room temperature for 20

hours, the n with 50 ml of a 10% sodium sulfite solution

until a negative starch-iodid e test was observed .

The

phases were separated and the organic phase was washe d

with 5% sodium hydrogen c arbonate solution, water, saturated
sodium chloride solution, and dried ove r anhydrous sodium

su lfate.

Removal of the solvent unde r re duc ed pressure

provide d 67 0 mg of a waxy white solid, mp 59-74 ° .

A 559 mg

portion of this mate rial was chromatographe d on 27 g of
60-10 0 mesh Florisil (Fishe r),

Elution with 1% ether

petroleum eth e r afforde d 269 mg ( an overal l yie ld of 57%)

of epoxide XXX I I I as a white solid, mp 90-91° . The infrared
spe ctrum show e d 1 CHC l3 1247 cm -1 (me dium, epoxide), 877
max
-1
(sharp, strong, epoxide), and 837 cm -1 (sharp, strong,
cm
The nmr spe ctrum (CDC13) showed maxima for 9
aromatic protons at 7,18-7,7 1 ppm, 1 proton as a pair of
epoxide).

doublets c entered at 3,86 ppm (Ar-y-H), 1 proton as a pair
I

of doublets c ente red at 3,12 ppm (Hb Figure 13, R = phenyl),
and 1 proton as a pair of doublets c e ntered at 2,78 ppm
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(Ha Figure 13, R = phenyl) , This material was used as an
analytical specimen with no further preparation after chroma-

tography.

Anal.

Calcd. for

C , 85 , 7; H , 6. 4.

c 14H 12 o:

C, 85 , 7; H , 6.2.

Found:

1-(4-Biphenylyl)-2-butyn-1-ol (XL). - A modification

of the procedure of Smith and Kuehn (192) was used ,

three-necked flask equipped with a magnetic stirrer,

To a

pressure compensating dropping funnel, nitrogen atmosphere

and oil bath were added 506 mg (11 mmoles) of propynyl

lithium (Alpha-Ventron) and 13 ml of tetrahydrofuran which

had been freshly distilled from lithium aluminum hydride.

To the resulting suspension was added, in a dropwise manner

over a period of 10 minutes with stirring at 40 ° , a solution
of 1. 82 g (10 mmoles) of 4-biphenylcarboxaldehyde (Aldrich,
base washed) dissolved in 2,5 ml of tetrahydrofuran which

had been freshly distilled from lithium aluminum hydride .
Following the addition, the reaction mixture was stirred

at 4o 0 for 5 minutes, then placed into an ice bath and 25
ml of ether was added in one portion followed by 15 ml of

saturated ammonium chloride solution which had been ad j usted
to pH 7 with concentrated ammonium hydroxide solution.

resulting mixture was stirred for 5 minutes, the phases

The

were separated and the organic phase was washed once with
water, with saturated sodium chloride solution, and dried

over anhydrous sodium sulfate.

Removal of the solvent

under reduced pressure provided 1 , 79 g of a yellow-brown

solid which was d issolved in 4. o ml of chloroform and
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chromatographed on 80 g of 60-100 mesh Florisil (Fisher).
Elution w ith 10% ether-petroleum ether afforded 1. 04 g
(47%) of butynyl alcohol XL as a white solid.

Recrystal

lization from petroleum ether (60-70 ) afforded a white
solid, mp 88-90 ° . The infrared spectrum showed A CHCl3
max
3590 cm -1 (medium, free 0-H), 3420 cm-1 (medium, broad,
-1 (weak, C=C),
hydrogen bonded 0-H), 2280 cm
and 2220 cm - 1
°

The nmr spectrum (CDC1 3) showed maxima for 9
aromatic protons at 7,24 - 7, 63 ppm, 1 proton as a quartet
(weak, C=C),

at 5, 41 ppm (R 3C-H), 1 proton as a broad singlet at 2. 42
ppm (0-H), and 3 protons as a doublet at 1,83 ppm (-CH3).
Two recrystallizations of this compound from petroleum

ether (60-70 ° ) afforded an analytical specimen of butynyl
alcohol XL as a white solid, mp 88-90 °.
Anal.

Calcd. for

C, 86. 2 ; H, 6. 2.

c 16H14 o :

C, 86,5 ; H, 6. 4.

Found :

1-(4-Biphenylyl)-2-butynyl Hydrogen Succinate (XL I). -

The ester was prepared from the aforementioned butynyl

alcohol XL as previously described for the butenyl hydrogen
glutarate V I I Ib to give 1. 12 g of clear, brown, very

viscous oil.

A 515 mg portion of this material was chroma

tographed on 25 g of washed silicic acid (196).

Elution

with 50% ether in petroleum ether afforded 263 mg (33%) of

hydrogen succinate XLI as a beautiful, clear, colorless oil.
.
CHG 1 3 2290 cm-1 (weak, C=C),
The infrared spectrum showed ')A max
2230 cm -1 (weak, C=C), 1735 cm - 1 (strong, C=O), and 1713 cm -1
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The nmr spectrum showed maxima for 1 proton

( strong, C=O),

as a broad singlet at 9,65 ppm ( -COOH), 9 aromatic protons

at 7 , 2 1-7,7 2 ppm, 1 proton as a quartet at 6,49 ppm ( R3C-H),
4 protons as a sharp singlet at 2 . 64 ppm ( -CH 2 -CH 2 -), and
3 protons as a doublet at 1,90 ppm ( -CH3).

This compound

was analytically characterized as described below.

S-Benzylthiuronium Salt of 1-(4-Biphenylyl)- 2 -butynyl

Hydrogen Succinate (XLI-S). - The salt of the aforementioned
hydrogen succinate XLI was prepared as previously described
from 2 69 mg ( 0. 8 4 mmole) of the ester .

Two recrystallizations

of the crude salt from ethyl acetate-petroleum ether

( 60-70 ° ) afforded an analytical sample of S-benzylthiuron-

°
ium salt XLI-S as a white solid, mp 112-114 .

N,

Anal,

5 , 7,

Calcd. for

Found:
C.

c 2 8 H 2 8 N 2 o 4s :

C ' 6 8 ,7; H,

C, 6 8 ,9; H, 5,8;

5 , 7 ; N, 5 , 7 ,

Preparation of Rat Liver Microsomes

The method of Shapiro and Rodwell ( 82 ) was used.

Male

Sprague-Dawley rats ( approximately 100 g) obtained from

Holtzman were fed Purina Laboratory Chow ( Ralston Purina

Company) ad _ libitum and housed for at _ least 4 days with light
from 7 AM to 7 PM and dark from 7 PM to 7 AM,

A group of

eight rats was used for each microsome preparation.

Between

1 2 : 05 and 12: 25 AM the animals were stunned by a sharp blow
to the head, decapitated, and the livers were excised into
ice-cold ESM solution at pH 6. 0 ( ESM solution is composed

of JOmM ethylenediamine tetraacetic acid, 70 mM sodium

chloride and 10 mM (3 -mercaptoethanol),
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The mass of the

livers was determined ; they were minced and forced through a

tissue press into 2,5 ml of ice-cold ESM solution per gram

of liver.

The resulting tissue mixture was homogenized in a

Potter-Elvehjem homogenizer with five strokes of a Teflon
pestle.

The homogenate was centrifuged twice for 15 minutes

at 12 , 000 X g and the pellet was discarded each time.

The

supernatant solution was centrifuged for 1 hour at 48 , 000

X g, the resulting supernatant was discarded, and the micro
somal pellets were frozen in a dry ice-iso-propyl alcohol

bath.

The tubes were sealed with Parafilm and stored at

-60 ° for up to three weeks.
D.

Assay of Enzyme Inhibitors

A slight modification of the method developed by Rodwell

(82, 193) was employed.

A portion of the rat liver micro

some preparation was suspended in 1, 5 ml of the previously
described ESM solution , pH 6. 8.

tained 9, 7 fa moles of NADP

Each assay mixture con-

(Sigma), 59 , 7 p. moles of glucose-

6-phosphate dehydrogenase Type X I I from torula yeast (Sigma),
0,15 ml of microsome suspension, 0. 1 ml of ethylene glycol

monoethyl ether (Fisher) and the appropriate concentration
of inhibitor in a total volume of 2,9 ml.

The total assay

mixture contained 1. 6-2. 1 mg of protein as determined by the
method of Slakey et al. (84 ).

The enzyme reaction was

started by the addition of 0. 1 ml of solution containing
9 4 nmoles of

J- c 1 4-HMG-CoA.

The assay system was incubated

for

JO
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minutes with shaking at 37° , then the reaction was

stopped by the addition of 0. 2 ml of concentrated

hydrochloric acid and a known amount of HJ -mevalonic acid

as the mevalonolactone (New England Nuclear) was added as
an internal standard.

The resulting mixture was set aside

for 16 hours at room temperature; then it was saturated with

anhydrous sodium sulfate and the mevalonolactone was ex

tracted with ether.

The organic phase was evaporated to

dryness under a stream of nitrogen; the residue was dis

solved in 0. 2 ml of acetone and applied as a streak to an

activated (JO minutes at 100 ° ) Mylar backed silica gel G

thin layer chromatography sheet (Eastman).

The chromato

grams were developed with benzene-acetone, 1/1 (v/v).

The area corresponding to mevalonolactone (Rf = 0. 6-1. 0)
was removed with a razor blade and placed into a liquid

scintillation vial for counting.

To account for variations

of enzyme activity in microsomes from different prepara

tions, one inhibitor, 1-(4-biphenylyl)-g-pentyl hydrogen

succinate (III, m = 2), was assayed concurrently with
each of the other inhibitors.

Therefore, all inhibition

activities were directly compared with a compound of

known inhibitory properties.

E.

Discussion of Experimen:tal . Prooedures
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The preparation of 1-(4-biphenylyl)-n-pentyl hydrogen

3-Methyl-3-methoxyglutarate (V) is described below.

The

approaches used in the preparation of this compound are
illustrated in scheme I .

Synthesis of the 4, 4-disubsti

tuted heptadiene X IV was smoothly accomplished in 77-89%

yields.

The use of the double addition method developed

by Tschesche and Machleidt (165) provided a means of

minimizing side reactions of the highly reactive allyl

Grignard reagent.

The infrared spectrum of this compound
exhibited absorption bands at 3400 cm-1 due to the 0-H
stretching vibration of the alcohol and at 1647 cm-1 due
to double bond vibration.

Further evidence that the

desired unsaturated alcohol was obtained was shown by the
nuclear magnetic resonance (nmr) spectrum.

Multiplets at

5 . 60-6. 37 ppm and at 4, 83-5,16 ppm proved the presence of

the terminal vinyl group, and observation of a doublet at

2, 17 ppm showed the presence and position of the methylene
groups.

Supporting the infrared evidence, the hydroxyl

group was observed as a sharp singlet at 2. 38 ppm which
was destroyed by exchange with deuterium oxide.

The resulting tertiary alcohol X IV was alkylated with

methyl iodide to give the corresponding ether XV in a yield
of 65%.

Absence of hydroxyl absorption and survival of

the double bond absorption in the infrared spectrum showed
that the methylation was complete.

Similarly, the nmr
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spec trum showed no hydroxyl proton ; ins tead , a sharp

s ingle t attributed to the me thoxyl protons was observed

at 3 , 2 0 ppm .

Oz onoly s i s of XV fol lowed by very c areful oxidative

d e s truc t i on of the o z onide afforded 3 -me thyl-3 -me thoxy
glutaric a c i d ( XV I ) in a y i e ld of 7 5% ,

Thi s c ompound was

the key inte rmediate of the entire sequenc e of reac tions .

Pre s enc e of the ac id was c l e arly indicated by the severely
broadened 0 -H s tre tching band in the 2 50 0 -2 7 0 0 cm- 1
region of the infrared spec trum and b y the carbonyl peak
The s truc ture of the diacid was proved by
at 1 7 1 0 cm - l
the nmr obs e rvat i on of two exchangeable protons at 9 , 93

ppm as w e l l as o ther peaks d e s c ribed above for c orre spond
ing porti ons of the molecule .

S everal methods of e s terif i cation of XVI with 1 - ( 4 -

biphenylyl ) -n-pentano l ( XV I I ) were examined before the
d e s ired half e s ter-half ac id was obtained .

Ini tially i t

w a s thought that the e s ter c ould b e obtained b y opening

anhydride XLI I w i th the alcohol us ing the method of Palaz z o
e t al . ( 1 62 ) .

Thi s route exhibi ted two defic i enc ie s :

first , dehydra t i on of the di ac id XVI provided the anhydride

XLI I as a heavy o i l which re s i s ted both spec tral c.harac 
terization and purificat i on .

Furthermore , i t appeared

that this c ompound was not s table under normal c ond i tions

and even attempts to e s terify the c rude anhydride were
unsuc c e s s ful .

Se c ond , Palaz z o ' s me thod of e s terific ation

require s harsh c ond i t i ons for extended periods ( he ating
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at reflux in pyridine for 8 hours).

The esterification method of Steglich and Hoffle (1 75)

appeared promising since it takes place under mild condi

tions with catalysis by 4-dimethylaminopyridine.

this method also requires the anhydride,

However,

Perhaps because

of the necessity of using crude anhydride, this reaction
afforded very low yields (5%) of impure acid-ester V.

The method of Bilchi et al. (1 67) was found to provide

the desired ester V in acceptable yields.

The problem

of using impure anhydride was surmounted with this technique
because the diacid XVI is the substrate for esterification.

Even though a statistical yield (50%) of the desired mono
ester V was obtained, this reaction was superior to the

other esterification methods available.

This acid-ester was spectrally characterized by the
broadened infrared absorption in the 2500-2800 cm-1 region

indicating the free carboxylic acid. Additionally, both
ester (1 740 cm-1 ) and carboxylic acid (1713 cm - 1 ) carbonyl
bands were observed.

A significant aspect of the nmr

spectrum was the internal consistency of integral ratios

between the aromatic absorption at 7,00-7 ,79 ppm and both

the absorptions due to the methoxyl and methyl protons at

J ,1 5 and 2 ,72 ppm, respectively.

Since the latter two

functional groups were derived from a different reagent

than the aromatic protons, this self-consistency indicates

that the desired monoester was obtained in good purity.
The preparation of N- [1 -(4-Biphenylyl)-rr-pentyl]

Succinamic (VI) and Glutaramic (VII) acids is described

below.
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The synthetic sequence followed for the preparation

of these amides is shown in Scheme II.

Oxidation of al

cohol XVII led smoothly to the corresponding ketone XVIII

in excellent yields (80-90%),

This compound was spectrally

characterized by the absence of hydroxyl absorption and the
presence of a strong ketone band (1669 cm -1) in the infra
red as well as by loss of signals for the exchangeable

proton as observed in the nmr spectrum.

Similarly, con

version of ketone XVIII to the methoxylimine XIX by the

method of Feuer and Braunstein (171) took place smoothly

and in good yield (90%),

This conversion was readily

followed with infrared spectra by the loss of the ketone

.
carbonyl band and the appearance of absorption
at 1610 cm-1

in the infrared spectrum due to C=N stretching vibrations.
Appearance of a very sharp singlet at 3,97 ppm in the nmr

spectrum (-OCH3) also indicated presence of the desired
imine. Reduction of this compound by the method of Boots
et al. (172) proceeded as expected; however, the major

difficulty in this series of reactions was purification
and characterization of the free amine XLIII.

The free amine XLIII was initially obtained as a thick

and impure oil or semi-solid and spectral characterization
of this material was not conclusive.

This problem was

solved by a minor modification of the work-up procedure.

Rather than isolating the free amine as a semi-solid, the

dry solution of suspected free amine was treated with
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ethereal hydrogen chloride (195).

This afforded a pre

cipitate of the amine hydrochloride XX which was easily

purified in a yield of 89% and characterized both spectrally
and by elemental analysis.

Conversion of the amine to its hydrochloride salt XX

to facilitate handling required slight modification of
the subsequent preparation of the amides V I and VII.

Thus,

prior to each amidation reaction a slight excess of amine

hydrochloride was treated with dilute base, then extracted
into the solvent to be used for amide formation and dried.
The use of this solution of the amine XLIII greatly aided

in the preparation of amides V I and VII in high yields (7784%).

The amides were readily characterized by infrared
spectroscopy by the N-H vibration in the 3250 cm-1 region

as well as by a pair of carbonyl bands due to the free
carboxylic acid and the amide carbonyl vibrations.

The

nmr spectrum of these compounds showed a pair of protons

as broad singlets (-CONH and -COOH) downfield from the

aromatic absorption as well as the characteristic methine

absorption in the 5,0 ppm range.

The synthesis of 1-(4-biphenylyl)-alkenyl (VIIIa-f)

and epoxyalkyl (IXa-f) hydrogen succinates and hydrogen

glutarates is described below.

The general approach to

the synthesis of these acid esters is outlined in Scheme
III.

The Grignard reagents derived from

c.>

-bromo-1-alkenes

reacted smoothly with 4-biphenylcarboxaldehyde (XLIV) to

RMgX
XLIV
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The synthesis of 1 -(4-biphenylyl)-alkenyl
and epoxyalkyl hydrogen suc cinates and
hydrogen glutarates.
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provide the alcohols XX I I - XX IV in 70-90% yields.

Special

precautions were necessary only for the synthesis of

alcohol XXII because of the highly reactive nature of the
allyl Grignard reagent.

The double addition method of

Tschesche and Machleidt (165) was used in order to maximize

the yield of the desired alcohol and minimize the occurrence

of coupling of the Grignard reagent, the ma jor side reaction
in this system.

Alcohols XX II-XX IV have several common spectral

features which were used to structurally identify each
member of the series.

The infrared spectrum was used only

as an indicator of the presence of the alcohol functional

Absorption bands used for this purpose were those
derived from the free 0-H (3500-3600 cm-1) and hydrogen
bonded 0-H (3400-3500 cm-1) vibrations. Proof of structure

group.

was accomplished with nmr spectrometry.

Several of the

maxima exhibited by these alcohols became important features

of the spectra of subsequent compounds.

The vinyl group

of XX I I-XXIV was observed as a very complex series of mul
tiplets at approximately 5, 5-6. 1 ppm (-CH=) and as a

second set of multiplets at 4. 8-5,2 ppm (=CH2). Only in
the case of XXI I was the methylene group located ff to
the aromatic ring observed as a separate maximum .

In the

other cases these protons were either partially superim

posed upon or obscured by absorption due to the remaining
methylene groups.

Finally, the methine proton � to the

aromatic rings was diagnostic of alcohols XXII-XXIV as well
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as subsequent compounds and consistently appeared as a
well defined triplet at approximately 4. 6 ppm.

As with the J-methyl-J-methoxyglutaric acid ester V

discussed above, a number of methods were investigated

for conversion of the 1 -(4-biphenylyl)-alkenyl alcohols
XXI I-XXIV to their respective hydrogen succinates and

hydrogen glutarates before a satisfactory procedure was
found.

Since several of the desired acid-esters are poly

functional systems bearing delicate functional groups, one
of the ma jor criteria for the choice of an esterification
method was the necessity to avoid strenuous reaction con
ditions.

Thus, the method of Palaz zo et al. (1 62) was un

acceptable due to the extended reaction times and elevated
temperatures involved.

Alternatively, the method of Buchi

al. (1 67) provided a gentle method of esterification;
et however, this method requires the acceptance of only a

statistical yield (50%) of monoester from a dicarboxylic
acid.

With respect to vigor of reaction conditions and

available yields, the esterification method of Steglich

and Hoffle (1 75) provided an acceptable means of synthesis
of the desired half acid esters.

The reaction, catalyzed

by 4-dimethylaminopyridine, takes place entirely at room

temperature and has provided satisfactory yields of both
the alkenyl (40-80%) and epoxyalkyl (J0-70%) hydrogen

succinates and hydrogen glutarates.

In their original

procedure Steglich and Hoffle employed an excess of
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trie thylamine to bind the free carboxylic ac id as i t was

f ormed ,

Howeve r , examination of the react ion c ondi t ions

showed that b o th the integri ty of the produc t and the ac 

c e p table y i e ld of the reac t ion c ould be maintained when
thi s reagent was omitted from the reac tion s olut ion .

There

f ore , e ach of the e s ters i l lus trated in Scheme I I I have been

prepared us ing this mod ification of the original pro c e dure .

Infrared spe c tra of e s ters V I I Ia-f and IXa-f ind i c ated

that the d e s ired ac id-e s ters had been obtained .

Broadening

region and the medium very broad
abs orp t i on obs e rved at 2 50 0 - 2 7 0 0 cm -1 i s diagnos tic of the
i n the 3 1 0 0 - J J O O cm

-1

free c arboxy l i c acid p ortion of the s e c omp ounds .

Ad 

d i t i onally , for each of the s e e s ters a pair of c arbonyl

peaks was observe d , the one at highe r wavenumber be ing due
to the e s te r c arbonyl wh ile the l ower wavenumber peak i s

attributable to c arboxy l i c a c i d c arbonyl vibrati on .

Abs orpt i on due t o the epoxide ring , a s discussed below for
epoxya l c ohols XXV-XXV I I , was also obs e rve d .

Struc tural inf ormation obtained from the nmr spec tra

of V I I Ia-f inc lud e s the maxima charac teristic of the

vinyl group as previ ous ly discussed f or the alkenyl alcohols .
Similarly , b o th the alkenyl e s ters V I I Ia-f and the ep oxy
alkyl e s ters IXa-f exhibited maxima d e s cribed above for

the me thine pro ton

o<.

to the aromatic rings .

In every

case , the suc c inate e s ters showed a very sharp s ingle t

c aused b y the f our suc c inate me thylene protons .

Self

c ons i s tency of the rat i o of the integral of thi s peak to
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that of the aromatic absorption was an important criterion
of purity since the respective peaks originated from dif

ferent reagents,

This was not always possible with the

hydrogen glutarates because the glutarate methylene protons

were observed as a comple x set of multiplets which over
lapped with the peaks from the methylene protons of the
alkenyl or epoxyalkyl side chain.

Epoxidation of the alkenyl alcohols was accomplished

using the technique described by Fieser (176) which pro

vided mild reaction conditions.

Reaction of alkenyl

alcohols XXII-XXIV with fil-chloroperbenzoic acid in chloro
form at and below room temperature provided the desired

1-(4-biphenylyl)-epoxyalkyl alcohols XXV-XXVII in yields
of 92-99%,

Conversion of alkenes XXII-XXIV to the cor

responding epoxides XXV-XXVII was readily followed with

infrared spectra by the appearance of the characteristic
epoxide peaks around 840, 910, and 1260 cm -1 • Nuclear
magnetic resonance spectra of these compounds showed a

very clear loss of absorption due to the vinyl protons and
the appearance of complex multiplets due to epoxide ring

protons in the region 1,5-J,O ppm.
methine proton

cl...

The triplet due to the

to the aromatic rings continued to be

a useful diagnostic signal.

Placement of the epoxidation reaction in the complete

synthetic design is worthy of note.

It may appear from

Scheme III that the epoxidation of alcohols XXII-XXIV could

conceivably be performed either before or after esterification
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with equal success.

A co-product of the epoxidation

reaction is m-chlorobenzoic acid which is separated from

the crude epoxide as its sodium salt.
by treatment with mild aqueous base.

This is accomplished

If the epoxidation

were performed subsequent to esterification, a mixture of

the sodium salts of m-chlorobenzoic acid and the desired

hydrogen succinate or hydrogen glutarate would be obtained,
providing a rather difficult separation problem.

For this

reason , the epoxidation reaction must be performed only
prior to esterification,

In this instance, the sequence

of reactions means the difference between obtaining the

desired compounds fairly pure and in good yield or an in

separable mixture,

The alkenyl esters V IIIa-f and the epoxyalkyl esters

IXa-f exist under standard conditions as clear , viscous

oils.

To facilitate elemental analysis of these compounds

they were converted to the corresponding S-benzylthiuronium

salts by the method of Donleavy (1 68) as modified by Boots
et al. (158) as illustrated in equation 6.

These salts

are moderately high melting solids which may be purified
by recrystallization.

Since they were used only for

elemental analysis , infrared and nmr spectra were not
determined for these salts.

Elemental analysis of these salts provided an interest

ing problem.

Several S-benzylthiuronium salts which had

been prepared from esters whose structure and purity had
been proved by infrared and nuclear magnetic resonance
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1

(eq. 6)

techniques consistently exhibited carbon analysis 1. 0-1,5
percent below theory while nitrogen and hydrogen analyses

were within the acceptable range (± 0. 4%).

The explanation

and solution to this formidable problem lay in the fact

that the S-benzylthiuronium salts were initially precipi

tated from aqueous solution before they were recrystal

lized.

The crude salts appear to have precipitated as a

complex with one - half mole of water associated with each
mole of salt.

Thus, inclusion of one-half mole of water

in the calculation of theoretical elemental composition
gave values for percent carbon which were consistently

1.0-1 , 5% lower than the theoretical carbon percent cal

culated without inclusion of water.

The inclusion of
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one -half mol e of water in the calculation of the ore tica l

nitr ogen and hydrogen perc ent gave value s wh ich differed

from tho s e calculated w i thout inc lus i on of water by an

amount l e s s than the experimental error of me asurement , that
i s , wi thin approximate ly ± 0 . 2 5% of the ory calculated

w i thout wate r .

In two ins tanc e s the assoc iation of one

mo le of water per mole of salt was observed .

Proof of thi s hyp othe s i s required removal of the water

and subsequent analyt i c al re sults showing agre ement with
the or e t i c al perc entage s .

A s ingl e salt , the S-benzylthi

uronium salt of 1 - ( 4-biphenylyl ) - J - butenyl hydrogen

succ inate ( V I I Ia-S ) had a me lt ing po int high enough to

w i ths tand the drying proc edure s required to remove the
f i rmly a s s o c iated wate r .

I f the dry ing period was t o o short

not all of the water was removed and if too long , the salt
d e c omp o s e d .

Dry ing the above salt for 8 , 5 hours at 1 1 0 °

under 1 mm Hg pre s sure afforded the truly dry salt whose

e lemental analys i s f e l l within experimental error of the
c alculated value s .

Further support for thi s hypo the s i s

and i t s proof i s the fac t that a s drying c ond i t i ons became

more vi gorous ( that i s , progr e s s ive ly increas ing time and

tempe rature of dry ing from short periods at room temperature

to the f inal c ond i t i ons ) the perc ent carbon de termined

s l owly increased unti l it was within experimental error of

the ory when dried under the f inal c ondi t i ons .

The attemp ted synthe s i s of alkynyl alc ohol XX IX for

the s tudy of ge ometrical i s omerism in the e s ter s ide chain
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is described below.

Each agent described above contains

the double bond or epoxide functional group in a terminal

position of the alkyl moiety where geometric isomerism
is not possible.

Therefore, it was of great interest to

determine the effect of geometrical isomers in the alkyl
group on the activity of these agents.

This would pro

vide very useful information not only about the structural

requirements for efficient inhibition of rat liver f3 -

hydroxy- � -methylglutaryl coenzyme A reductase but also

concerning the structure of the enzyme itself in the region
where these inhibitors bind.

The study of these effects

requires the synthesis of internal alkenyl hydrogen suc

cinates and hydrogen glutarates and the proposed synthetic

sequence to obtain these compounds is outlined in Scheme IV.
It should be noted that this sequence of reactions provides

a means of obtaining not only the cis and trans alkenyl
esters (X I and XII, respectively) but also the alkynyl

esters X which are structurally locked into linearity in

the region of interest.

The key intermediate in this

proposed synthetic sequence is the alkynyl alcohol XX IX,

and several methods were examined in the attempted synthesis
of this compound.

The first attempt to prepare alkynyl alcohol XX IX was

by the Grignard reaction (equation 8),

Using the method

of Sharifkanov and Skhmedova (177), 1-bromo-2-butyne (XXVIII)
was prepared (equation 7) ,

The presence of this compound

was readily demonstrated by infrared absorption at 2235 cm-1
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( eq . 7 )

XXVIII

XLIV

XXV I I I

caused by alkyne stretching vibrations.

XXIX

( eq . 8 )

The nmr spectrum

exhibited the expected quartet and triplet (methylene and

methyl protons, respectively) due to coupling across the
triple bond.

The reaction of 1-bromo-2-butyne (XXVI I I) with 4-

biphenylcarboxaldehyde (XLIV) in the normal Grignard manner

afforded in every case unchanged starting aldehyde.

The

double addition technique of Tschesche and Machleidt (165)

for highly reactive Grignard reagents and the use of con

centrated solutions did not provide any improvement.

Failure of the reaction to take place was demonstrated by

the identical infrared spectra of the recovered material
and authentic 4-biphenylcarboxaldehyde.

An alternate route to alcohol XXIX was via a zinc

complex as described i_11._, the work of Henbest et al. (178).
These workers were able to carry out Reformatsky-type

reactions with propargyl bromides ; however, it was not
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Ph@i-H + CH3 -csc -ctt 2 Br
XLIV

XXVIII

iJ
II

zn

> Ph

-C=C-CHJ
@ CH
I 2

O

XXIX

y-

H

OH

(eq. 9)

possible to successfully apply their techniques to the

present work (equation 9),

Several variations of the

reaction conditions were made and in each case an allene

was obtained rather than the desired alkynyl alcohol.

The allene was detected by absence of alkyne absorp
tion at 21 0 0-2300 cm-1 and the presence of a sharp peak at
.
cm-1 in the infrared spectrum. The nmr spectrum of
the material obtained from the initial attempt to prepare

the alkynyl alcohol by this method was inconclusive.

subsequent attempts if the infrared spectrum indicated

On

the presence of an undesired allene the nmr spectrum was
not recorded.

Modifications made in the above procedure may be

briefly described as follows:

the crude ether extract of

the ice-1 0% acetic acid slurry (see experimental section)
was washed with copious quantities of water rather than
with mild base.

This was an attempt to avoid base catalyzed

formation of the allene in the work-up procedure.

The

activity of the zinc surface was varied by altering the
etching time up to 40 minutes.

To guard against thermal

rearrangement, the reaction was conducted at room temperature
with the addition of reactants being carried out at ice
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bath temperature,

This experiment and one performed

entirely at -78 ° were fruitless.

In addition, discon

tinuation of the use of mercuric chloride as an initiator
and conducting the reaction in dilute solution afforded
products which were not well defined.

Each of these modi

fications of the reaction conditions gave a clear, yellow

liquid, the infrared spectrum of which consistently exhibited
a sharp, medium band at 1962-1965 cm-1, indicating the
presence of an allene, and a complete lack of absorption
in th� region 2100-2300 cm-1, indicating the absence of

an alkyne.

Several of the reactions attempted in the present

investigation were initially tested on a model system in

order to establish and refine the reaction conditions prior
to experiments with 4-biphenylcarboxaldehyde (XLIV) ,

The

model chosen was benzaldehyde and all structure determina
tions were made on the basis of infrared and nmr data.

In

general, elemental analyses were not determined for model
systems.

An attractive alternative to the Reformatsky-type

reaction was the work of Lauger et al. (181) who prepared
propynyl esters.

These workers recognized the problem of

allene formation and claimed that by employing an aluminum

complex rather than magnesium or zinc the alkyne could be
formed in high yields while formation of the allene was

essentially negligible.

Using benzaldehyde and 1-bromo-

2-propyne as a model system provided encouraging results;

XXV II I , R

XLIV , R = Ph

= CH 3

Al

>
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CH -C=C-R
I 2
c,-H
OH
(eq. 10)
XXIX, R = Ph, R ' = CH 3
XXX, R = H, R • = H

R

the infrared spectrum of the product exhibited both alkyne

and alcohol bands and the nmr spectrum provided structural
proof of the model alkynyl alcohol (equation 10, R = H,

R

'

= H).

Unfortunately, when the same reaction was attempt-

ed using the biphenyl and the 2-butynyl system (equation 10,
R

=

Ph, R

'

=

CH 3) only the starting aldehyde was recovered.

Failure of the aluminum method to provide the desired

alkynyl alcohol led to attempts to open an aryl substituted

epoxide as a means of synthesizing alcohol XXIX.

Extensive

use of the benzaldehyde model system was employed in this

series of reactions.

The model epoxide XXXII was prepared

ny the m��hod of Corey and Chaykovsky (183) via the ylide
derived from trimethylsulfoxonium iodide (XXXI) (182),
as shown in equations 11-13,

This elegant conversion of

an aldehyde to an epoxide had a single drawback:

the yield

of epoxide obtained in this investigation was very low.
The infrared spectrum of the epoxide showed the

expected characteristic peaks due to epoxide C-0 vibrations.

It is interesting to note that in the nmr spectrum of both
the phenyl and the biphenylyl epoxides each of the three

aliphatic protons is observed as a pair of doublets.

In

2 02

>

0

11 $
CHJ -S-CH3
I
CHJ
XXXI

-f?J

+

CH -y -CH
3
J
CHJ
0

11(f)

XXX I

NaH

>

CH3-S-CH2
1
CHJ
0

II (f)

>
XLIV
the case of the proton

f2>

(eq. 11)

(eq, 12)

8

l,
�
CH-CH2 (eq,
�

13)

XXX I I

o<.

to the aromatic rings the

multiplicity arises from spin-spin splitting by both �

protons.

The (9 protons are split into doublets by the �

proton, and the doublets from each � proton are further

split into a pair of doublets by the other (3 proton, a

case of geminal spin-spin interactions.

It was initially thought that the epoxide could be

opened in the desired direction by means of diethylpropynyl
aluminum (XLV) prepared (equation 1 4 ) by the method of
Nagata and Yoshioka ( 1 8 5 ) ,
XXX IV

This reagent wa� used in an
XLV

(eq. 1 4 )
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attempt to open the model epoxide (equation 15) by the

Surprisingly, the desired

method of Fried et al. (186),

1-phenyl-J-pentyn-1-ol (XXXV) was not obtained; the nmr
spectrum indicated that the epoxide may have opened in

the unanticipated direction to give the primary alcohol
XXXVI.

If XXXV had been obtained, the nmr spectrum would

be expected to show the methyl group as a triplet, the

methylene protons as a complex multiplet, and the methine
proton as the usual triplet.

The spectrum of the material

obtained was clearly not that of the desired alcohol XXXV
since it exhibited a doublet integrating for the same

number of protons as a sharp signal superimposed upon a

complex band.

These spectral features can be accounted for

by the primary alcohol XXXVI,

+

(eq. 15)

XXXV

XXXVI

Catalytic reduction (equation 16) of the suspected

2-phenyl-J-pentyn-1-ol (XXXVI) was shown by nmr data to

2 04

( eq . 1 6 )

>
XXXV I

XXXV I I

have produc ed the c o rre spond ing alkane 2 -phenyl - 1 -pentano l
( XXXV I I ) .

Th i s c onve rs i on was f o l l owed by the appe aranc e

o f broad c omp l e x mu l ti p l e ts at 0 . 6 -1 . 8 ppm ( -CH 2 -cH 2 -cH 3 ) ,

a sharp d oubl e t at J . 6 8 ppm ( -CH 2 - o- ) , and the s ingle

me th ine pro ton as a mul t i p l e t c entered on 2 . 74 ppm .

The

nmr s p e c trum was proof that satura ted alc ohol XXXV I I was

obtained f r om reduc t i on of XXXV I and the re f ore , XXXV I mus t

have b e e n 2 -pheny l - rathe r than the expec ted 1 -pheny l - J 

pe ntyn - 1 - o l ( XXXV ) .

The s e results are s imi lar to tho s e of

B o i r e au et al . ( 1 98 ) who s tu d i e d the reac t i on of tr ime thy l

aluminum w i th J -pheny l-1 , 2 -e poxypropane .

Pr imary a l c o h o l XXXV I I i s the s ingle case of a mod e l

sys tem whe r e e lemental analys i s data were de termined

and the s e data s h ow that the produc t from the cataly t i c

reduc t i on o f a l c oh o l XXXVI f i t t h e theore tical e lemental
c omp o s i t i on of 2 - pheny l - 1 -pentano l .

The nmr data f or

a l c oh o l XXXVI, the s p e c tral s truc ture proof of alcohol

XXXVII and the analytical data for th i s c omp ound c onc lu
s ive l y s h ow that the propynyl alane re agent caused the

e poxi d e to open in the S N 1 d i re c t i on rather than in the
anti c ipated S N 2 d ire c t i on .

It i s tempting to speculate on the mechanistic

implications of these results.
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Apparently, the aluminum

atom of the alane reagent is a strong enough Lewis acid to
preferentially associate with the oxygen atom _ of the

epoxide.

This would weaken the two carbon-oxygen bonds

and cause some electron deficiency in the epoxide ring
(XLVI ) .

Since the

o<

carbon atom is capable of forming

a relatively stable carbonium ion by virtue of resonance

delocalization of the charge into the benzene ring it is
reasonable to suggest that structure XLVIa provides a

great contribution to the true electronic structure of the
suggested alane-epoxide complex.

If this is indeed the

case, then it is plausible that the alane reagent, by
virtue of its association with the oxygen atom of the

epoxide, delivers the propynyl group exclusively to the �

rather than to the � carbon atom of the epoxide (equation
17),

This agrees with the mechanistic proposal of Lundeen

and Oehlschlager (199) who have studied the reaction of
triethylaluminum with 1, 2-epoxypropane.

These investigators

have observed evidence that a second alane molecule par
ticipates in opening the epoxide.

CHJ-C=C- �l- (C2H 5 ) 2
I
I
I

@c�t2
XLVI

r

CH -c�c- 1 1- (C2H 5) 2
3
I
I
I
I

XLVIa
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�rolysis

@t:��:��

(eq. 17)

XXXVI

In light of these interesting but unproductive results

w ith the alane reagent, attempts were made to open the

model system (equation 1 8, R = H) with propynyllithium.

For the model epoxide this reaction gave moderately low

yields (40-50%) of the desired alkynyl alcohol XXXV and
exhibited a poor material balance.

Infrared and nmr

spectra of XXXV provided clear proof that the anticipated
product had been obtained ,

When the same reaction was

attempted with the biphenylyl epoxide XXX I I I (equation 18,

R = Ph) yields and material balance became even worse than
for the model system.

XXX I I, R = H
XXX I II, R = Ph

(eq. 18)

XXXV , R = H
XXIX, R = Ph
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Since the solvent used for this reaction was dimethyl

sulf oxide it was considered possible that the desired

product was not sufficiently soluble in the extraction

solvent (ether) to be efficiently removed from the reaction
mixture during the work-up procedure .

Testing this pos

sibility, it was f ound that the desired alkynyl alcohol

was indeed sufficiently soluble in ether to have been re
moved from the reaction mixture .

In addition, using known

alkynyl alcohol, the work-up procedure was scaled down by
a factor of fifty and the entire work-up was carried out.
In this experiment 8. 0 mg of a 9,4 mg sample of alkynyl

alcohol XXIX survived the procedure .

This indicated that

the low yeild and material balance of this reaction was

not caused by a preferential solubility of the product in
the dimethylsulfoxide-water phase.

A possible but untested explanation for the low yields

and poor material balance of alcohols XXXV and XXIX is

that propynyllithium may have participated in an exchange

reaction with the solvent, generating the dimsyl carbanion
(XLV I I, equation 19),

The presence of this carbanion in

XLVII

Li 9 + HC=C-CHJ

(eq. 1 9)

the reaction mixture would provide a nucleophile capable of
opening the epoxide (equation 20) to give a polar product

>

@
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1CH2 -CH 2 -S-CH
J
II
0
C-H
OH
(eq, 2 0 )

which could have been trapped in the dimethylsulfoxide
water phase.

However, as noted above, this possibility is

entirely speculative and untested,

Because preparation of biphenylyl epoxide XXX I I I was

a very low yield reaction, it was decided to employ an

alternate route to epoxide preparation. . The route chosen

is shown in equations 21-24 and utilized the Wittig reaction
( 1 8 9 , 1 90 ) ,

@
��-:>
;;:i,,. (Ph) -P-CHJ
3
XXXV I I I

(Ph)J-P-CHJ
(t)

XXXV I I I

e e

(Ph) -P-CH2
J

+

Ph--@- CH=CH2
XXX IX

NaH

e

Br

DMSO

pir@- g-H

(eq. 21)

Br

e

@
(Ph)3-P-CH2

>

Ph--@-CH=CH
2
XXX IX

+

�Cl

>

(eq. 22)

(eq, 2J)

Ph---@-c&�btt2

(eq. 24)

XXX I I I
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Both formation of (4-biphenylyl)ethene (XXX IX),

(equation 23) and its subsequent epoxidation product XXX III

(equation 24) took place smoothly and provided the desired
products in acceptable yields (45 and 50%, respectively) .

Alkene XXXIX exhibits an nmr spectrum which is similar to

and lends itself to the same analysis as the spectrum of

epoxides XXXII and XXXI I I discussed above.

Unfortunately,

opening of this epoxide by the method of Fries (1 88) as

illustrated in equation 1 8 failed to provide the necessary
key intermediate alkynyl alcohol XXIX in sufficient

quantities to continue the study of geometrical isomers

derived from this compound.

Therefore, attempts to com

plete this study were postponed.

The homologous butynyl system XL also lends itself

to study of geometrical isomers derived from it.

Using

a slight modification of the work of Smith and Kuehn (1 92)
1 -(4-biphenylyl)-2-butyn-1 -ol (XL) was prepared (equation

25) by addition of propynyllithium to the carbonyl group
of 4-biphenylcarboxaldehyde.

The conditions of this

reaction are very delicate and time is a critical factor .

The expected doublet and quartet of the methyl and methine
protons respectively were clearly observed in the nmr

spectrum of XL .

It is important to note that since

propynyllithium will add to the carbonyl group of 4-bi

phenylcarboxaldehyde, perhaps minor modifications of the

reaction conditions will provide a means of opening the
previously discussed epoxides in the desired manner.

THF

Th

-@
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C=C-CH
3
/
�H
OH

XL

( eq .

25)

Finally, esterification of alkynol XL with succinic

anhydride has been accomplished by the method of Steglich

and Hoffle (175) to give the corresponding monoester XLI

in 31% yield.

This ester shows the expected spectral

characteristics similar to the previously described esters
and to the parent alcohol XL.

This compound provides the

entrance to a geometrical isomer study similar to that
depicted in Scheme IV.
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BIOLOG ICAL RESULTS

Hepatic microsomes were obtained from male Sprague

Dawley rats by the method described in the experimental
section.

In order to maximize HMG CoA reductase content

in these preparations, the livers were harvested between

12: 05 and 12: 25 AM during the peak of the diurnal rhythm.
In spite of this precaution, the enzyme activity of dif 

ferent preparations was found to vary.

Shefer et al.

(197) have observed that the specific activity of HMG CoA
reductase is highest in young animals and decreases with
increasing age;

than in males.

this decrease is more pronounced in females

The use of young male rats with a mass

of approximately 100 g as the source of microsomes pro

vided preparations with fairly consistent activity of the

enzyme among different preparations.

An additional method was employed to ensure that the

inhibitory activity of all compounds could be compared even
though they were tested with several different microsomal

preparations .

A previously prepared compound with known

inhibitory properties, 1 -(4-biphenylyl)-rr-pentyl hydrogen
succinate, (III, m = 2) was tested concurrently with all

other inhibitors.

This allowed comparison of all inhibitors

to the standard III (m = 2) and therefore also allowed
valid comparisons to be made among all the inhibitors.

The unit used to express inhibitory activity is the

ratio of inhibitor concentration to substrate concentration

21 2

which r e s ults in 50% inhibi t i on of the c onver s i on of HMG C oA
to mevalonic ac id .

Thi s uni t is expre s s ed as ( I/S ) 0 . 5

and i s de termined by varying the inhibitor c onc entration in
the t e s t sys tem .

In s ome c a s e s the s o lubi lity of the in

hibitor l imits the degr e e of inhibit i on and a reduc t i on of
50% c anno t be obtained .

When this 0 c curs , the degree of

inhibi t i on at the s tated inhibi tor c onc entration is spe c if ied .
Table I l i s ts the inhibitory ac tivity of the J -me thyl

J -me thoxy subs trate analog V as well as the J -me thyl- 3 -

hydroxy derivative IV for c ompar i s on .

The fac t that the

J -me thoxy c ompound V i s e l evenfold le s s ac tive than the

c orre s p onding ) -hydroxy analog IV may be interpre ted in two

ways .

The J -me thyl -J -hydroxy analog IV may bind to the

enzyme in such a manner that the )-hydroxy group is l o c ated
in a p o c k e t or other c onf ining s truc ture formed by the

enzyme surfac e .

I f thi s area is small enough to acc omodate

only the hydroxyl group then e ther V may be too large to

b ind in a manner analogous to the normal bind ing of the
) -hydroxy l group .

If true , thi s c ould s l ightly alter the

b ind ing p o s i t i on of other parts of the inhibitor and the
observed l o s s of activity for V would be caused by the

0 -me thyl group blocking the proper approach of the inhibitor

to the bind ing sub s i t e s .

A more reas onable explana tion of the l o s s of ac tivity

s e en w i th v i s based on a d ir e c t b ind ing func tion of the
) �hydroxy group .

As previ ous ly d i scussed , thi s group c ould

parti c ipate in bind ing by a c t ing as a hydrog en donor

Table I:

Inhibition of Rat Liver Microsomal HMG CoA
Reductase by

Compound
Number
IV

V
VI

VII

R

H
1 3
-0-C-CH 2-C-CH2-c o 2H
II
I
0
OH

� HJ
-O- ?i - CH 2- -cH 2-c o 2H
0
0-CHJ

1

- �- �-CH2-CH 2-c o 2H
H 0

-N-C-CH2-CH 2-CH 2-CO -? H
I II
H 0

(I/S)
0. 5
1

11

30
(18% inhibition)
20

11

III
(m = 2)
(Reference
Standard)

2 13

11
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(through the hydroxyl hydrogen) or as a hydrogen acceptor

(through the hydroxyl oxygen) in hydrogen bonding with the

enzyme.

Replacement of the hydroxyl hydrogen of IV with

the methyl group of V destroys only the ability of the in

hibitor to act as hydrogen donor, not i·ts ability to act
as acceptor.

Therefore, it can be concluded that the loss

of activity exhibited by V with respect to IV is caused by
its inability to participate in hydrogen bonding with the

enzyme.

The demonstration of hydrogen bonding in these

compounds also clearly shows that a hydrogen bond acceptor
is located on the enzyme surface at the binding site.

This

is a valuable binding aid and its presence may be exploited
by future inhibitors to enhance reversible binding.

The inhibition of HMG CoA reductase caused by the

amides V I and V I I is shown in Table i .

As can be seen, the

succinamide exhibited poor activity while the correspond
ing glutaramide was approximately one-half as active as

the reference ester III (m = 2).

Previous discussion

showed that the ester functional group is not necessary
for binding.

However, it should be noted that the com

pounds examined to prove this contained either no sub

stituent capable of hydrogen bonding in the ester region
(carbon analog) or groups capable only of acting as
hydrogen acceptor (ether and ester analogs).

Therefore,

these experiments not only showed that the ester group is

not required for binding, but also that the surface of the
enzyme probably does not contain a hydrogen donor for
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hydrogen bonding in proximity to the ester function when it

is bound.

It is possible that a hydrogen acceptor for

hydrogen bonding is located on the enzyme close to the ester
group of the inhibitors.

If this were true, it would not

participate in the binding of inhibitors which contained

no hydrogen donor, such as the esters, ether and carbon

analogs.

Amides VI and VII represent replacement of the

ester function with a group which is similar to the ester
group in steric and electronic properties and which also

has the ability to act as a hydrogen donor for hydrogen
bonding .

If an acceptor is located on the enzyme in this

region it would be expected that these amides would be
bound more firmly than the corresponding esters.
I shows, this is not the case.

As Table

Glutaramide VII exhibited

loss of activity and succinamide VI was almost completely

inactive.

It is clear that no hydrogen acceptor for

hydrogen bonding exists in this region of the enzyme and
that, in the case of the succinamide, binding of the in
hibitor actually appears to be blocked rather than un
changed or favored.

The total absence of enhanced binding by the carbon,

ether, or amide analogs with respect to the ester III

(m = 2) provides information about the enzyme surface in
this area.

Because of the lack of effect from these

functional groups it is tempting to suggest that the enzyme

surface contains no functional groups which aid in binding
in this region.
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Table I I shows the (I/s)0. 5 values for alkenyl esters
VIIIa-f and epoxyalkyl esters IXa-f, For comparison
purposes the reference standard compound III (m = 2) is

These data provide valuable

also included in the table.

information concerning the nature of inhibitor binding as
well as considerations for future inhibitors.

As a group,

alkenyl esters VIIIa-f exhibited inhibition equal to

reference standard III (m = 2).

This could be an indication

that the hydrophobic area in which the rr-butyl group of
III (m = 2) binds (158) is capable of accomodating the

flat alkene moiety as effectively as the methylene units
of the reference compound.

Binding was not enhanced by

the alkene function as shown by the essentially unchanged

activity.

Since the �lkene group of esters VIIIa-f is

terminal, it might 9e _ postulated that the unchanged

activity could be caused by the unsaturation not partici
pating in binding in any way.

This could take place if

the alkene moiety pro jects away from the enzyme surface

when the inhibitor is bound.

If this were true, it would

be anticipated that the inhibition would decrease because

of loss of hydrophobic binding units as compared to the
rr-butyl group of III (m = 2).

Therefore, it is more

reasonable to suggest that unsaturation in this region

contributes to binding as effectively as a fully saturated
alkyl group.

Proposed compounds X-XII would have aided the

stereochemical examination of this portion of the enzyme;
however, satisfactory methods of synthesis for these
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Table II:

Inhibition of Rat Live� HMG CoA Reductase by

@@-

R

-H
10-C-(CH
11

Compound
Number

R

-CH 2 -CH=CH 2

VIIIa

-CO 2H
2 )m

(I/S)0, 5
m = 2

10

Compound
Number
VIIIb

(I/S)0,5

m = 3

9

13
(26% in
hibition)

IXa

20

IXb

VIIIc

11

VIIId

IXc

13

IXd

13

-CH2-CH2-CH 2-CH=CH 2

VIIIe

11

VIIIf

8

o

IXe

13

IXf

10

-CH2 -CH2 -CH2-CH3

III

11

III

11

l

\

-CH2-CH2-CH2-CH-C H2

11
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co�pounds could not be developed during this invest igation.
The inhibition of rat liver HMG CoA reductase by
epoxyalkyl esters IXa-f is also shown in Table I I.

As

with the corresponding alkenyl esters V I I Ia-f, these com

pounds exhibited no general trend of either enhancing or
decreasing reversible binding to the enzyme.

Only in the

case of the epoxybutyl system IXa and b was inhibition
lowered with respect to alkenes VIIIa-f and reference
inhibitor I I I (m = 2).

This slight loss of activity

appears to be unexplainable since examinat ion of molecular
models shows that the epoxide group of IX a is able to

adopt conformations similar to those of the remaining
epoxyalkyl esters.

However, a possible explanation for

the low activity of epoxy esters IXa and IXb is available.

These esters are the only members of the entire epoxy ester

series which are capable of forming a fairly stable ring
conformation (Figure 15),

In this instance the dipole

interaction between the oxygen electron pair of the epoxide

and the electron deficient carbonyl carbon atom of the ester
provide a stabilizing influence for this conformation.

It

is possible that this ring stability retards esters IXa and

IXb from forming the enzyme-binding open chain conformat ion�
It should be noted that ester IXb showed 26% inhibition at
its maximum solubility in the test system and therefore

an ( I/S)O,S value could not be obtained.

The most important aspect of these results is that the

incorporat ion of the epoxide functional group into the side
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Figure 15:

A possible stable conformation of esters IXa
and IXb contributing to the loss of inhibitory
activity.

chain definitely did not destabilize reversible binding.

This is clearly demonstrated by the fact that these com

pounds are as active as the reference standard III (m = 2).

It must be emphasized that the epoxide group is more polar

than the n-butyl chain of I I I (m = 2) and the alkenyl
chain of VIIIa-f.

In addition, Boots et al. (158) have

clearly demonstrated that the region in which these groups

bind to the enzyme is a nonpolar area and that this binding

is probably hydrophobic in nature.

This strongly suggests

that the epoxide oxygen of IXa-f is oriented away from the
enzyme surface during binding.

This conformation allows

the most polar portion of the epoxide ring, the oxygen

atom, to be pro jecting into the polar aqueous medium sur

rounding the enzyme while the least polar portion of the

ring is free to contribute to binding on the nonpolar
enzyme surface.

The present work includes only the study of the

reversible binding characteristics of these compounds and

provides the preliminary evidence required before irrever
sible binding studies may be initiated.

The next phase
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of this investigation will consist of prolonged preincubation of the enzyme and inhibitor followed by the addition of substrate.

These experiments will provide a

means of evaluating the possible irreversible inhibition
of HMG CoA reductase by potential alkylators IXa-f.
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ABSTRACT OF

SYNTHESIS AND EVALUATION OF SOME ARYLALKENYL AND ARYLEPOXY

ALKYL HYDROGEN SUCC INATES AND HYDROGEN GLUTARATES AS INHIBI
TORS OF RAT LIVER (3 -HYDROXY- � -METHYLGLUTARYL COENZYME A
REDUCTASE
BY

Paul Emil Marecki, Department of Pharmaceutical Chemistry,

Medical College of Virginia, Health Sciences Division,
Virginia Commonwealth University, May 1974,

Atherosclerotic disease is an almost universal

phenomenon and increases in severity and frequency with
increasing age.

Atherosclerosis may contribute to several

disorders including bursting of an artery, blockage of an

artery, or induction of arterial clotting.

The culmination

of these diseases is usually premature since at the time of
death the unaffected organs are in reasonably satisfactory

condition and could have operated for several more years.

Among the many factors which act in concert to produce the
disease, serum cholesterol levels play a central role.

It

has been suggested that the lowering of cholesterol levels

w i l l provide an effective means of treatment and pro

phylaxis of atherosclerosis.

The purpose of this investigation was to rationally

design, synthesize, and evaluate agents to lower serum
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cholesterol levels by the inhibition of cholesterol bio-

synthesii at the site of the reduction of � -hydroxy-p -

methylglutaryl coenzyme A (HMG CoA) to mevalonic acid.

This reaction, mediated by HMG CoA reductase, was chosen

as the inhibition target because it is the first irrever

sible reaction, the rate limiting step for the pathway,

and the site of physiological regulation of cholesterol
biosynthesis.

Rat liver HMG CoA reductase provided a con

venient test system for these agents.

Using the previously reported compound, 1-(4-biphenylyl)

n-pentyl hydrogen succinate as parent inhibitor, the present
study accomplished two goals :

first, a contribution toward

elucidation of reversible binding sites for these inhibi-

tors and second, probing of the suggested nonpolar n-pentyl
binding area of the enzyme by introduction of a functional

group capable of alkylating the enzyme and providing ir

reversible inhibition.

The first ob jective was approached

by replacing the ester of the parent inhibitor with an

amide functional group.

The resulting glutaramide exhibited

inhibition comparable to that of the parent inhibitor.

This

may be taken as evidence that isosteric replacement of the

parent ester group with the amide N-H did not seriously

alter the ability of the inhibitor to bind to the enzyme

and that an additional binding site in this region is not
available.

The data also support the suggestion that the

ester group of the parent agent is not necessary for binding.

3
A similar i�hibition study was made possible by syn

thesis of 1-(4-biphenylyl)-rr-pentyl hydrogen 3 -methyl-3methoxyglutarate.

With respect to the corresponding 3-

methyl-3-hydroxyglutarate this compound showed an eleven

fold decrease of activity.

This considerable activity

loss indicates that the 3-methoxy group interferes with
reversi ble bind ing of inhibitor to the enzyme.

The

inh i bition data ind icate that the 3-hydroxy group of the

3-methyl-3-hydroxy compound contributes to reversible bind 
ing by participating as a hydrogen donor in hydrogen bond

ing with the enzyme.

The major portion of this investigation was designed

to probe a region of the enzyme which is nonpolar and binds

the rr-alkyl moiety of the parent inhibitor.

The purpose

was to determine the feasibility of incorporating a

functional group into this region of the inhibitor which

could act as an acceptor for an enzymic nucleophile located
in proximity to the reversible b inding area.

If successful,

this could provide irreversible inhibition of the enzyme.

A series of compounds was synthesized which bore a terminal

alkenyl group two to four carbon atoms removed from the

ester moiety.

Test ing showed that, with respect to the

parent inhib itor, no appreciable loss of b ind ing took place.
Similarly, a series of epoxyalkyl esters was prepared, the

epoxide group being the portion of the inhibitor susceptible
to nucleophilic attack,

Reversible bind ing of these com

pounds was found to be equal to that of the parent inhibitor
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and it was therefore concluded that the enzyme does

accomodate this alkylating group with no loss of reversible
binding.

This provided the necessary preliminary work

upon which subsequent irreversible binding studies will be

based.

